<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>300</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="300"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=300&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=200&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=400&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353347"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353347?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353347&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353347&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005367"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353347</prism:url><dc:identifier>SCOPUS_ID:84929353347</dc:identifier><eid>2-s2.0-84929353347</eid><dc:title>Interval exercise training increases maximal and submaximal exercise performance in heart failure with biventricular assist device therapy</dc:title><dc:creator>Christle J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>104-105</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.296</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015035</affiliation-url><afid>60015035</afid><affilname>Klinikum rechts der Isar</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000291</affiliation-url><afid>60000291</afid><affilname>Klinikum der Universitat Munchen</affilname><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113642928</affiliation-url><afid>113642928</afid><affilname>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance</affilname><name-variant>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37088090500</author-url><authid>37088090500</authid><authname>Christle J.</authname><surname>Christle</surname><given-name>J. W.</given-name><initials>J.W.</initials><afid>60015035</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8866524600</author-url><authid>8866524600</authid><authname>Boscheri A.</authname><surname>Boscheri</surname><given-name>A.</given-name><initials>A.</initials><afid>60015035</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24071737400</author-url><authid>24071737400</authid><authname>Pressler A.</authname><surname>Pressler</surname><given-name>A.</given-name><initials>A.</initials><afid>60015035</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6508081245</author-url><authid>6508081245</authid><authname>Grinninger C.</authname><surname>Grinninger</surname><given-name>C.</given-name><initials>C.</initials><afid>60000291</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56519518800</author-url><authid>56519518800</authid><authname>Schramm R.</authname><surname>Schramm</surname><given-name>R.</given-name><initials>R.</initials><afid>60000291</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004007939</author-url><authid>7004007939</authid><authname>Hagl C.</authname><surname>Hagl</surname><given-name>C. M.</given-name><initials>C.M.</initials><afid>60000291</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56579896500</author-url><authid>56579896500</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60015035</afid><afid>113642928</afid><afid>60019722</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56579896500</author-url><authid>56579896500</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60015035</afid><afid>113642928</afid><afid>60019722</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56579896500</author-url><authid>56579896500</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60015035</afid><afid>113642928</afid><afid>60019722</afid></author><intid>35945860</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929307496"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929307496?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929307496&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929307496&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006737"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929307496</prism:url><dc:identifier>SCOPUS_ID:84929307496</dc:identifier><eid>2-s2.0-84929307496</eid><dc:title>Answer. Reverse remodeling in systolic heart failure. The ST2-R2 score: A puzzle yet to be solved?</dc:title><dc:creator>Lupón J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>556</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.410</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028462</affiliation-url><afid>60028462</afid><affilname>Hospital Universitari Germans Trias i Pujol</affilname><name-variant>Hospital Germans Trias i Pujol</name-variant><affiliation-city>Badalona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018312</affiliation-url><afid>60018312</afid><affilname>Universidad Autonoma de Barcelona, Facultad de Medicina</affilname><name-variant>Universitat Autònoma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603285283</author-url><authid>6603285283</authid><authname>Lupón J.</authname><surname>Lupón</surname><given-name>Josep</given-name><initials>J.</initials><afid>60028462</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004094140</author-url><authid>7004094140</authid><authname>Bayes-Genis A.</authname><surname>Bayes-Genis</surname><given-name>Antoni</given-name><initials>A.</initials><afid>60028462</afid><afid>60018312</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004094140</author-url><authid>7004094140</authid><authname>Bayes-Genis A.</authname><surname>Bayes-Genis</surname><given-name>Antoni</given-name><initials>A.</initials><afid>60028462</afid><afid>60018312</afid></author><intid>535947292</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929332775"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929332775?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929332775&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929332775&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005537"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929332775</prism:url><dc:identifier>SCOPUS_ID:84929332775</dc:identifier><eid>2-s2.0-84929332775</eid><dc:title>Long-term effect of If-channel inhibition on diastolic function and exercise capacity in heart failure patients with preserved ejection fraction</dc:title><dc:creator>Simantirakis E.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>9-11</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.313</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011303</affiliation-url><afid>60011303</afid><affilname>Heraklion University Hospital</affilname><name-variant>University Hospital of Heraklion</name-variant><affiliation-city>Heraklion</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603927258</author-url><authid>6603927258</authid><authname>Simantirakis E.</authname><surname>Simantirakis</surname><given-name>E. N.</given-name><initials>E.N.</initials><afid>60011303</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56503737300</author-url><authid>56503737300</authid><authname>Nakou E.</authname><surname>Nakou</surname><given-name>E. S.</given-name><initials>E.S.</initials><afid>60011303</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7801399241</author-url><authid>7801399241</authid><authname>Kallergis E.</authname><surname>Kallergis</surname><given-name>E. M.</given-name><initials>E.M.</initials><afid>60011303</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26632831500</author-url><authid>26632831500</authid><authname>Arkolaki E.</authname><surname>Arkolaki</surname><given-name>E. G.</given-name><initials>E.G.</initials><afid>60011303</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55406501300</author-url><authid>55406501300</authid><authname>Patrianakos A.</authname><surname>Patrianakos</surname><given-name>A. P.</given-name><initials>A.P.</initials><afid>60011303</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644380200</author-url><authid>56644380200</authid><authname>Papakonstantinou P.</authname><surname>Papakonstantinou</surname><given-name>P. E.</given-name><initials>P.E.</initials><afid>60011303</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35413770700</author-url><authid>35413770700</authid><authname>Chlouverakis G.</authname><surname>Chlouverakis</surname><given-name>G. I.</given-name><initials>G.I.</initials><afid>60011303</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35391927700</author-url><authid>35391927700</authid><authname>Vardas P.</authname><surname>Vardas</surname><given-name>P. E.</given-name><initials>P.E.</initials><afid>60011303</afid></author><authkeywords>Cardiopulmonary stress test | Exercise capacity | Heart failure with preserved ejection fraction | Ivabradine</authkeywords><intid>1785944783</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929317990"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929317990?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929317990&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929317990&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005276"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929317990</prism:url><dc:identifier>SCOPUS_ID:84929317990</dc:identifier><eid>2-s2.0-84929317990</eid><dc:title>Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure</dc:title><dc:creator>Ma X.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>387-388</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.287</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011715</affiliation-url><afid>60011715</afid><affilname>Tianjin Medical University</affilname><name-variant>Tianjin Medical University General Hospital</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54929978900</author-url><authid>54929978900</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xianghong</given-name><initials>X.</initials><afid>60011715</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643670900</author-url><authid>56643670900</authid><authname>Sun F.</authname><surname>Sun</surname><given-name>Fei</given-name><initials>F.</initials><afid>60011715</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640123200</author-url><authid>56640123200</authid><authname>Ma J.</authname><surname>Ma</surname><given-name>Junwei</given-name><initials>J.</initials><afid>60011715</afid></author><authkeywords>Congestive | Heart failure | Nesiritide</authkeywords><intid>1035941513</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359001"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359001?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359001&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359001&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007500"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359001</prism:url><dc:identifier>SCOPUS_ID:84929359001</dc:identifier><eid>2-s2.0-84929359001</eid><dc:title>Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis</dc:title><dc:creator>Bavishi C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>99-101</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.031</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242250</affiliation-url><afid>115242250</afid><affilname>Mount Sinai St. Luke's and Roosevelt Hospitals</affilname><name-variant>Mount Sinai St. Luke's and Roosevelt Hospitals</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60077414</affiliation-url><afid>60077414</afid><affilname>University of Toledo Medical Center</affilname><name-variant>University of Toledo Medical Center</name-variant><affiliation-city>Toledo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027086</affiliation-url><afid>60027086</afid><affilname>University of Alabama at Birmingham</affilname><name-variant>University of Alabama at Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54779339200</author-url><authid>54779339200</authid><authname>Bavishi C.</authname><surname>Bavishi</surname><given-name>Chirag</given-name><initials>C.</initials><afid>115242250</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56573127100</author-url><authid>56573127100</authid><authname>Khan A.</authname><surname>Khan</surname><given-name>Abdur Rahman</given-name><initials>A.R.</initials><afid>60077414</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56638793700</author-url><authid>56638793700</authid><authname>Ather S.</authname><surname>Ather</surname><given-name>Sameer</given-name><initials>S.</initials><afid>60027086</afid></author><authkeywords>Atrial fibrillation | Digoxin | Heart failure</authkeywords><intid>1785946968</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302433"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302433?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302433&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302433&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007688"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302433</prism:url><dc:identifier>SCOPUS_ID:84929302433</dc:identifier><eid>2-s2.0-84929302433</eid><dc:title>A potential linkage between mitochondrial function of the heart and leg muscles in patients with heart failure</dc:title><dc:creator>Kato T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>67-69</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.049</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014044</affiliation-url><afid>60014044</afid><affilname>Kitano Hospital</affilname><name-variant>Kitano Hosp.</name-variant><affiliation-city>Kita-ku</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640228400</author-url><authid>56640228400</authid><authname>Kato T.</authname><surname>Kato</surname><given-name>Takao</given-name><initials>T.</initials><afid>60014044</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12776934800</author-url><authid>12776934800</authid><authname>Nakane E.</authname><surname>Nakane</surname><given-name>Eisaku</given-name><initials>E.</initials><afid>60014044</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55357612500</author-url><authid>55357612500</authid><authname>Funasako M.</authname><surname>Funasako</surname><given-name>Moritoshi</given-name><initials>M.</initials><afid>60014044</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56465372300</author-url><authid>56465372300</authid><authname>Miyamoto S.</authname><surname>Miyamoto</surname><given-name>Shoichi</given-name><initials>S.</initials><afid>60014044</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:37093206000</author-url><authid>37093206000</authid><authname>Izumi T.</authname><surname>Izumi</surname><given-name>Toshiaki</given-name><initials>T.</initials><afid>60014044</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56576095900</author-url><authid>56576095900</authid><authname>Haruna T.</authname><surname>Haruna</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>60014044</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005703872</author-url><authid>7005703872</authid><authname>Nohara R.</authname><surname>Nohara</surname><given-name>Ryuji</given-name><initials>R.</initials><afid>60014044</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003663212</author-url><authid>7003663212</authid><authname>Inoko M.</authname><surname>Inoko</surname><given-name>Moriaki</given-name><initials>M.</initials><afid>60014044</afid></author><authkeywords>Heart failure | Mitochondrial function | Peripheral muscle | Tc-MIBI</authkeywords><intid>1785944786</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330725"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330725?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330725&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330725&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007573"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330725</prism:url><dc:identifier>SCOPUS_ID:84929330725</dc:identifier><eid>2-s2.0-84929330725</eid><dc:title>Reverse epidemiology in patients with heart failure: The role of circulatory power and cardiac reserve</dc:title><dc:creator>Lin G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>54-55</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.038</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109499771</affiliation-url><afid>109499771</afid><affilname>Armed-Forces Hualien General Hospital</affilname><name-variant>Hualien Armed Forces General Hospital</name-variant><affiliation-city/><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016433</affiliation-url><afid>60016433</afid><affilname>Tzu Chi University</affilname><name-variant>Tzu-Chi University</name-variant><affiliation-city>Hualien</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004965</affiliation-url><afid>60004965</afid><affilname>National Defense Medical Center Taiwan</affilname><name-variant>National Defense Medical Center</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235732</affiliation-url><afid>115235732</afid><affilname>Mennorite Christian Hospital</affilname><name-variant>Mennorite Christian Hospital</name-variant><affiliation-city>Hualien</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011828</affiliation-url><afid>60011828</afid><affilname>Triservice General Hospital Taiwan</affilname><name-variant>Tri-Service General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013314</affiliation-url><afid>60013314</afid><affilname>Veterans General Hospital-Taipei</affilname><name-variant>Taipei Veterans General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16040006600</author-url><authid>16040006600</authid><authname>Lin G.</authname><surname>Lin</surname><given-name>Gen Min</given-name><initials>G.M.</initials><afid>109499771</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37098885800</author-url><authid>37098885800</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yi Hwei</given-name><initials>Y.H.</initials><afid>60016433</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640225400</author-url><authid>56640225400</authid><authname>Liu P.</authname><surname>Liu</surname><given-name>Pang Yen</given-name><initials>P.Y.</initials><afid>60004965</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640032900</author-url><authid>56640032900</authid><authname>Wu C.</authname><surname>Wu</surname><given-name>Ching Fen</given-name><initials>C.F.</initials><afid>115235732</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640136600</author-url><authid>56640136600</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wen Been</given-name><initials>W.B.</initials><afid>60011828</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8338374400</author-url><authid>8338374400</authid><authname>Han C.</authname><surname>Han</surname><given-name>Chih Lu</given-name><initials>C.L.</initials><afid>60013314</afid></author><authkeywords>Cardiac reserve | Circulatory power | Heart failure | Reverse epidemiology</authkeywords><intid>2035939409</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353343"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353343?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353343&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353343&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008931"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353343</prism:url><dc:identifier>SCOPUS_ID:84929353343</dc:identifier><eid>2-s2.0-84929353343</eid><dc:title>Withdrawal of heart failure medications in peripartum cardiomyopathy after myocardial recovery</dc:title><dc:creator>Tahir U.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>212-213</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.169</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019674</affiliation-url><afid>60019674</afid><affilname>Boston University</affilname><name-variant>Boston University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019674</affiliation-url><afid>60019674</afid><affilname>Boston University</affilname><name-variant>Boston University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019674</affiliation-url><afid>60019674</afid><affilname>Boston University</affilname><name-variant>Boston University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35200005900</author-url><authid>35200005900</authid><authname>Tahir U.</authname><surname>Tahir</surname><given-name>Usman</given-name><initials>U.</initials><afid>60019674</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602177226</author-url><authid>6602177226</authid><authname>Sam F.</authname><surname>Sam</surname><given-name>Flora</given-name><initials>F.</initials><afid>60019674</afid><afid>60019674</afid><afid>60019674</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602177226</author-url><authid>6602177226</authid><authname>Sam F.</authname><surname>Sam</surname><given-name>Flora</given-name><initials>F.</initials><afid>60019674</afid><afid>60019674</afid><afid>60019674</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602177226</author-url><authid>6602177226</authid><authname>Sam F.</authname><surname>Sam</surname><given-name>Flora</given-name><initials>F.</initials><afid>60019674</afid><afid>60019674</afid><afid>60019674</afid></author><authkeywords>Heart failure medications | Left ventricular function recovery | Peripartum cardiomyopathy</authkeywords><intid>2035938397</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929307250"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929307250?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929307250&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929307250&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008864"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929307250</prism:url><dc:identifier>SCOPUS_ID:84929307250</dc:identifier><eid>2-s2.0-84929307250</eid><dc:title>The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction</dc:title><dc:creator>Yamamoto E.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>335-337</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.162</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021120</affiliation-url><afid>60021120</afid><affilname>Kumamoto University</affilname><name-variant>Kumamoto University</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021120</affiliation-url><afid>60021120</afid><affilname>Kumamoto University</affilname><name-variant>Kumamoto University</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100503921</affiliation-url><afid>100503921</afid><affilname>Jinnouchi Hospital</affilname><name-variant>Jinnouchi Hospital</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8528284300</author-url><authid>8528284300</authid><authname>Yamamoto E.</authname><surname>Yamamoto</surname><given-name>Eiichiro</given-name><initials>E.</initials><afid>60021120</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56089350200</author-url><authid>56089350200</authid><authname>Hirata Y.</authname><surname>Hirata</surname><given-name>Yoshihiro</given-name><initials>Y.</initials><afid>60021120</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56012276800</author-url><authid>56012276800</authid><authname>Tokitsu T.</authname><surname>Tokitsu</surname><given-name>Takanori</given-name><initials>T.</initials><afid>60021120</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56012621100</author-url><authid>56012621100</authid><authname>Kusaka H.</authname><surname>Kusaka</surname><given-name>Hiroaki</given-name><initials>H.</initials><afid>60021120</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56405911900</author-url><authid>56405911900</authid><authname>Sakamoto K.</authname><surname>Sakamoto</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006219663</author-url><authid>7006219663</authid><authname>Yamamuro M.</authname><surname>Yamamuro</surname><given-name>Megumi</given-name><initials>M.</initials><afid>60021120</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603691533</author-url><authid>6603691533</authid><authname>Kaikita K.</authname><surname>Kaikita</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56453724700</author-url><authid>56453724700</authid><authname>Watanabe H.</authname><surname>Watanabe</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60021120</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603712750</author-url><authid>6603712750</authid><authname>Hokimoto S.</authname><surname>Hokimoto</surname><given-name>Seiji</given-name><initials>S.</initials><afid>60021120</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56471244600</author-url><authid>56471244600</authid><authname>Sugiyama S.</authname><surname>Sugiyama</surname><given-name>Seigo</given-name><initials>S.</initials><afid>60021120</afid><afid>100503921</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56471244600</author-url><authid>56471244600</authid><authname>Sugiyama S.</authname><surname>Sugiyama</surname><given-name>Seigo</given-name><initials>S.</initials><afid>60021120</afid><afid>100503921</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56643775100</author-url><authid>56643775100</authid><authname>Maruyama T.</authname><surname>Maruyama</surname><given-name>Toru</given-name><initials>T.</initials><afid>60021120</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56559155300</author-url><authid>56559155300</authid><authname>Ogawa H.</authname><surname>Ogawa</surname><given-name>Hisao</given-name><initials>H.</initials><afid>60021120</afid></author><authkeywords>eNOS uncoupling | Heart failure with preserved left ventricular function | Vascular endothelial dysfunction</authkeywords><intid>35945797</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929312876"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929312876?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929312876&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929312876&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008621"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929312876</prism:url><dc:identifier>SCOPUS_ID:84929312876</dc:identifier><eid>2-s2.0-84929312876</eid><dc:title>A temperature-sensitive, self-adhesive hydrogel to deliver iPSC-derived cardiomyocytes for heart repair</dc:title><dc:creator>Wang X.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>177-180</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.139</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:111295067</affiliation-url><afid>111295067</afid><affilname>Veterans Affairs Tennessee Valley Healthcare System</affilname><name-variant>Veteran's Affairs Tennessee Valley Healthcare System</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56148960500</author-url><authid>56148960500</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xintong</given-name><initials>X.</initials><afid>60003915</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644038500</author-url><authid>56644038500</authid><authname>Chun Y.</authname><surname>Chun</surname><given-name>Young Wook</given-name><initials>Y.W.</initials><afid>60003915</afid><afid>60003915</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644038500</author-url><authid>56644038500</authid><authname>Chun Y.</authname><surname>Chun</surname><given-name>Young Wook</given-name><initials>Y.W.</initials><afid>60003915</afid><afid>60003915</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55192887500</author-url><authid>55192887500</authid><authname>Zhong L.</authname><surname>Zhong</surname><given-name>Lin</given-name><initials>L.</initials><afid>60003915</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54990259700</author-url><authid>54990259700</authid><authname>Chiusa M.</authname><surname>Chiusa</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60003915</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55700411200</author-url><authid>55700411200</authid><authname>Balikov D.</authname><surname>Balikov</surname><given-name>Daniel A.</given-name><initials>D.A.</initials><afid>60003915</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6506579422</author-url><authid>6506579422</authid><authname>Frist A.</authname><surname>Frist</surname><given-name>Audrey Y.</given-name><initials>A.Y.</initials><afid>60003915</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643671400</author-url><authid>56643671400</authid><authname>Lim C.</authname><surname>Lim</surname><given-name>Chee C.</given-name><initials>C.C.</initials><afid>60003915</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14045665300</author-url><authid>14045665300</authid><authname>Maltais S.</authname><surname>Maltais</surname><given-name>Simon</given-name><initials>S.</initials><afid>60003915</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8601045200</author-url><authid>8601045200</authid><authname>Bellan L.</authname><surname>Bellan</surname><given-name>Leon</given-name><initials>L.</initials><afid>60003915</afid><afid>60003915</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8601045200</author-url><authid>8601045200</authid><authname>Bellan L.</authname><surname>Bellan</surname><given-name>Leon</given-name><initials>L.</initials><afid>60003915</afid><afid>60003915</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35750091400</author-url><authid>35750091400</authid><authname>Hong C.</authname><surname>Hong</surname><given-name>Charles C.</given-name><initials>C.C.</initials><afid>60003915</afid><afid>111295067</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35750091400</author-url><authid>35750091400</authid><authname>Hong C.</authname><surname>Hong</surname><given-name>Charles C.</given-name><initials>C.C.</initials><afid>60003915</afid><afid>111295067</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7201871300</author-url><authid>7201871300</authid><authname>Sung H.</authname><surname>Sung</surname><given-name>Hak Joon</given-name><initials>H.J.</initials><afid>60003915</afid><afid>60003915</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7201871300</author-url><authid>7201871300</authid><authname>Sung H.</authname><surname>Sung</surname><given-name>Hak Joon</given-name><initials>H.J.</initials><afid>60003915</afid><afid>60003915</afid></author><authkeywords>Cardiomyocyte | Cell delivery | Heart repair | iPSC | Polymer hydrogel</authkeywords><intid>1535943745</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929457552"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929457552?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929457552&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929457552&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007937"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929457552</prism:url><dc:identifier>SCOPUS_ID:84929457552</dc:identifier><eid>2-s2.0-84929457552</eid><dc:title>Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients</dc:title><dc:creator>Gruson D.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>185-187</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.074</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012936</affiliation-url><afid>60012936</afid><affilname>Cliniques Universitaires Saint-Luc, Brussels</affilname><name-variant>Cliniques Universitaires Saint-Luc</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012936</affiliation-url><afid>60012936</afid><affilname>Cliniques Universitaires Saint-Luc, Brussels</affilname><name-variant>Cliniques Universitaires Saint-Luc</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000874</affiliation-url><afid>60000874</afid><affilname>Universite Catholique de Louvain</affilname><name-variant>Université Catholique de Louvain</name-variant><affiliation-city>Louvain-la-Neuve</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012936</affiliation-url><afid>60012936</afid><affilname>Cliniques Universitaires Saint-Luc, Brussels</affilname><name-variant>Cliniques Universitaires Saint-Luc</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000874</affiliation-url><afid>60000874</afid><affilname>Universite Catholique de Louvain</affilname><name-variant>Université Catholique de Louvain</name-variant><affiliation-city>Louvain-la-Neuve</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22937466500</author-url><authid>22937466500</authid><authname>Gruson D.</authname><surname>Gruson</surname><given-name>Damien</given-name><initials>D.</initials><afid>60012936</afid><afid>60012936</afid><afid>60000874</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22937466500</author-url><authid>22937466500</authid><authname>Gruson D.</authname><surname>Gruson</surname><given-name>Damien</given-name><initials>D.</initials><afid>60012936</afid><afid>60012936</afid><afid>60000874</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22937466500</author-url><authid>22937466500</authid><authname>Gruson D.</authname><surname>Gruson</surname><given-name>Damien</given-name><initials>D.</initials><afid>60012936</afid><afid>60012936</afid><afid>60000874</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648202800</author-url><authid>56648202800</authid><authname>Ferracin B.</authname><surname>Ferracin</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60012936</afid><afid>60000874</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648202800</author-url><authid>56648202800</authid><authname>Ferracin B.</authname><surname>Ferracin</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60012936</afid><afid>60000874</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401989943</author-url><authid>7401989943</authid><authname>Ahn S.</authname><surname>Ahn</surname><given-name>Sylvie A.</given-name><initials>S.A.</initials><afid>60012936</afid><afid>60000874</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401989943</author-url><authid>7401989943</authid><authname>Ahn S.</authname><surname>Ahn</surname><given-name>Sylvie A.</given-name><initials>S.A.</initials><afid>60012936</afid><afid>60000874</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7101954099</author-url><authid>7101954099</authid><authname>Rousseau M.</authname><surname>Rousseau</surname><given-name>Michel F.</given-name><initials>M.F.</initials><afid>60012936</afid><afid>60000874</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7101954099</author-url><authid>7101954099</authid><authname>Rousseau M.</authname><surname>Rousseau</surname><given-name>Michel F.</given-name><initials>M.F.</initials><afid>60012936</afid><afid>60000874</afid></author><authkeywords>Biomarker | BNP | FGF-23 | Galectin-3 | Heart failure | NT-proBNP | Prognosis | ST2</authkeywords><intid>2035958275</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929306732"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929306732?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929306732&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929306732&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007032"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929306732</prism:url><dc:identifier>SCOPUS_ID:84929306732</dc:identifier><eid>2-s2.0-84929306732</eid><dc:title>Being cast into the shade of β blockers for concomitant heart failure and atrial fibrillation?</dc:title><dc:creator>Long D.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>35</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.431</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640517100</author-url><authid>56640517100</authid><authname>Long D.</authname><surname>Long</surname><given-name>Da</given-name><initials>D.</initials><afid>60082822</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55437328300</author-url><authid>55437328300</authid><authname>Xiao Y.</authname><surname>Xiao</surname><given-name>Yichao</given-name><initials>Y.</initials><afid>60082822</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56305125400</author-url><authid>56305125400</authid><authname>Dong B.</authname><surname>Dong</surname><given-name>Bin</given-name><initials>B.</initials><afid>60082822</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56401367700</author-url><authid>56401367700</authid><authname>Zhou S.</authname><surname>Zhou</surname><given-name>Shenghua</given-name><initials>S.</initials><afid>60082822</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55712203000</author-url><authid>55712203000</authid><authname>Liu Q.</authname><surname>Liu</surname><given-name>Qiming</given-name><initials>Q.</initials><afid>60082822</afid></author><authkeywords>Atrial fibrillation | Heart failure | β blockers</authkeywords><intid>1535945118</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929306612"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929306612?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929306612&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929306612&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008797"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929306612</prism:url><dc:identifier>SCOPUS_ID:84929306612</dc:identifier><eid>2-s2.0-84929306612</eid><dc:title>Magnetic fields in noninvasive heart stimulation: Novel approach for anti-atrial fibrillation</dc:title><dc:creator>Wang S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>54-55</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.155</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56231354500</author-url><authid>56231354500</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Songyun</given-name><initials>S.</initials><afid>60080982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56231023800</author-url><authid>56231023800</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiaoya</given-name><initials>X.</initials><afid>60080982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56400341600</author-url><authid>56400341600</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhuo</given-name><initials>Z.</initials><afid>60080982</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55572503600</author-url><authid>55572503600</authid><authname>Huang B.</authname><surname>Huang</surname><given-name>Bing</given-name><initials>B.</initials><afid>60080982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640120200</author-url><authid>56640120200</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Liping</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55882770400</author-url><authid>55882770400</authid><authname>Chen M.</authname><surname>Chen</surname><given-name>Mingxian</given-name><initials>M.</initials><afid>60082822</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35312999700</author-url><authid>35312999700</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lilei</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56278651700</author-url><authid>56278651700</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><authkeywords>Atrial fibrillation | Autonomic nervous system | Magnetic stimulation | Vagal stimulation</authkeywords><intid>35944674</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379597"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379597?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379597&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379597&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006385"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379597</prism:url><dc:identifier>SCOPUS_ID:84929379597</dc:identifier><eid>2-s2.0-84929379597</eid><dc:title>Response to letter regarding "Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure"</dc:title><dc:creator>Gao R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>434-435</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.380</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242241</affiliation-url><afid>115242241</afid><affilname>Clinical School of Weifang Medical University</affilname><name-variant>Clinical School of Weifang Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027963</affiliation-url><afid>60027963</afid><affilname>Taishan Medical University</affilname><name-variant>Taishan Medical College</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643848900</author-url><authid>56643848900</authid><authname>Gao R.</authname><surname>Gao</surname><given-name>Rui Jie</given-name><initials>R.J.</initials><afid>115242241</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640135100</author-url><authid>56640135100</authid><authname>Zhou Y.</authname><surname>Zhou</surname><given-name>Yan Hong</given-name><initials>Y.H.</initials><afid>60027963</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55700840700</author-url><authid>55700840700</authid><authname>Liu T.</authname><surname>Liu</surname><given-name>Tao</given-name><initials>T.</initials><afid>60027963</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55484886300</author-url><authid>55484886300</authid><authname>Han Q.</authname><surname>Han</surname><given-name>Qian Feng</given-name><initials>Q.F.</initials><afid>60027963</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35217151100</author-url><authid>35217151100</authid><authname>Yao H.</authname><surname>Yao</surname><given-name>Heng Chen</given-name><initials>H.C.</initials><afid>115242241</afid><afid>60027963</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35217151100</author-url><authid>35217151100</authid><authname>Yao H.</authname><surname>Yao</surname><given-name>Heng Chen</given-name><initials>H.C.</initials><afid>115242241</afid><afid>60027963</afid></author><authkeywords>Endothelial cells | High mobility group box 1 | Ischemic heart disease</authkeywords><intid>535944998</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929321377"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929321377?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929321377&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929321377&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006002"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929321377</prism:url><dc:identifier>SCOPUS_ID:84929321377</dc:identifier><eid>2-s2.0-84929321377</eid><dc:title>Endothelial cell is critical in HMGB1 mediated cardiac impairment in ischemic heart disease</dc:title><dc:creator>Zhu Z.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>39-40</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.342</prism:doi><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56139614700</author-url><authid>56139614700</authid><authname>Zhu Z.</authname><surname>Zhu</surname><given-name>Zhaowei</given-name><initials>Z.</initials><afid>60082822</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56185293800</author-url><authid>56185293800</authid><authname>Hu X.</authname><surname>Hu</surname><given-name>Xinqun</given-name><initials>X.</initials><afid>60082822</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56537471000</author-url><authid>56537471000</authid><authname>Fang Z.</authname><surname>Fang</surname><given-name>Zhenfei</given-name><initials>Z.</initials><afid>60082822</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56401367700</author-url><authid>56401367700</authid><authname>Zhou S.</authname><surname>Zhou</surname><given-name>Shenghua</given-name><initials>S.</initials><afid>60082822</afid></author><authkeywords>Endothelial cells | HMGB1 | Ischemic heart disease</authkeywords><intid>1035940315</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209177"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209177?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209177&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209177&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001558"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209177</prism:url><dc:identifier>SCOPUS_ID:84930209177</dc:identifier><eid>2-s2.0-84930209177</eid><dc:title>Losartan treatment attenuates tumor-induced myocardial dysfunction</dc:title><dc:creator>Stevens S.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>37-47</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.007</prism:doi><pii>S0022282815001558</pii><dc:description>© 2015 Elsevier Ltd. Fatigue and muscle wasting are common symptoms experienced by cancer patients. Data from animal models demonstrate that angiotensin is involved in tumor-induced muscle wasting, and that tumor growth can independently affect myocardial function, which could contribute to fatigue in cancer patients. In clinical studies, inhibitors of angiotensin converting enzyme (ACE) can prevent the development of chemotherapy-induced cardiovascular dysfunction, suggesting a mechanistic role for the renin-angiotensin-aldosterone system (RAAS). In the present study, we investigated whether an angiotensin (AT) 1-receptor antagonist could prevent the development of tumor-associated myocardial dysfunction. Methods and results: Colon26 adenocarcinoma (c26) cells were implanted into female CD2F1 mice at 8 weeks of age. Simultaneously, mice were administered Losartan (10. mg/kg) daily via their drinking water. In vivo echocardiography, blood pressure, in vitro cardiomyocyte function, cell proliferation assays, and measures of systemic inflammation and myocardial protein degradation were performed 19 days following tumor cell injection. Losartan treatment prevented tumor-induced loss of muscle mass and in vitro c26 cell proliferation, decreased tumor weight, and attenuated myocardial expression of interleukin-6. Furthermore, Losartan treatment mitigated tumor-associated alterations in calcium signaling in cardiomyocytes, which was associated with improved myocyte contraction velocity, systolic function, and blood pressures in the hearts of tumor-bearing mice. Conclusions: These data suggest that Losartan may mitigate tumor-induced myocardial dysfunction and inflammation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000076</affiliation-url><afid>60000076</afid><affilname>Children's Hospital Columbus</affilname><name-variant>Columbus Children's Hospital</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007493</affiliation-url><afid>60007493</afid><affilname>Universitat Bonn</affilname><name-variant>Universität Bonn</name-variant><affiliation-city>Bonn</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015720</affiliation-url><afid>60015720</afid><affilname>Marquette University</affilname><name-variant>Marquette University</name-variant><affiliation-city>Milwaukee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090016</affiliation-url><afid>60090016</afid><affilname>Dorothy M. Davis Heart and Lung Research Institute</affilname><name-variant>Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35103592300</author-url><authid>35103592300</authid><authname>Stevens S.</authname><surname>Stevens</surname><given-name>Sarah C W</given-name><initials>S.C.W.</initials><afid>60000076</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23399272600</author-url><authid>23399272600</authid><authname>Velten M.</authname><surname>Velten</surname><given-name>Markus</given-name><initials>M.</initials><afid>60007493</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26533669100</author-url><authid>26533669100</authid><authname>Youtz D.</authname><surname>Youtz</surname><given-name>Dane J.</given-name><initials>D.J.</initials><afid>60000076</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56318246500</author-url><authid>56318246500</authid><authname>Clark Y.</authname><surname>Clark</surname><given-name>Yvonne</given-name><initials>Y.</initials><afid>60003500</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56317858100</author-url><authid>56317858100</authid><authname>Jing R.</authname><surname>Jing</surname><given-name>Runfeng</given-name><initials>R.</initials><afid>60003500</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006857401</author-url><authid>7006857401</authid><authname>Reiser P.</authname><surname>Reiser</surname><given-name>Peter J.</given-name><initials>P.J.</initials><afid>60003500</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602701759</author-url><authid>6602701759</authid><authname>Bicer S.</authname><surname>Bicer</surname><given-name>Sabahattin</given-name><initials>S.</initials><afid>60003500</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56467801800</author-url><authid>56467801800</authid><authname>Devine R.</authname><surname>Devine</surname><given-name>Raymond D.</given-name><initials>R.D.</initials><afid>60003500</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56662734000</author-url><authid>56662734000</authid><authname>McCarthy D.</authname><surname>McCarthy</surname><given-name>Donna O.</given-name><initials>D.O.</initials><afid>60003500</afid><afid>60015720</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56662734000</author-url><authid>56662734000</authid><authname>McCarthy D.</authname><surname>McCarthy</surname><given-name>Donna O.</given-name><initials>D.O.</initials><afid>60003500</afid><afid>60015720</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35924582400</author-url><authid>35924582400</authid><authname>Wold L.</authname><surname>Wold</surname><given-name>Loren E.</given-name><initials>L.E.</initials><afid>60000076</afid><afid>60003500</afid><afid>60090016</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35924582400</author-url><authid>35924582400</authid><authname>Wold L.</authname><surname>Wold</surname><given-name>Loren E.</given-name><initials>L.E.</initials><afid>60000076</afid><afid>60003500</afid><afid>60090016</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35924582400</author-url><authid>35924582400</authid><authname>Wold L.</authname><surname>Wold</surname><given-name>Loren E.</given-name><initials>L.E.</initials><afid>60000076</afid><afid>60003500</afid><afid>60090016</afid></author><authkeywords>Calcium signaling | Cancer cachexia | Cardiomyocyte | Cardiovascular function | Losartan</authkeywords><intid>1036083048</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325742"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325742?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325742&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325742&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008335"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325742</prism:url><dc:identifier>SCOPUS_ID:84929325742</dc:identifier><eid>2-s2.0-84929325742</eid><dc:title>Inflammation in HFpEF: Key or circumstantial?</dc:title><dc:creator>Van Empel V.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>259-263</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.110</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Heart failure (HF) can be split into HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). Currently the pathophysiologic mechanisms involved in HFpEF remain largely unknown. The neurohumoral and sympathetic nervous systems seem not to play a crucial role in HFpEF, as treatments targeting these pathways do not show beneficial effects in HFpEF patients, in contrast to HFrEF patients. A better understanding of the pathophysiological processes involved in HFpEF is needed, as there is no proven treatment for this disease at the moment. Recent data have yielded growing attention to the role of inflammation in HFpEF. In this review we discuss increased inflammation in HFpEF as demonstrated in translational animal models and human studies. This review evaluates whether inflammation plays a key role in HFpEF or is just a by-product of various comorbidities. Additionally, we analyze the involvement of oxidative stress and endothelial dysfunction and lastly we outline potential therapeutic targets.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8961428600</author-url><authid>8961428600</authid><authname>Van Empel V.</authname><surname>Van Empel</surname><given-name>Vanessa</given-name><initials>V.</initials><afid>60018869</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003352089</author-url><authid>7003352089</authid><authname>Brunner-La Rocca H.</authname><surname>Brunner-La Rocca</surname><given-name>Hans Peter</given-name><initials>H.P.</initials><afid>60018869</afid></author><authkeywords>Endothelial dysfunction | Heart failure | Heart failure with preserved ejection fraction | Heart failure with reduced ejection fraction | Inflammation | Oxidative stress</authkeywords><intid>1035940940</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928248647"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928248647?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928248647&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928248647&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S8756328215001258"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928248647</prism:url><dc:identifier>SCOPUS_ID:84928248647</dc:identifier><eid>2-s2.0-84928248647</eid><dc:title>Deficits in bone density and structure in children and young adults following Fontan palliation</dc:title><dc:creator>Avitabile C.</dc:creator><prism:publicationName>Bone</prism:publicationName><prism:issn>87563282</prism:issn><prism:volume>77</prism:volume><prism:pageRange>12-16</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bone.2015.04.012</prism:doi><pii>S8756328215001258</pii><dc:description>© 2015. Background: Survival of patients with congenital heart disease has improved such that there are now more adults than children living with these conditions. Complex single ventricle congenital heart disease requiring Fontan palliation is associated with multiple risk factors for impaired bone accrual. Bone density and structure have not been characterized in these patients. Methods: Tibia peripheral quantitative computed tomography (pQCT) was used to assess trabecular and cortical volumetric bone mineral density (vBMD), cortical dimensions, and calf muscle area in 43 Fontan participants (5-33. years old), a median of 10. years following Fontan palliation. pQCT outcomes were converted to sex- and race-specific Z-scores relative to age based on &gt;. 700 healthy reference participants. Cortical dimensions and muscle area were further adjusted for tibia length. Results: Height Z-scores were lower in Fontan compared to reference participants (mean. ±. SD: -. 0.29. ±. 1.00 vs. 0.25. ±. 0.93, p. &lt;. 0.001); BMI Z-scores were similar (0.16. ±. 0.88 vs. 0.35. ±. 1.02, p. =. 0.1). Fontan participants had lower trabecular vBMD Z-scores (-. 0.85. ±. 0.96 vs. 0.01. ±. 1.02, p. &lt;. 0.001); cortical vBMD Z-scores were similar (-. 0.17. ±. 0.98 vs. 0.00. ±. 1.00, p. =. 0.27). Cortical dimensions were reduced with lower cortical area (-. 0.59. ±. 0.84 vs. 0.00. ±. 0.88, p. &lt;. 0.001) and periosteal circumference (-. 0.50. ±. 0.82 vs. 0.00. ±. 0.84, p. &lt;. 0.001) Z-scores, compared to reference participants. Calf muscle area Z-scores were lower in the Fontan participants (-. 0.45. ±. 0.98 vs. 0.00. ±. 0.96, p. =. 0.003) and lower calf muscle area Z-scores were associated with smaller periosteal circumference Z-scores (R. =. 0.62, p. &lt;. 0.001). Musculoskeletal deficits were not associated with age, Fontan characteristics, parathyroid hormone or vitamin D levels. Conclusions: Children and young adults demonstrate low trabecular vBMD, cortical structure and muscle area following Fontan. Muscle deficits were associated with smaller periosteal dimensions. Future studies should determine the fracture implications of these deficits and identify interventions to promote musculoskeletal development.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030118</affiliation-url><afid>60030118</afid><affilname>The Children's Hospital of Philadelphia</affilname><name-variant>The Children's Hospital of Philadelphia</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030118</affiliation-url><afid>60030118</afid><affilname>The Children's Hospital of Philadelphia</affilname><name-variant>The Children's Hospital of Philadelphia</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113823195</affiliation-url><afid>113823195</afid><affilname>Mid-Hudson Medical Group</affilname><name-variant>Mid-Hudson Medical Group</name-variant><affiliation-city>Hopewell Junction</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030118</affiliation-url><afid>60030118</afid><affilname>The Children's Hospital of Philadelphia</affilname><name-variant>The Children's Hospital of Philadelphia</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004902</affiliation-url><afid>60004902</afid><affilname>St. Christopher's Hospital for Children Philadelphia</affilname><name-variant>St. Christopher's Hosp. for Children</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54410291900</author-url><authid>54410291900</authid><authname>Avitabile C.</authname><surname>Avitabile</surname><given-name>Catherine M.</given-name><initials>C.M.</initials><afid>60030118</afid><afid>60004902</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54410291900</author-url><authid>54410291900</authid><authname>Avitabile C.</authname><surname>Avitabile</surname><given-name>Catherine M.</given-name><initials>C.M.</initials><afid>60030118</afid><afid>60004902</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55598331600</author-url><authid>55598331600</authid><authname>Goldberg D.</authname><surname>Goldberg</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55598331600</author-url><authid>55598331600</authid><authname>Goldberg D.</authname><surname>Goldberg</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004295797</author-url><authid>7004295797</authid><authname>Zemel B.</authname><surname>Zemel</surname><given-name>Babette S.</given-name><initials>B.S.</initials><afid>60006297</afid><afid>60030118</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004295797</author-url><authid>7004295797</authid><authname>Zemel B.</authname><surname>Zemel</surname><given-name>Babette S.</given-name><initials>B.S.</initials><afid>60006297</afid><afid>60030118</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55094984300</author-url><authid>55094984300</authid><authname>Brodsky J.</authname><surname>Brodsky</surname><given-name>Jill L.</given-name><initials>J.L.</initials><afid>113823195</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9733647000</author-url><authid>9733647000</authid><authname>Dodds K.</authname><surname>Dodds</surname><given-name>Kathryn</given-name><initials>K.</initials><afid>60030118</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56228552100</author-url><authid>56228552100</authid><authname>Hayden-Rush C.</authname><surname>Hayden-Rush</surname><given-name>Christina</given-name><initials>C.</initials><afid>60030118</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8644051400</author-url><authid>8644051400</authid><authname>Whitehead K.</authname><surname>Whitehead</surname><given-name>Kevin K.</given-name><initials>K.K.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8644051400</author-url><authid>8644051400</authid><authname>Whitehead K.</authname><surname>Whitehead</surname><given-name>Kevin K.</given-name><initials>K.K.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56247915100</author-url><authid>56247915100</authid><authname>Goldmuntz E.</authname><surname>Goldmuntz</surname><given-name>Elizabeth</given-name><initials>E.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56247915100</author-url><authid>56247915100</authid><authname>Goldmuntz E.</authname><surname>Goldmuntz</surname><given-name>Elizabeth</given-name><initials>E.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55004487400</author-url><authid>55004487400</authid><authname>Rychik J.</authname><surname>Rychik</surname><given-name>Jack</given-name><initials>J.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55004487400</author-url><authid>55004487400</authid><authname>Rychik J.</authname><surname>Rychik</surname><given-name>Jack</given-name><initials>J.</initials><afid>60030118</afid><afid>60006297</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201687182</author-url><authid>7201687182</authid><authname>Leonard M.</authname><surname>Leonard</surname><given-name>Mary B.</given-name><initials>M.B.</initials><afid>60006297</afid><afid>60030118</afid><afid>60006297</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201687182</author-url><authid>7201687182</authid><authname>Leonard M.</authname><surname>Leonard</surname><given-name>Mary B.</given-name><initials>M.B.</initials><afid>60006297</afid><afid>60030118</afid><afid>60006297</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201687182</author-url><authid>7201687182</authid><authname>Leonard M.</authname><surname>Leonard</surname><given-name>Mary B.</given-name><initials>M.B.</initials><afid>60006297</afid><afid>60030118</afid><afid>60006297</afid></author><authkeywords>Bone mineral density | Congenital heart disease | Fontan | Muscle | Peripheral quantitative computed tomography</authkeywords><intid>535754076</intid><source-id>29551</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929310966"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929310966?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929310966&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929310966&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007317"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929310966</prism:url><dc:identifier>SCOPUS_ID:84929310966</dc:identifier><eid>2-s2.0-84929310966</eid><dc:title>Long non-coding RNAs, a new important regulator of cardiovascular physiology and pathology</dc:title><dc:creator>Ma Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>105-110</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.021</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. LncRNAs were previously considered to be the 'noise' of gene transcription having no biological functions, but now it has become evident that lncRNAs function as modulators of gene expression network. LncRNAs may regulate diverse gene expression levels which were roughly summarized to epigenetic, transcriptional and post-transcriptional levels. It has been clarified that some lncRNAs were expressed differentially in cardiovascular diseases, and aberrant changes of those lncRNAs were involved in the development of heart disorders. The role of lncRNAs in this process transcended the tradition of protein regulatory platform to be the orchestrator of cardiac sophisticated governing system of heart development, adaptation and pathological reaction. This review summarizes recent advances in the study of functions and mechanisms of lncRNAs in cardiovascular physiology and pathology. The regulatory roles of lncRNAs in cardiovascular diseases provide new strategy for interventional therapy of heart diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021615</affiliation-url><afid>60021615</afid><affilname>Harbin Medical University</affilname><name-variant>Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56497289400</author-url><authid>56497289400</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yidi</given-name><initials>Y.</initials><afid>60021615</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472166900</author-url><authid>56472166900</authid><authname>Ma W.</authname><surname>Ma</surname><given-name>Wenya</given-name><initials>W.</initials><afid>60021615</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56497315200</author-url><authid>56497315200</authid><authname>Huang L.</authname><surname>Huang</surname><given-name>Lina</given-name><initials>L.</initials><afid>60021615</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56472236800</author-url><authid>56472236800</authid><authname>Feng D.</authname><surname>Feng</surname><given-name>Dan</given-name><initials>D.</initials><afid>60021615</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16244340300</author-url><authid>16244340300</authid><authname>Cai B.</authname><surname>Cai</surname><given-name>Benzhi</given-name><initials>B.</initials><afid>60021615</afid></author><authkeywords>Cardiovascular disease | Development | Long non-coding rna | Myocardial infarction | Vascular diseases</authkeywords><intid>35945086</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929574486"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929574486?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929574486&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929574486&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001455"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929574486</prism:url><dc:identifier>SCOPUS_ID:84929574486</dc:identifier><eid>2-s2.0-84929574486</eid><dc:title>Hypoxia-driven sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) downregulation depends on low-density lipoprotein receptor-related protein 1 (LRP1)-signalling in cardiomyocytes</dc:title><dc:creator>Revuelta-López E.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>25-36</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.028</prism:doi><pii>S0022282815001455</pii><dc:description>© 2015 Elsevier Ltd. The maintenance of sarcoplasmic reticulum Ca&lt;sup&gt;2+&lt;/sup&gt; ATPase (SERCA2) activity is crucial for cardiac function and SERCA2 is dramatically reduced in the heart exposed to hypoxic/ischemic conditions. Previous work from our group showed that hypoxia upregulates the phosphorylated form of the Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent nonreceptor protein tyrosine kinase (PTK) proline-rich tyrosine kinase 2 (pPyk2) protein levels in a low-density lipoprotein receptor-related protein (LRP1)-dependent manner. Pyk2 in turn may modulate SERCA2 in cardiomyocytes although this remains controversial. We therefore aimed to investigate the role of LRP1 on hypoxia-induced SERCA2 depletion in cardiomyocytes and to establish LRP1 signalling mechanisms involved. Western blot analysis showed that hypoxia reduced SERCA2 concomitantly with a sustained increase in LRP1 and pPyk2 protein levels in HL-1 cardiomyocytes. By impairing hypoxia-induced Pyk2 phosphorylation and HIF-1α accumulation, LRP1 deficiency prevented SERCA2 depletion and reduction of the sarcoplasmic reticulum calcium content in cardiomyocytes. Moreover, the inhibition of Pyk2 phosphorylation (with the Src-family inhibitor PP2) or the specific silencing of Pyk2 (with siRNA-anti Pyk2) preserved low HIF-1α and high SERCA2 levels in HL-1 cardiomyocytes exposed to hypoxia. We determined that the LRP1/Pyk2 axis represses SERCA2 mRNA expression via HIF-1α since HIF-1α overexpression abolished the protective effect of LRP1 deficiency on SERCA2 depletion. Our findings show a crucial role of LRP1/Pyk2/HIF-1α in hypoxia-induced cardiomyocyte SERCA2 downregulation, a pathophysiological process closely associated with heart failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103750</affiliation-url><afid>60103750</afid><affilname>CSIC-ICCC - Centro de Investigacion Cardiovascular (CIC)</affilname><name-variant>Cardiovascular Research Center</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112601570</affiliation-url><afid>112601570</afid><affilname>Health Sciences Research Institute Germans Trias i Pujol</affilname><name-variant>Germans Trias i Pujol Research Institute in Health Sciences</name-variant><affiliation-city>Badalona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54795888400</author-url><authid>54795888400</authid><authname>Revuelta-López E.</authname><surname>Revuelta-López</surname><given-name>Elena</given-name><initials>E.</initials><afid>60103750</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:52263317400</author-url><authid>52263317400</authid><authname>Cal R.</authname><surname>Cal</surname><given-name>Roi</given-name><initials>R.</initials><afid>60103750</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56586145500</author-url><authid>56586145500</authid><authname>Herraiz-Martínez A.</authname><surname>Herraiz-Martínez</surname><given-name>Adela</given-name><initials>A.</initials><afid>60103750</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25823698600</author-url><authid>25823698600</authid><authname>de Gonzalo-Calvo D.</authname><surname>de Gonzalo-Calvo</surname><given-name>David</given-name><initials>D.</initials><afid>60103750</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55225991200</author-url><authid>55225991200</authid><authname>Nasarre L.</authname><surname>Nasarre</surname><given-name>Laura</given-name><initials>L.</initials><afid>60103750</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003438756</author-url><authid>7003438756</authid><authname>Roura S.</authname><surname>Roura</surname><given-name>Santiago</given-name><initials>S.</initials><afid>112601570</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35310127000</author-url><authid>35310127000</authid><authname>Gálvez-Montón C.</authname><surname>Gálvez-Montón</surname><given-name>Carolina</given-name><initials>C.</initials><afid>112601570</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004094140</author-url><authid>7004094140</authid><authname>Bayes-Genis A.</authname><surname>Bayes-Genis</surname><given-name>Antoni</given-name><initials>A.</initials><afid>112601570</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102141956</author-url><authid>7102141956</authid><authname>Badimon L.</authname><surname>Badimon</surname><given-name>Lina</given-name><initials>L.</initials><afid>60103750</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603913006</author-url><authid>6603913006</authid><authname>Hove-Madsen L.</authname><surname>Hove-Madsen</surname><given-name>Leif</given-name><initials>L.</initials><afid>60103750</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6602294652</author-url><authid>6602294652</authid><authname>Llorente-Cortés V.</authname><surname>Llorente-Cortés</surname><given-name>Vicenta</given-name><initials>V.</initials><afid>60103750</afid></author><authkeywords>Cardiomyocytes | Hypoxia | LRP1 | Pyk2 | SERCA2</authkeywords><intid>535983178</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921509674"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921509674?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921509674&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921509674&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012076"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921509674</prism:url><dc:identifier>SCOPUS_ID:84921509674</dc:identifier><eid>2-s2.0-84921509674</eid><dc:title>Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting</dc:title><dc:creator>Ezhov M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>477-482</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.944</prism:doi><pii>S0021915014012076</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: To evaluate the relationships of lipoprotein(a) (Lp(a)) concentration and apolipoprotein(a) (apo(a)) phenotype to major adverse cardiovascular events after coronary artery bypass grafting (CABG) in long-term follow-up. Methods: This single-center study included 356 patients with stable coronary heart disease (CHD) who underwent successful CABG. At baseline, we assessed the patient's risk factor profile for atherosclerosis, Lp(a) concentration and apo(a) phenotype. The primary endpoint was the composite of cardiovascular death and non-fatal myocardial infarction (MI). The secondary endpoint also included hospitalization for recurrent or unstable angina and repeat revascularization. Results: Over a mean of 8.5±3.5 years (range 0.9-15.0 years), the primary and secondary endpoints were registered in 46 (13%) and 107 (30%) patients, respectively. Patients with Lp(a) ≥30mg/dL were at significantly greater risk for the primary endpoint (hazard ratio (HR) 2.98, 95% confidence interval (CI) 1.76-5.03, p&lt;0.001) and secondary endpoint (HR 3.47, 95% CI 2.48-4.85, p&lt;0.001) than patients with Lp(a) values &lt;30mg/dL. The low molecular-weight apo(a) phenotype was also associated with higher risk of both primary and secondary endpoints (3.57 (1.87-6.82) and 3.05 (2.00-4.62), respectively; p&lt;0.001 for both), regardless of conventional risk factors and statins use. Conclusion: In stable CHD patients Lp(a) concentration and low molecular-weight apo(a) phenotype are independently associated with three-fold increase in risk of major adverse cardiovascular events within 15 years after CABG. Lp(a) levels may provide an additional information for postoperative cardiovascular risk assessment.</dc:description><citedby-count>5</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069625</affiliation-url><afid>60069625</afid><affilname>Ministry of Health of Russian Federation</affilname><name-variant>Min. Zdravookhr. SSSR</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069625</affiliation-url><afid>60069625</afid><affilname>Ministry of Health of Russian Federation</affilname><name-variant>Min. Zdravookhr. SSSR</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><pubmed-id>24952151</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602097331</author-url><authid>6602097331</authid><authname>Ezhov M.</authname><surname>Ezhov</surname><given-name>Marat V.</given-name><initials>M.V.</initials><afid>60069625</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:49664128700</author-url><authid>49664128700</authid><authname>Safarova M.</authname><surname>Safarova</surname><given-name>Maya S.</given-name><initials>M.S.</initials><afid>60069625</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602283831</author-url><authid>6602283831</authid><authname>Afanasieva O.</authname><surname>Afanasieva</surname><given-name>Olga I.</given-name><initials>O.I.</initials><afid>60069625</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005928189</author-url><authid>7005928189</authid><authname>Kukharchuk V.</authname><surname>Kukharchuk</surname><given-name>Valery V.</given-name><initials>V.V.</initials><afid>60069625</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004155877</author-url><authid>7004155877</authid><authname>Pokrovsky S.</authname><surname>Pokrovsky</surname><given-name>Sergei N.</given-name><initials>S.N.</initials><afid>60069625</afid></author><authkeywords>Apo(a) phenotype | Apolipoprotein(a) | Coronary artery bypass grafting | Coronary heart disease | Lipoprotein(a) | Long-term prognosis | Vein graft disease</authkeywords><intid>34655239</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929190824"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929190824?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929190824&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929190824&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0731708515002666"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929190824</prism:url><dc:identifier>SCOPUS_ID:84929190824</dc:identifier><eid>2-s2.0-84929190824</eid><dc:title>Urinary metabolomic strategy to evaluate Compound Danshen Dripping Pills for myocardial ischaemia in rats</dc:title><dc:creator>Zou H.</dc:creator><prism:publicationName>Journal of Pharmaceutical and Biomedical Analysis</prism:publicationName><prism:issn>07317085</prism:issn><prism:eIssn>1873264X</prism:eIssn><prism:volume>112</prism:volume><prism:pageRange>98-105</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jpba.2015.04.033</prism:doi><pii>S0731708515002666</pii><dc:description>© 2015 Elsevier B.V. Compound Danshen Dripping Pill (CDDP) has been used for the treatment of coronary heart disease for decades. We aimed to increase the understanding of the mechanisms by evaluating the urinary metabolomics of CDDP using Gas Chromatography-Mass Spectrometer (GC-MS) in a myocardial ischaemia (MI) rat model. One hundred Sprague-Dawley rats were divided into Con (normal saline and no surgery), Con+ (107. mg/kg. d CDDP solution and no surgery), Sham (normal saline and surgery without aorta ligation), Mod (normal saline and surgery with aorta ligation), and Mod+ (107. mg/kg. d CDDP solution and surgery with aorta ligation) groups. Urine samples on days 0, 3, 14, and 28 were tested using GC-MS and analyzed with PCA and partial least squares-discriminant analysis models. In the Mod group, creatine kinase and malondialdehyde levels were higher, and superoxide-dismutase levels were lower; the same variables normalized in the Mod+ group. CDDP resulted in improvement in the Mod+ group, as indicated by the reduced necrosis in the myocardial tissue. A total of 36 metabolites were identified in the urine samples, and 8 metabolites (malate, succinate, creatinine, methionine, cysteine, serine, phenylalanine, and tyrosine) were increased remarkably and recovered to normal levels after treatment with CDDP. Differentially expressed metabolites implied that energy, amino acid, fatty acid, and polyol metabolism might be disrupted by MI and reversed by CDDP. Urinary metabolomics provide a dynamic monitoring approach that highlights interference by MI and the therapeutic effects of CDDP on MI in rats throughout the recovery process.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115234968</affiliation-url><afid>115234968</afid><affilname>Shandong Wanjie Medical Institute</affilname><name-variant>Shandong Wanjie Medical Institute</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235232</affiliation-url><afid>115235232</afid><affilname>Shanghai Municipal Xuhui District Central Hospital</affilname><name-variant>Shanghai Municipal Xuhui District Central Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55735124700</author-url><authid>55735124700</authid><authname>Zou H.</authname><surname>Zou</surname><given-name>Hai Miao</given-name><initials>H.M.</initials><afid>60025084</afid><afid>115234968</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55735124700</author-url><authid>55735124700</authid><authname>Zou H.</authname><surname>Zou</surname><given-name>Hai Miao</given-name><initials>H.M.</initials><afid>60025084</afid><afid>115234968</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640093000</author-url><authid>56640093000</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Biao</given-name><initials>B.</initials><afid>60025084</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55735282100</author-url><authid>55735282100</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>Xin Chun</given-name><initials>X.C.</initials><afid>115235232</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640316400</author-url><authid>56640316400</authid><authname>Su J.</authname><surname>Su</surname><given-name>Jing</given-name><initials>J.</initials><afid>60025084</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640060800</author-url><authid>56640060800</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Ya Nan</given-name><initials>Y.N.</initials><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640532700</author-url><authid>56640532700</authid><authname>Xue S.</authname><surname>Xue</surname><given-name>Song</given-name><initials>S.</initials><afid>60025084</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55950729200</author-url><authid>55950729200</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xiao Yan</given-name><initials>X.Y.</initials><afid>60025084</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8444374400</author-url><authid>8444374400</authid><authname>Qiu M.</authname><surname>Qiu</surname><given-name>Ming Feng</given-name><initials>M.F.</initials><afid>60025084</afid></author><authkeywords>Compound Danshen Dripping Pills | Gas Chromatography-Mass Spectrometer | Myocardial ischaemia | Traditional Chinese medicine | Urinary metabolomics</authkeywords><intid>1535917962</intid><source-id>23061</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928995309"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928995309?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928995309&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928995309&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002565"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928995309</prism:url><dc:identifier>SCOPUS_ID:84928995309</dc:identifier><eid>2-s2.0-84928995309</eid><dc:title>A prospective 1-year study of postural tachycardia and the relationship to non-postural versus orthostatic symptoms</dc:title><dc:creator>Baker J.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>227-232</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.049</prism:doi><pii>S0031938415002565</pii><dc:description>© 2015 Elsevier Inc. Purpose: Healthy subjects with asymptomatic postural tachycardia at baseline were evaluated over a one year period to determine whether they developed non-postural versus orthostatic symptoms that could predispose them to develop Postural Tachycardia Syndrome (POTS). Methods: Participants (n = 30) were recruited for a 1-year follow-up (FUP) study if at baseline they demonstrated a heart rate increment of ≥ 30 bpm on head-up tilt (HUT). At FUP, HUT was repeated and four self-report questionnaires were used to assess symptoms. Results: Heart rate (HR) increment was reduced in 19 subjects (- 11.8 ± 7.4 bpm) and increased in 11 subjects (8.3 ± 6.1 bpm) at FUP versus baseline. Heart rate increment at FUP demonstrated no correlation to general fatigue (r = 0.006), body vigilance (r = 0.195), or the component scores for physical (r = - 0.087) and mental (r = - 0.137) health of the SF-36. Similarly, there was no correlation between HR increment at FUP and orthostatic scores (r = 0.04). However, orthostatic scores did show a significant positive correlation with general fatigue and body vigilance scores (r = 0.374, r = 0.392, respectively; p&lt; 0.05). Conclusions: Despite meeting the heart rate criteria for POTS, these findings further support that the majority of young individuals express benign orthostatic tachycardia. In addition, after one year this patient population showed no predisposition to develop non-postural or postural symptoms that could lead to the full syndrome of POTS. These data further argue for the re-evaluation of the heart rate criteria for diagnosing POTS in young populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030222</affiliation-url><afid>60030222</afid><affilname>London Health Sciences Centre</affilname><name-variant>London Health Sciences Centre</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010884</affiliation-url><afid>60010884</afid><affilname>Western University</affilname><name-variant>University of Western Ontario</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56609601200</author-url><authid>56609601200</authid><authname>Baker J.</authname><surname>Baker</surname><given-name>Jacquie</given-name><initials>J.</initials><afid>60030222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23106271600</author-url><authid>23106271600</authid><authname>Kimpinski K.</authname><surname>Kimpinski</surname><given-name>Kurt</given-name><initials>K.</initials><afid>60030222</afid><afid>60010884</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23106271600</author-url><authid>23106271600</authid><authname>Kimpinski K.</authname><surname>Kimpinski</surname><given-name>Kurt</given-name><initials>K.</initials><afid>60030222</afid><afid>60010884</afid></author><authkeywords>Body Vigilance Questionnaire | Multidimensional Fatigue Inventory | Orthostasis | Orthostatic tachycardia | Postural Tachycardia Syndrome | SF-36</authkeywords><intid>1785885525</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926627777"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926627777?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926627777&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926627777&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0957417415000822"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926627777</prism:url><dc:identifier>SCOPUS_ID:84926627777</dc:identifier><eid>2-s2.0-84926627777</eid><dc:title>Cardiovascular diseases identification using electrocardiogram health identifier based on multiple criteria decision making</dc:title><dc:creator>Chui K.</dc:creator><prism:publicationName>Expert Systems with Applications</prism:publicationName><prism:issn>09574174</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>13</prism:issueIdentifier><prism:pageRange>5684-5695</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eswa.2015.01.059</prism:doi><pii>S0957417415000822</pii><dc:description>© 2015 Published by Elsevier Ltd. Cardiovascular diseases can wreak havoc on human beings and lead to 30% of global death annually. The World Health Organization has always highlighted that there is a severe shortage of medical personnel, especially cardiologists, in most of the countries. In this paper, an electrocardiogram health identifier (ECGHI) has been proposed and developed for swift identification of heart diseases. The ECGHI has been applied to four most common types of cardiovascular diseases, namely Myocardial Infarction, Dysrhythmia, Bundle Branch Block and Heart Failure since these four types of cardiovascular diseases contribute to 25% of the overall population suffering from heart diseases. In the investigation of ECGHI, the binary classifier (BC) and multi-class classifier (MCC) are designed and analyzed. The MCC features a multi-class support vector machine (SVM) to diagnose the exact type of cardiovascular disease. The BC features a two-class SVM to identify healthiness of heart accurately. In this paper, the following indicators have been investigated, namely the overall accuracy, specificity, sensitivity, the dimensionality of feature vector, the total training and testing time of ECGHI and a newly defined confidence index. These six criteria form the basis to derive an analytic hierarchy process (AHP) to facilitate the multiple criteria decision making (MCDM) for the optimal evaluation of hyperplanes. Four kernels have been analyzed from which both the BC and MCC are evaluated and analyzed. The optimized ECGHI using BC yields an AHP Performance Score of 0.079 with score components (overall accuracy, specificity, sensitivity, average confidence index, dimensionality, total time for training and testing time) of 0.982, 0.978, 0.986, 0.608, 6, and 5.77 s respectively. Likewise, the optimized ECGHI using MCC yields an AHP Performance Score of 0.093 with score components of 0.882, 0.89, 0.874, 0.504, 9, and 7.32 s respectively. The BC is employed as a supplement of the MCC to achieve a further improvement in all six criteria. Such a novel process of identification and detection with high accuracy is referred as the MCC-BC scheme. The developed ECGHI (MCC) may identify the FOUR most common and important cardiovascular diseases simultaneously (with BC supplementing the MCC to achieve a high accuracy). Such simultaneous identification of cardiovascular diseases is the first of its kind in this research area, so no comparison can be made. The MCC-BC scheme will pave the way for speedy and accurate identification and detection of heart disease. The instant response of the ECGHI minimizes the probability of death from Myocardial Infarction, Bundle Branch Block, Dysrhythmia, and Heart Failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013983</affiliation-url><afid>60013983</afid><affilname>City University of Hong Kong</affilname><name-variant>City University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55975707100</author-url><authid>55975707100</authid><authname>Chui K.</authname><surname>Chui</surname><given-name>Kwok Tai</given-name><initials>K.T.</initials><afid>60013983</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55040562900</author-url><authid>55040562900</authid><authname>Tsang K.</authname><surname>Tsang</surname><given-name>Kim Fung</given-name><initials>K.F.</initials><afid>60013983</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56430026900</author-url><authid>56430026900</authid><authname>Wu C.</authname><surname>Wu</surname><given-name>Chung Kit</given-name><initials>C.K.</initials><afid>60013983</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56086326000</author-url><authid>56086326000</authid><authname>Hung F.</authname><surname>Hung</surname><given-name>Faan Hei</given-name><initials>F.H.</initials><afid>60013983</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55976278300</author-url><authid>55976278300</authid><authname>Chi H.</authname><surname>Chi</surname><given-name>Hao Ran</given-name><initials>H.R.</initials><afid>60013983</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7404007467</author-url><authid>7404007467</authid><authname>Chung H.</authname><surname>Chung</surname><given-name>Henry Shu Hung</given-name><initials>H.S.H.</initials><afid>60013983</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101754058</author-url><authid>7101754058</authid><authname>Man K.</authname><surname>Man</surname><given-name>Kim Fung</given-name><initials>K.F.</initials><afid>60013983</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202688626</author-url><authid>7202688626</authid><authname>Ko K.</authname><surname>Ko</surname><given-name>King Tim</given-name><initials>K.T.</initials><afid>60013983</afid></author><authkeywords>Cardiovascular diseases | Electrocardiogram | Feature vector | Multiple criteria decision making | Support vector machine</authkeywords><intid>35484485</intid><source-id>24201</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928474518"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928474518?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928474518&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928474518&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715002190"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928474518</prism:url><dc:identifier>SCOPUS_ID:84928474518</dc:identifier><eid>2-s2.0-84928474518</eid><dc:title>Predictors of depressive disorder following acute coronary syndrome: Results from K-DEPACS and EsDEPACS</dc:title><dc:creator>Kang H.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>181</prism:volume><prism:pageRange>1-8</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.04.004</prism:doi><pii>S0165032715002190</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Introduction Depression is common and associated with poor prognosis in acute coronary syndrome (ACS). There are few reports on the predictors of incident and persistent post-discharge depressive disorders in ACS. This study aimed to investigate the incidence and persistence of depressive disorder over a one year follow-up, and predictors of these outcomes. Methods 1152 patients with recently developed ACS were recruited at baseline, and 828 were followed one year thereafter. Depressive disorder (major and minor) was diagnosed according to DSM-IV criteria, and analyzed according to baseline prevalence, and follow up incidence and persistence. Of 446 baseline participants with depressive disorders, 300 were randomized to a 24-week double blind trial of escitalopram or placebo, while the remaining 146 received medical treatment as usual. Associations of baseline socio-demographic and clinical characteristics with depressive disorder were investigated using logistic regression models. Results Two-week prevalence, and one-year incidence and persistence of depressive disorder were 38.7%, 13.1%, and 46.3%, respectively. Baseline depressive disorder was independently associated with female, lower educational level, previous ACS and higher heart rate. Incident depressive disorder was independently predicted by current unemployment, family history of depression, higher baseline Hamilton Depression Rating Scale(HAMD) score and lower left ventricular ejection fraction, and persistent depressive disorder by higher baseline HAMD score and the placebo or medical treatment as usual group in the 24-week trial. Limitations The generalizability should be considered since this study conducted in a single center. Conclusions Depressive disorder in ACS patients is common and often persistent, and is associated with baseline characteristics and insufficient treatment. Appropriate detection and treatment of depressive disorder are clearly important in ACS patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017234</affiliation-url><afid>60017234</afid><affilname>Chonnam National University, College of Medicine</affilname><name-variant>Chonnam National University Hospital</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017234</affiliation-url><afid>60017234</afid><affilname>Chonnam National University, College of Medicine</affilname><name-variant>Chonnam National University Hospital</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52263660900</author-url><authid>52263660900</authid><authname>Kang H.</authname><surname>Kang</surname><given-name>Hee Ju</given-name><initials>H.J.</initials><afid>60017234</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35594617600</author-url><authid>35594617600</authid><authname>Stewart R.</authname><surname>Stewart</surname><given-name>Robert</given-name><initials>R.</initials><afid>60011520</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35085749900</author-url><authid>35085749900</authid><authname>Bae K.</authname><surname>Bae</surname><given-name>Kyung Yeol</given-name><initials>K.Y.</initials><afid>60017234</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34975065200</author-url><authid>34975065200</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sung Wan</given-name><initials>S.W.</initials><afid>60017234</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103409198</author-url><authid>7103409198</authid><authname>Shin I.</authname><surname>Shin</surname><given-name>Il Seon</given-name><initials>I.S.</initials><afid>60017234</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56438473700</author-url><authid>56438473700</authid><authname>Hong Y.</authname><surname>Hong</surname><given-name>Young Joon</given-name><initials>Y.J.</initials><afid>60017234</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202402413</author-url><authid>7202402413</authid><authname>Ahn Y.</authname><surname>Ahn</surname><given-name>Youngkeun</given-name><initials>Y.</initials><afid>60017234</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102344356</author-url><authid>7102344356</authid><authname>Jeong M.</authname><surname>Jeong</surname><given-name>Myung Ho</given-name><initials>M.H.</initials><afid>60017234</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:34878067000</author-url><authid>34878067000</authid><authname>Yoon J.</authname><surname>Yoon</surname><given-name>Jin Sang</given-name><initials>J.S.</initials><afid>60017234</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14007693400</author-url><authid>14007693400</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jae Min</given-name><initials>J.M.</initials><afid>60017234</afid></author><authkeywords>Acute coronary syndrome | Depressive disorder | Depressive symptoms | Escitalopram | Predictor</authkeywords><intid>1535793124</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302745"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302745?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302745&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302745&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006889"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302745</prism:url><dc:identifier>SCOPUS_ID:84929302745</dc:identifier><eid>2-s2.0-84929302745</eid><dc:title>Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction</dc:title><dc:creator>Liu C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>22-32</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.425</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Pretreatment of mesenchymal stem cells (MSCs) with growth factors is reported to be an effective route for improving cell-based therapy of myocardial infarction (MI). Angiotensin II (Ang II) triggers vascular endothelial growth factor (VEGF) synthesis in MSCs. This study aimed to investigate the effects and mechanisms of Ang II pretreatment in enhancing the therapeutic efficacy of MSCs in MI. Methods: MSCs and endothelial cells (ECs) were isolated from Sprague-Dawley rats. After pretreated with or without 100 nM of Ang II for 24 h, the MSCs were directly injected into the border zones of the ischemic heart. Cardiac function, fibrosis, infarct size, VEGF expression, angiogenesis, and cell differentiation in the infarcted myocardium were determined after 30 days. The cell apoptosis of MSCs post hypoxia was assessed using flow cytometry. The angiogenic activity of MSCs was analyzed using tube formation assay. The gap junction protein connexin-43 (Cx43) expression was detected. Results: Compared with the MSC group, pretreatment of MSCs with Ang II resulted in better cardiac function, less cardiac fibrosis, smaller infarct size, and higher expression of VEGF and Von Willebrand Factor in ischemic myocardium, but no promotion of cardiomyocyte-like differentiation of MSCs. Ang II pretreatment enhanced the survival of MSCs and the H9c2 cells surrounding MSCs, and augmented the tube formation of ECs and MSCs. Ang II pretreatment up-regulated the Cx43 expression. Conclusions: The pretreatment of MSCs with Ang II improved the outcome of MSC-based therapy for MI via the mechanisms of enhancing the paracrine production of VEGF, angiogenesis, and gap junction formation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56419011000</author-url><authid>56419011000</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chao</given-name><initials>C.</initials><afid>60018310</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56419123400</author-url><authid>56419123400</authid><authname>Fan Y.</authname><surname>Fan</surname><given-name>Yue</given-name><initials>Y.</initials><afid>60018310</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56419059400</author-url><authid>56419059400</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Lu</given-name><initials>L.</initials><afid>60018310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56599350500</author-url><authid>56599350500</authid><authname>Zhu H.</authname><surname>Zhu</surname><given-name>Hong Yi</given-name><initials>H.Y.</initials><afid>60018310</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56419061300</author-url><authid>56419061300</authid><authname>Song Y.</authname><surname>Song</surname><given-name>Yi Chen</given-name><initials>Y.C.</initials><afid>60018310</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56419161700</author-url><authid>56419161700</authid><authname>Hu L.</authname><surname>Hu</surname><given-name>Liang</given-name><initials>L.</initials><afid>60018310</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56236242900</author-url><authid>56236242900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60018310</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56419005400</author-url><authid>56419005400</authid><authname>Li Q.</authname><surname>Li</surname><given-name>Qing Ping</given-name><initials>Q.P.</initials><afid>60018310</afid></author><authkeywords>Angiogenesis | Angiotensin II | Mesenchymal stem cells | Myocardial infarction | Pretreatment | Vascular endothelial growth factor</authkeywords><intid>1535945876</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930193991"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930193991?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930193991&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930193991&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001510"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930193991</prism:url><dc:identifier>SCOPUS_ID:84930193991</dc:identifier><eid>2-s2.0-84930193991</eid><dc:title>Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories</dc:title><dc:creator>Hwang H.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>79-88</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.003</prism:doi><pii>S0022282815001510</pii><dc:description>© 2015. Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are being increasingly used to model human heart diseases. hiPSC-CMs generated by earlier aggregation-based methods (i.e., embryoid body) often lack functional sarcoplasmic reticulum (SR) Ca stores characteristic of mature mammalian CMs. Newer monolayer-based cardiac differentiation methods (i.e., Matrigel sandwich or small molecule-based differentiation) produce hiPSC-CMs of high purity and yield, but their Ca handling has not been comprehensively investigated. Here, we studied Ca handling and cytosolic Ca buffering properties of hiPSC-CMs generated independently from multiple hiPSC lines at Stanford University, Vanderbilt University and University of Wisconsin-Madison. hiPSC-CMs were cryopreserved at each university. Frozen aliquots were shipped, recovered from cryopreservation, plated at low density and compared 3-5. days after plating with acutely-isolated adult rabbit and mouse ventricular CMs. Although hiPSC-CM cell volume was significantly smaller, cell capacitance to cell volume ratio and cytoplasmic Ca buffering were not different from rabbit-CMs. hiPSC-CMs from all three laboratories exhibited robust L-type Ca currents, twitch Ca transients and caffeine-releasable SR Ca stores comparable to adult CMs. Ca transport by sarcoendoplasmic reticulum Ca ATPase (SERCA) and Na/Ca exchanger (NCX) was similar in all hiPSC-CM lines, but slower compared to rabbit-CMs. However, the relative contribution of SERCA and NCX to Ca transport of hiPSC-CMs was comparable to rabbit-CMs. Ca handling maturity of hiPSC-CMs increased from 15 to 21. days post-induction. We conclude that hiPSC-CMs generated independently from multiple iPSC lines using monolayer-based methods can be reproducibly recovered from cryopreservation and exhibit comparable and functional SR Ca handling.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006475</affiliation-url><afid>60006475</afid><affilname>Vanderbilt University School of Medicine</affilname><name-variant>Vanderbilt Univ. School of Medicine</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006475</affiliation-url><afid>60006475</afid><affilname>Vanderbilt University School of Medicine</affilname><name-variant>Vanderbilt Univ. School of Medicine</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006475</affiliation-url><afid>60006475</afid><affilname>Vanderbilt University School of Medicine</affilname><name-variant>Vanderbilt Univ. School of Medicine</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100694473</affiliation-url><afid>100694473</afid><affilname>Research Medicine</affilname><name-variant>Research Medicine</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032838</affiliation-url><afid>60032838</afid><affilname>Stanford University School of Medicine</affilname><name-variant>Stanford University School of Medicine</name-variant><affiliation-city>Stanford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025553</affiliation-url><afid>60025553</afid><affilname>University of Wisconsin School of Medicine and Public Health</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35205308900</author-url><authid>35205308900</authid><authname>Hwang H.</authname><surname>Hwang</surname><given-name>Hyun Seok</given-name><initials>H.S.</initials><afid>60006475</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6504096959</author-url><authid>6504096959</authid><authname>Kryshtal D.</authname><surname>Kryshtal</surname><given-name>Dmytro O.</given-name><initials>D.O.</initials><afid>60006475</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36159422700</author-url><authid>36159422700</authid><authname>Feaster T.</authname><surname>Feaster</surname><given-name>T. K.</given-name><initials>T.K.</initials><afid>60006475</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:28568062200</author-url><authid>28568062200</authid><authname>Sánchez-Freire V.</authname><surname>Sánchez-Freire</surname><given-name>Verónica</given-name><initials>V.</initials><afid>60032838</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55209110700</author-url><authid>55209110700</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jianhua</given-name><initials>J.</initials><afid>60025553</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003801244</author-url><authid>7003801244</authid><authname>Kamp T.</authname><surname>Kamp</surname><given-name>Timothy J.</given-name><initials>T.J.</initials><afid>60025553</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35750091400</author-url><authid>35750091400</authid><authname>Hong C.</authname><surname>Hong</surname><given-name>Charles C.</given-name><initials>C.C.</initials><afid>60006475</afid><afid>100694473</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35750091400</author-url><authid>35750091400</authid><authname>Hong C.</authname><surname>Hong</surname><given-name>Charles C.</given-name><initials>C.C.</initials><afid>60006475</afid><afid>100694473</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56643384900</author-url><authid>56643384900</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>Joseph C.</given-name><initials>J.C.</initials><afid>60032838</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602739156</author-url><authid>6602739156</authid><authname>Knollmann B.</authname><surname>Knollmann</surname><given-name>Björn C.</given-name><initials>B.C.</initials><afid>60006475</afid></author><intid>2036082312</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84908217682"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84908217682?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84908217682&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84908217682&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501401171X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84908217682</prism:url><dc:identifier>SCOPUS_ID:84908217682</dc:identifier><eid>2-s2.0-84908217682</eid><dc:title>Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease</dc:title><dc:creator>Fandiño-Vaquero R.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>281-288</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.921</prism:doi><pii>S002191501401171X</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Type 2 diabetes mellitus (T2DM) is associated with fat and autonomic system dysfunction. Epicardial adipose tissue (EAT) plays an endocrine role over the heart. Since orosomucoid (ORM) has local actions around the coronaries, our aim was to assess the relationship between its secretion profile by EAT and its catecholaminergic regulation in patients with T2DM and coronary artery disease (CAD). Methods: We obtained EAT, subcutaneous adipose tissue (SAT) and plasma from 55 patients undergoing cardiac surgery. Fat explants were stimulated with isoproterenol (ISO) 1μM for 6h. After, the fat explants released-ORM and plasma levels were analyzed by ELISA. mRNA or protein expression was analyzed by real time PCR or western blot, respectively. The effects of ORM on endothelial cells were analyzed by impedance and wound healing assays. Results: We observed that EAT-released ORM levels were higher than SAT (328±185 vs 58±45ng/mL; p&lt;0.001). Interestingly, EAT secretion was lower in patients with than those without T2DM (260±141 vs 370±194ng/mL; p&lt;0.05) and this difference was enhanced after ISO stimulation (. p&lt;0.01). However, plasma levels (412±119 vs 594±207μg/mL) and EAT-released ORM levels were higher in patients with than those without CAD (384±195 vs 279±159ng/mL; p&lt;0.05). ISO stimulation, also reduced the EAT released-ORM levels in patients with CAD. On human endothelial cells, ORM induced an increase of healing and proliferation in a dose-dependent manner. Conclusion: EAT-released ORM levels in patients with T2DM or CAD and its regulation by catecholamines might be the mirror of local endothelium dysfunction or inflammatory process in different cardiovascular disorders.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106452812</affiliation-url><afid>106452812</afid><affilname>Clinical Hospital of Santiago de Compostela</affilname><name-variant>Clinical Hospital of Santiago de Compostela</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112808316</affiliation-url><afid>112808316</afid><affilname>Health Research Institute</affilname><name-variant>Health Research Institute</name-variant><affiliation-city>Donostia-San Sebastian</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106452812</affiliation-url><afid>106452812</afid><affilname>Clinical Hospital of Santiago de Compostela</affilname><name-variant>Clinical Hospital of Santiago de Compostela</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><pubmed-id>24905138</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55490938500</author-url><authid>55490938500</authid><authname>Fandiño-Vaquero R.</authname><surname>Fandiño-Vaquero</surname><given-name>Rubén</given-name><initials>R.</initials><afid>106452812</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55924571300</author-url><authid>55924571300</authid><authname>Fernández-Trasancos A.</authname><surname>Fernández-Trasancos</surname><given-name>Angel</given-name><initials>A.</initials><afid>112808316</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7203082720</author-url><authid>7203082720</authid><authname>Álvarez E.</authname><surname>Álvarez</surname><given-name>Ezequiel</given-name><initials>E.</initials><afid>112808316</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56269743200</author-url><authid>56269743200</authid><authname>Ahmad S.</authname><surname>Ahmad</surname><given-name>Samah</given-name><initials>S.</initials><afid>112808316</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56269767400</author-url><authid>56269767400</authid><authname>Batista-Oliveira A.</authname><surname>Batista-Oliveira</surname><given-name>Ana Lucía</given-name><initials>A.L.</initials><afid>112808316</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6503854920</author-url><authid>6503854920</authid><authname>Adrio B.</authname><surname>Adrio</surname><given-name>Belén</given-name><initials>B.</initials><afid>106452812</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56489332600</author-url><authid>56489332600</authid><authname>Fernández Á.</authname><surname>Fernández</surname><given-name>Ángel Luis</given-name><initials>Á.L.</initials><afid>106452812</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005529659</author-url><authid>7005529659</authid><authname>González-Juanatey J.</authname><surname>González-Juanatey</surname><given-name>José Ramón</given-name><initials>J.R.</initials><afid>106452812</afid><afid>112808316</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005529659</author-url><authid>7005529659</authid><authname>González-Juanatey J.</authname><surname>González-Juanatey</surname><given-name>José Ramón</given-name><initials>J.R.</initials><afid>106452812</afid><afid>112808316</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8862187000</author-url><authid>8862187000</authid><authname>Eiras S.</authname><surname>Eiras</surname><given-name>Sonia</given-name><initials>S.</initials><afid>112808316</afid></author><authkeywords>Epicardial adipose tissue | Orosomucoid | Type 2 diabetes mellitus</authkeywords><intid>1782428208</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929492262"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929492262?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929492262&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929492262&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0160412015001026"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929492262</prism:url><dc:identifier>SCOPUS_ID:84929492262</dc:identifier><eid>2-s2.0-84929492262</eid><dc:title>Housing interventions and health: Quantifying the impact of indoor particles on mortality and morbidity with disease recovery</dc:title><dc:creator>Milner J.</dc:creator><prism:publicationName>Environment International</prism:publicationName><prism:issn>01604120</prism:issn><prism:eIssn>18736750</prism:eIssn><prism:volume>81</prism:volume><prism:pageRange>73-79</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envint.2015.04.011</prism:doi><pii>S0160412015001026</pii><dc:description>© 2015 Elsevier Ltd. Housing interventions for energy efficiency and greenhouse gas emission reduction have the potential to reduce exposure to indoor air pollution if they are implemented correctly. This work assessed the health impacts of home energy efficiency measures in England and Wales resulting in a reduction in average indoor PM&lt;inf&gt;2.5&lt;/inf&gt; exposures of 3μgm&lt;sup&gt;-3&lt;/sup&gt;. The assessment was performed using a new multistate life table model which allows transition into and between multiple morbid states, including recovery to disease-free status and relapse, with transition rates informed by age- and cause-specific disease prevalence, incidence and mortality data. Such models have not previously included disease recovery. The results demonstrate that incorporation of recovery in the model is necessary for conditions such as asthma which have high incidence in early life but likelihood of recovery in adulthood. The impact assessment of the home energy efficiency intervention showed that the reduction in PM&lt;inf&gt;2.5&lt;/inf&gt; exposure would be associated with substantial benefits for mortality and morbidity from asthma, coronary heart disease and lung cancer. The overall impact would be an increase in life expectancy of two to three months and approximately 13 million QALYs gained over the 90year follow-up period. Substantial quality-of-life benefits were also observed, with a decrease in asthma over all age groups and larger benefits due to reduced coronary heart disease and lung cancer, particularly in older age groups. The multistate model with recovery provides important additional information for assessing the impact on health of environmental policies and interventions compared with mortality-only life tables, allowing more realistic representation of diseases with substantial non-mortality burdens.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031331</affiliation-url><afid>60031331</afid><affilname>London School of Hygiene &amp; Tropical Medicine</affilname><name-variant>London School of Hygiene and Tropical Medicine</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113647901</affiliation-url><afid>113647901</afid><affilname>Centre for Radiation, Chemical and Environmental Hazards</affilname><name-variant>Centre for Radiation, Chemical and Environmental Hazards</name-variant><affiliation-city>Didcot</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14421319200</author-url><authid>14421319200</authid><authname>Milner J.</authname><surname>Milner</surname><given-name>James</given-name><initials>J.</initials><afid>60031331</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701780461</author-url><authid>6701780461</authid><authname>Chalabi Z.</authname><surname>Chalabi</surname><given-name>Zaid</given-name><initials>Z.</initials><afid>60031331</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16835481000</author-url><authid>16835481000</authid><authname>Vardoulakis S.</authname><surname>Vardoulakis</surname><given-name>Sotiris</given-name><initials>S.</initials><afid>60031331</afid><afid>113647901</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16835481000</author-url><authid>16835481000</authid><authname>Vardoulakis S.</authname><surname>Vardoulakis</surname><given-name>Sotiris</given-name><initials>S.</initials><afid>60031331</afid><afid>113647901</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7201434649</author-url><authid>7201434649</authid><authname>Wilkinson P.</authname><surname>Wilkinson</surname><given-name>Paul</given-name><initials>P.</initials><afid>60031331</afid></author><authkeywords>Disease recovery | Health impact assessment | Indoor air pollution | Particulate matter | Quality of life</authkeywords><intid>2035958174</intid><source-id>20912</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929580818"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929580818?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929580818&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929580818&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166445X15001460"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929580818</prism:url><dc:identifier>SCOPUS_ID:84929580818</dc:identifier><eid>2-s2.0-84929580818</eid><dc:title>Comparison of the acute effects of benzo-a-pyrene on adult zebrafish (Danio rerio) cardiorespiratory function following intraperitoneal injection versus aqueous exposure</dc:title><dc:creator>Gerger C.</dc:creator><prism:publicationName>Aquatic Toxicology</prism:publicationName><prism:issn>0166445X</prism:issn><prism:eIssn>18791514</prism:eIssn><prism:volume>165</prism:volume><prism:pageRange>19-30</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquatox.2015.05.008</prism:doi><pii>S0166445X15001460</pii><dc:description>© 2015 Elsevier B.V. Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants. PAH exposure causes developmental toxicity in multiple fish species, while acute adult fish toxicity is thought to be minimal. The literature increasingly suggests sublethal PAH effects may occur, but differences in exposure route may confound conclusions. We hypothesized that acute PAH exposure in adult fish will cause cardiorespiratory impairment that will not differ with exposure route. In order to investigate this hypothesis, adult zebrafish (Danio rerio) were injected intraperitoneal (i.p.) twice with increasing concentrations of the prototypical PAH, benzo-a-pyrene (BaP; 0.1, 10, and 1000μg/kg) or exposed aqueously (static, renewal at 24h; 16.2 and 162μg/L) for 48h and compared to corresponding dimethylsulfoxide controls. No mortalities or significant effects on weight of the fish were noted at any exposure concentration or route. At 48h, fish were subjected to swimming tests with concurrent oxygen consumption measurement (n=10 fish/treatment) or echocardiography (n=12 fish/treatment). Oxygen consumption (MO&lt;inf&gt;2&lt;/inf&gt;) was increased at three swimming speeds in BaP-injected groups compared to control (p&lt;0.01 in Fisher's LSD tests after two-way ANOVA). In contrast, aqueously BaP-exposed fish showed increased MO&lt;inf&gt;2&lt;/inf&gt; under only basal conditions. Despite increased oxygen demand, ventricular heart rate was significantly decreased in BaP-exposed fish, both injected and aqueously-exposed. Analysis of BaP body burdens in fish tissue allowed for identification of an overlapping dose group between exposure routes, through which comparisons of cardiorespiratory toxicity were then made. This comparison revealed most effects were similar between the two exposures routes, although minor differences were noted. At similar BaP body burdens, injected fish suffered from more severe bradycardia than aqueously exposed fish and had greater levels of increases in cytochrome P4501A (CYP1A) mRNA levels in liver and heart tissue compared to aqueous exposed fish. In conclusion, acute BaP exposure in adult zebrafish had negative effects on cardiorespiratory function. Differences in effect between exposure routes were attributed primarily to differences in bioavailability, since overall, similar effects were noted between the two exposure routes when similar BaP body burdens were achieved.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56033390900</author-url><authid>56033390900</authid><authname>Gerger C.</authname><surname>Gerger</surname><given-name>Courtney J.</given-name><initials>C.J.</initials><afid>60015186</afid><afid>60015186</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56033390900</author-url><authid>56033390900</authid><authname>Gerger C.</authname><surname>Gerger</surname><given-name>Courtney J.</given-name><initials>C.J.</initials><afid>60015186</afid><afid>60015186</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202243313</author-url><authid>7202243313</authid><authname>Weber L.</authname><surname>Weber</surname><given-name>Lynn P.</given-name><initials>L.P.</initials><afid>60015186</afid><afid>60015186</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202243313</author-url><authid>7202243313</authid><authname>Weber L.</authname><surname>Weber</surname><given-name>Lynn P.</given-name><initials>L.P.</initials><afid>60015186</afid><afid>60015186</afid></author><authkeywords>Acute toxicity | Benzo-a-pyrene | Cardiac toxicity | Exposure route | Metabolic rate | Zebrafish</authkeywords><intid>535982748</intid><source-id>24602</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927619465"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927619465?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927619465&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927619465&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002139"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927619465</prism:url><dc:identifier>SCOPUS_ID:84927619465</dc:identifier><eid>2-s2.0-84927619465</eid><dc:title>Can perceptual indices estimate physiological strain across a range of environments and metabolic workloads when wearing explosive ordnance disposal and chemical protective clothing?</dc:title><dc:creator>Borg D.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>71-77</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.018</prism:doi><pii>S0031938415002139</pii><dc:description>© 2015 Elsevier Inc. Objective: Explosive ordnance disposal (EOD) often requires technicians to wear multiple protective garments in challenging environmental conditions. The accumulative effect of increased metabolic cost coupled with decreased heat dissipation associated with these garments predisposes technicians to high levels of physiological strain. It has been proposed that a perceptual strain index (PeSI) using subjective ratings of thermal sensation and perceived exertion as surrogate measures of core body temperature and heart rate, may provide an accurate estimation of physiological strain. Therefore, this study aimed to determine if the PeSI could estimate the physiological strain index (PSI) across a range of metabolic workloads and environments while wearing heavy EOD and chemical protective clothing. Methods: Eleven healthy males wore an EOD and chemical protective ensemble while walking on a treadmill at 2.5, 4 and 5.5km·h&lt;sup&gt;-1&lt;/sup&gt; at 1% grade in environmental conditions equivalent to wet bulb globe temperature (WBGT) 21, 30 and 37°C. WBGT conditions were randomly presented and a maximum of three randomised treadmill walking trials were completed in a single testing day. Trials were ceased at a maximum of 60-min or until the attainment of termination criteria. A Pearson's correlation coefficient, mixed linear model, absolute agreement and receiver operating characteristic (ROC) curves were used to determine the relationship between the PeSI and PSI. Results: A significant moderate relationship between the PeSI and the PSI was observed [r = 0.77; p &lt; 0.001; mean difference = 0.8 ± 1.1. a.u. (modified 95% limits of agreement - 1.3 to 3.0)]. The ROC curves indicated that the PeSI had a good predictive power when used with two, single-threshold cut-offs to differentiate between low and high levels of physiological strain (area under curve: PSI three cut-off = 0.936 and seven cut-off = 0.841). Conclusions: These findings support the use of the PeSI for monitoring physiological strain while wearing EOD and chemical protective clothing. However, future research is needed to confirm the validity of the PeSI for active EOD technicians operating in the field.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011019</affiliation-url><afid>60011019</afid><affilname>Queensland University of Technology</affilname><name-variant>Queensland University of Technology</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025475</affiliation-url><afid>60025475</afid><affilname>University of Portsmouth</affilname><name-variant>University of Portsmouth</name-variant><affiliation-city>Portsmouth</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56592377400</author-url><authid>56592377400</authid><authname>Borg D.</authname><surname>Borg</surname><given-name>David N.</given-name><initials>D.N.</initials><afid>60011019</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35273668600</author-url><authid>35273668600</authid><authname>Stewart I.</authname><surname>Stewart</surname><given-name>Ian B.</given-name><initials>I.B.</initials><afid>60011019</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36090945400</author-url><authid>36090945400</authid><authname>Costello J.</authname><surname>Costello</surname><given-name>Joseph T.</given-name><initials>J.T.</initials><afid>60011019</afid><afid>60025475</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36090945400</author-url><authid>36090945400</authid><authname>Costello J.</authname><surname>Costello</surname><given-name>Joseph T.</given-name><initials>J.T.</initials><afid>60011019</afid><afid>60025475</afid></author><authkeywords>Heat strain | Perceived exertion | Subjective measures | Thermal sensation | Thermoregulation</authkeywords><intid>35645503</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929319304"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929319304?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929319304&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929319304&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002358"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929319304</prism:url><dc:identifier>SCOPUS_ID:84929319304</dc:identifier><eid>2-s2.0-84929319304</eid><dc:title>Mild hypohydration increases the frequency of driver errors during a prolonged, monotonous driving task</dc:title><dc:creator>Watson P.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>313-318</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.028</prism:doi><pii>S0031938415002358</pii><dc:description>© 2015 The Authors. The aim of the present study was to examine the effect of mild hypohydration on performance during a prolonged, monotonous driving task. Methods: Eleven healthy males (age 22. ±. 4. y) were instructed to consume a volume of fluid in line with published guidelines (HYD trial) or 25% of this intake (FR trial) in a crossover manner. Participants came to the laboratory the following morning after an overnight fast. One hour following a standard breakfast, a 120. min driving simulation task began. Driver errors, including instances of lane drifting or late breaking, EEG and heart rate were recorded throughout the driving task. Results: Pre-trial body mass (P= 0.692), urine osmolality (P= 0.838) and serum osmolality (P= 0.574) were the same on both trials. FR resulted in a 1.1. ±. 0.7% reduction in body mass, compared to - 0.1. ±. 0.6% in the HYD trial (P= 0.002). Urine and serum osmolality were both increased following FR (P&lt; 0.05). There was a progressive increase in the total number of driver errors observed during both the HYD and FR trials, but significantly more incidents were recorded throughout the FR trial (HYD 47 ± 44, FR 101 ± 84; ES = 0.81; P= 0.006). Conclusions: The results of the present study suggest that mild hypohydration, produced a significant increase in minor driving errors during a prolonged, monotonous drive, compared to that observed while performing the same task in a hydrated condition. The magnitude of decrement reported, was similar to that observed following the ingestion of an alcoholic beverage resulting in a blood alcohol content of approximately 0.08% (the current UK legal driving limit), or while sleep deprived.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000891</affiliation-url><afid>60000891</afid><affilname>Loughborough University</affilname><name-variant>Loughborough University</name-variant><affiliation-city>Loughborough</affiliation-city><affiliation-country/></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000891</affiliation-url><afid>60000891</afid><affilname>Loughborough University</affilname><name-variant>Loughborough University</name-variant><affiliation-city>Loughborough</affiliation-city><affiliation-country/></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026810</affiliation-url><afid>60026810</afid><affilname>Vrije Universiteit Brussel</affilname><name-variant>Vrije Universiteit Brussel</name-variant><affiliation-city>Elsene</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56343569000</author-url><authid>56343569000</authid><authname>Watson P.</authname><surname>Watson</surname><given-name>Phillip</given-name><initials>P.</initials><afid>60000891</afid><afid>60026810</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56343569000</author-url><authid>56343569000</authid><authname>Watson P.</authname><surname>Watson</surname><given-name>Phillip</given-name><initials>P.</initials><afid>60000891</afid><afid>60026810</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644569900</author-url><authid>56644569900</authid><authname>Whale A.</authname><surname>Whale</surname><given-name>Andrew</given-name><initials>A.</initials><afid>60000891</afid><afid>60000891</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644569900</author-url><authid>56644569900</authid><authname>Whale A.</authname><surname>Whale</surname><given-name>Andrew</given-name><initials>A.</initials><afid>60000891</afid><afid>60000891</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55945379300</author-url><authid>55945379300</authid><authname>Mears S.</authname><surname>Mears</surname><given-name>Stephen A.</given-name><initials>S.A.</initials><afid>60000891</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602129255</author-url><authid>6602129255</authid><authname>Reyner L.</authname><surname>Reyner</surname><given-name>Louise A.</given-name><initials>L.A.</initials><afid>60000891</afid><afid>60000891</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602129255</author-url><authid>6602129255</authid><authname>Reyner L.</authname><surname>Reyner</surname><given-name>Louise A.</given-name><initials>L.A.</initials><afid>60000891</afid><afid>60000891</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35829587300</author-url><authid>35829587300</authid><authname>Maughan R.</authname><surname>Maughan</surname><given-name>Ronald J.</given-name><initials>R.J.</initials><afid>60000891</afid></author><authkeywords>Cognitive function | Dehydration | Fluid balance | Road traffic accident</authkeywords><intid>1035941415</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930221761"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930221761?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930221761&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930221761&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0163638314200208"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930221761</prism:url><dc:identifier>SCOPUS_ID:84930221761</dc:identifier><eid>2-s2.0-84930221761</eid><dc:title>Investigating the association between parental reflective functioning and distress tolerance in motherhood</dc:title><dc:creator>Rutherford H.</dc:creator><prism:publicationName>Infant Behavior and Development</prism:publicationName><prism:issn>01636383</prism:issn><prism:eIssn>19348800</prism:eIssn><prism:volume>40</prism:volume><prism:pageRange>54-63</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.infbeh.2015.04.005</prism:doi><pii>S0163638314200208</pii><dc:description>© 2015 Elsevier Inc.. Parental reflective functioning, referring to the capacity of a parent to consider their child's mental states as they relate to their behavior, may support sensitive and adaptive parenting. We investigated the relationship between parental reflective functioning and tolerance of distress in a sample of recent mothers (N=59). Participants completed self-report measures of parental reflective functioning and distress tolerance, as well as two behavioral distress tolerance tasks. We also examined blood pressure and heart rate during the laboratory session. Mothers reporting more difficulty in recognizing and understanding their child's mental states displayed decreased tolerance of distress on our behavioral and self-report measures. Further, we found evidence of a relationship between these measures and assessments of peripheral physiology. These findings are discussed in the context of reflective functioning and distress tolerance in parenthood, and their implications for parenting interventions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015278</affiliation-url><afid>60015278</afid><affilname>Yale Child Study Center</affilname><name-variant>Yale University</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009550</affiliation-url><afid>60009550</afid><affilname>Northern Illinois University</affilname><name-variant>Northern Illinois University</name-variant><affiliation-city>DeKalb</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36118230700</author-url><authid>36118230700</authid><authname>Rutherford H.</authname><surname>Rutherford</surname><given-name>Helena J V</given-name><initials>H.J.V.</initials><afid>60015278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662732000</author-url><authid>56662732000</authid><authname>Booth C.</authname><surname>Booth</surname><given-name>Cortney R.</given-name><initials>C.R.</initials><afid>60015278</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55583729200</author-url><authid>55583729200</authid><authname>Luyten P.</authname><surname>Luyten</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60025063</afid><afid>60022148</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55583729200</author-url><authid>55583729200</authid><authname>Luyten P.</authname><surname>Luyten</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60025063</afid><afid>60022148</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55955278900</author-url><authid>55955278900</authid><authname>Bridgett D.</authname><surname>Bridgett</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60009550</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006290250</author-url><authid>7006290250</authid><authname>Mayes L.</authname><surname>Mayes</surname><given-name>Linda C.</given-name><initials>L.C.</initials><afid>60015278</afid></author><authkeywords>Affect regulation | Baby simulator/BSIM | Distress tolerance | Motherhood | Parental reflective functioning</authkeywords><intid>2036082092</intid><source-id>14830</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928741958"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928741958?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928741958&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928741958&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0145305X15000713"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928741958</prism:url><dc:identifier>SCOPUS_ID:84928741958</dc:identifier><eid>2-s2.0-84928741958</eid><dc:title>β-Thymosins participate in antiviral immunity of red swamp crayfish (Procambarus clarkii)</dc:title><dc:creator>Shi X.</dc:creator><prism:publicationName>Developmental and Comparative Immunology</prism:publicationName><prism:issn>0145305X</prism:issn><prism:eIssn>18790089</prism:eIssn><prism:volume>51</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>213-225</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.dci.2015.04.003</prism:doi><pii>S0145305X15000713</pii><dc:description>© 2015 Elsevier Ltd. β-Thymosins participate in numerous biological activities, including cell proliferation and differentiation, wound healing, and anti-inflammatory and antimicrobial activities. Many studies have investigated vertebrate β-thymosins, whereas few reports have focused on invertebrate β-thymosins. In this study, nine isoforms of β-thymosins ( PcThy-1 to PcThy-8) were identified from the red swamp crayfish Procambarus clarkii. The isoforms contained different numbers of the thymosin β actin-binding motif. PcThy-1 contained one thymosin β actin-binding motif, whereas PcThy-8 contained eight motifs. Western blot analysis with anti-. PcThy-4 antibody showed that three to six isoforms were present in one tissue, and PcThy-4, PcThy-5, PcThy-6, and PcThy-7 were the main isoforms in several tissues. Time course expression analysis of PcThys at the protein level showed that PcThy-4 was upregulated in hemocytes and gills after white spot syndrome virus (WSSV) challenge. PcThy-4, which contained four thymosin β actin-binding motifs, was selected for further research. Tissue distribution analysis by quantitative real-time PCR showed that PcThy-4 was present in tissues of the hemocytes, heart, hepatopancreas, gills, stomach, and intestine at the transcriptional level. Transcriptional expression profiles showed that PcThy-4 was upregulated after WSSV challenge. In vivo RNAi and protein injection assay results showed that PcThy-4 inhibited the replication of WSSV in crayfish and enhanced the survival rate after WSSV infection. Furthermore, PcThy-4 promoted hemocyte phagocytosis of WSSV. Overall, results suggested that PcThys protected crayfish from WSSV infection and played an important role in antiviral immune response.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031031</affiliation-url><afid>60031031</afid><affilname>Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56611031200</author-url><authid>56611031200</authid><authname>Shi X.</authname><surname>Shi</surname><given-name>Xiu Zhen</given-name><initials>X.Z.</initials><afid>60031031</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55265630400</author-url><authid>55265630400</authid><authname>Shi L.</authname><surname>Shi</surname><given-name>Li Jie</given-name><initials>L.J.</initials><afid>60031031</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55911965000</author-url><authid>55911965000</authid><authname>Zhao Y.</authname><surname>Zhao</surname><given-name>Yan Ran</given-name><initials>Y.R.</initials><afid>60031031</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56504038400</author-url><authid>56504038400</authid><authname>Zhao X.</authname><surname>Zhao</surname><given-name>Xiao Fan</given-name><initials>X.F.</initials><afid>60031031</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35276370400</author-url><authid>35276370400</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jin Xing</given-name><initials>J.X.</initials><afid>60031031</afid></author><authkeywords>Antiviral immunity | Innate immunity | Procambarus clarkii | White spot syndrome virus | β-thymosin</authkeywords><intid>1535838359</intid><source-id>20775</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930202400"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930202400?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930202400&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930202400&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0278691515001386"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930202400</prism:url><dc:identifier>SCOPUS_ID:84930202400</dc:identifier><eid>2-s2.0-84930202400</eid><dc:title>Feed supplemented with byproducts from olive oil mill wastewater processing increases antioxidant capacity in broiler chickens</dc:title><dc:creator>Gerasopoulos K.</dc:creator><prism:publicationName>Food and Chemical Toxicology</prism:publicationName><prism:issn>02786915</prism:issn><prism:eIssn>18736351</prism:eIssn><prism:volume>82</prism:volume><prism:pageRange>42-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fct.2015.04.021</prism:doi><pii>S0278691515001386</pii><dc:description>© 2015. In the present study, a ceramic membrane microfiltration method was used for the separation of two liquid products, the downstream permeate and the upstream retentate, from olive mill wastewater (OMWW). These liquid products were examined for their antioxidant activity by incorporating them into broilers' feed. Twenty four broilers 13 d old were divided into two feeding groups receiving supplementation with OMWW retentate or permeate for 37 d. Blood was drawn at 17, 27 and 37 d, while tissues (muscle, heart, liver) were collected at 37 d. The antioxidant effects were assessed by measuring oxidative stress biomarkers in blood and tissues. The results showed that broilers given feed supplemented with OMWW retentate or permeate had significantly lower protein oxidation and lipid peroxidation levels and higher total antioxidant capacity in plasma and tissues compared to control group. In both OMWW groups, catalase activity in erythrocytes and tissues was significantly increased compared to control group. OMWW retentate administration increased significantly GSH in erythrocytes in broilers with low GSH, although both OMWW products significantly reduced GSH in broilers with high GSH. Thus, it has been demonstrated for the first time that supplementation with OMWW processing residues could be used for enhancing broilers' redox status.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025812</affiliation-url><afid>60025812</afid><affilname>Panepistimio Thesalias</affilname><name-variant>University of Thessaly</name-variant><affiliation-city>Volos</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115293924</affiliation-url><afid>115293924</afid><affilname>Technical Education Institute of Thessaly</affilname><name-variant>Technical Education Institute of Thessaly</name-variant><affiliation-city/><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56663095500</author-url><authid>56663095500</authid><authname>Gerasopoulos K.</authname><surname>Gerasopoulos</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60025812</afid><afid>115293924</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56663095500</author-url><authid>56663095500</authid><authname>Gerasopoulos K.</authname><surname>Gerasopoulos</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60025812</afid><afid>115293924</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16040531800</author-url><authid>16040531800</authid><authname>Stagos D.</authname><surname>Stagos</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60025812</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56663235900</author-url><authid>56663235900</authid><authname>Kokkas S.</authname><surname>Kokkas</surname><given-name>Stylianos</given-name><initials>S.</initials><afid>115293924</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506403818</author-url><authid>6506403818</authid><authname>Petrotos K.</authname><surname>Petrotos</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>115293924</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55360598200</author-url><authid>55360598200</authid><authname>Kantas D.</authname><surname>Kantas</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>115293924</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6604061530</author-url><authid>6604061530</authid><authname>Goulas P.</authname><surname>Goulas</surname><given-name>Panagiotis</given-name><initials>P.</initials><afid>115293924</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004229191</author-url><authid>7004229191</authid><authname>Kouretas D.</authname><surname>Kouretas</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60025812</afid></author><authkeywords>Antioxidant feed | Ceramic membrane microfiltration | Chickens | Natural products | Olive mill wastewater | Oxidative stress</authkeywords><intid>536086924</intid><source-id>25096</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926433316"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926433316?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926433316&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926433316&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0269749115001748"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926433316</prism:url><dc:identifier>SCOPUS_ID:84926433316</dc:identifier><eid>2-s2.0-84926433316</eid><dc:title>Cyhalofop-butyl has the potential to induce developmental toxicity, oxidative stress and apoptosis in early life stage of zebrafish (Danio rerio)</dc:title><dc:creator>Zhu L.</dc:creator><prism:publicationName>Environmental Pollution</prism:publicationName><prism:issn>02697491</prism:issn><prism:eIssn>18736424</prism:eIssn><prism:volume>203</prism:volume><prism:pageRange>40-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envpol.2015.03.044</prism:doi><pii>S0269749115001748</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Cyhalofop-butyl is a selective herbicide widely employed in paddy field, which can transfer into aquatic environments. However, details of the environmental risk and aquatic toxicity of cyhalofop-butyl have not been fully investigated. In this study, zebrafish (Danio rerio) embryos were exposed to a range of cyhalofop-butyl until 120 hour post-fertilization (hpf) to assess embryonic toxicity of the chemical. Our results demonstrated that cyhalofop-butyl was highly toxic to zebrafish embryos, with concentration-dependent negative effects in embryonic development. In addition, exposure to cyhalofop-butyl resulted in significant increases in reactive oxygen species (ROS) production and cell apoptosis in heart area. The mRNA levels of the genes related to oxidative stress and apoptosis were also altered significantly after cyhalofop-butyl exposure. Moreover, the activity of capspase-9 and caspase-3 were significantly increased. Therefore, we speculated that oxidative stress-induced apoptosis should be responsible for abnormal development during embryogenesis after cyhalofop-butyl exposure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013551</affiliation-url><afid>60013551</afid><affilname>China Agricultural University</affilname><name-variant>China Agricultural University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56054203900</author-url><authid>56054203900</authid><authname>Zhu L.</authname><surname>Zhu</surname><given-name>Lizhen</given-name><initials>L.</initials><afid>60013551</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55580813100</author-url><authid>55580813100</authid><authname>Mu X.</authname><surname>Mu</surname><given-name>Xiyan</given-name><initials>X.</initials><afid>60013551</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56254727400</author-url><authid>56254727400</authid><authname>Wang K.</authname><surname>Wang</surname><given-name>Kai</given-name><initials>K.</initials><afid>60013551</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56481143500</author-url><authid>56481143500</authid><authname>Chai T.</authname><surname>Chai</surname><given-name>Tingting</given-name><initials>T.</initials><afid>60013551</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56054595700</author-url><authid>56054595700</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60013551</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7201538005</author-url><authid>7201538005</authid><authname>Qiu L.</authname><surname>Qiu</surname><given-name>Lihong</given-name><initials>L.</initials><afid>60013551</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36992665200</author-url><authid>36992665200</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chengju</given-name><initials>C.</initials><afid>60013551</afid></author><authkeywords>Apoptosis | Cyhalofop-butyl | Developmental toxicity | Oxidative stress | Zebrafish embryo</authkeywords><intid>35453918</intid><source-id>23916</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330584"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330584?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330584&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330584&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005446"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330584</prism:url><dc:identifier>SCOPUS_ID:84929330584</dc:identifier><eid>2-s2.0-84929330584</eid><dc:title>First description of successful weaning from ECMO in a patient with Eisenmenger syndrome after repair of pulmonary artery dissection</dc:title><dc:creator>Platzmann A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>144-145</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.304</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56331945400</author-url><authid>56331945400</authid><authname>Platzmann A.</authname><surname>Platzmann</surname><given-name>Anna M.</given-name><initials>A.M.</initials><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644820000</author-url><authid>56644820000</authid><authname>Schmiady M.</authname><surname>Schmiady</surname><given-name>Martin</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8625322000</author-url><authid>8625322000</authid><authname>Rudiger A.</authname><surname>Rudiger</surname><given-name>Alain</given-name><initials>A.</initials><afid>60019619</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644498100</author-url><authid>56644498100</authid><authname>Huebler M.</authname><surname>Huebler</surname><given-name>Michael</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16636346100</author-url><authid>16636346100</authid><authname>Greutmann M.</authname><surname>Greutmann</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35475478500</author-url><authid>35475478500</authid><authname>Bettex D.</authname><surname>Bettex</surname><given-name>Dominique A.</given-name><initials>D.A.</initials><afid>60019619</afid></author><authkeywords>Congenital heart disease | ECMO | Great vessel anomalies | Pulmonary artery dissection</authkeywords><intid>35943715</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353006"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353006?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353006&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353006&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007469"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353006</prism:url><dc:identifier>SCOPUS_ID:84929353006</dc:identifier><eid>2-s2.0-84929353006</eid><dc:title>Normal values of right pulmonary to left pulmonary flow ratio in healthy individuals determined by cardiovascular magnetic resonance</dc:title><dc:creator>Fratz S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>84-85</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.027</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023561</affiliation-url><afid>60023561</afid><affilname>Centre Hospitalier Universitaire Vaudois</affilname><name-variant>CHUV</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602514238</author-url><authid>6602514238</authid><authname>Fratz S.</authname><surname>Fratz</surname><given-name>Sohrab</given-name><initials>S.</initials><afid>60019722</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602331049</author-url><authid>6602331049</authid><authname>Meierhofer C.</authname><surname>Meierhofer</surname><given-name>Christian</given-name><initials>C.</initials><afid>60019722</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602435225</author-url><authid>6602435225</authid><authname>Martinoff S.</authname><surname>Martinoff</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60019722</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004344110</author-url><authid>7004344110</authid><authname>Ewert P.</authname><surname>Ewert</surname><given-name>Peter</given-name><initials>P.</initials><afid>60019722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202088072</author-url><authid>7202088072</authid><authname>Stern H.</authname><surname>Stern</surname><given-name>Heiko</given-name><initials>H.</initials><afid>60019722</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26640716300</author-url><authid>26640716300</authid><authname>Rutz T.</authname><surname>Rutz</surname><given-name>Tobias</given-name><initials>T.</initials><afid>60019722</afid><afid>60023561</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26640716300</author-url><authid>26640716300</authid><authname>Rutz T.</authname><surname>Rutz</surname><given-name>Tobias</given-name><initials>T.</initials><afid>60019722</afid><afid>60023561</afid></author><authkeywords>Cardiac magnetic resonance | Congenital heart disease | Pulmonary flow ratio</authkeywords><intid>35944737</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346547"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346547?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346547&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346547&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007779"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346547</prism:url><dc:identifier>SCOPUS_ID:84929346547</dc:identifier><eid>2-s2.0-84929346547</eid><dc:title>Percutaneous mitral commissurotomy during pregnancy with or without pelvic lead apron use?</dc:title><dc:creator>Leroux L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>70-72</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.058</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24066732900</author-url><authid>24066732900</authid><authname>Leroux L.</authname><surname>Leroux</surname><given-name>Lionel</given-name><initials>L.</initials><afid>60102125</afid><afid>60102125</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24066732900</author-url><authid>24066732900</authid><authname>Leroux L.</authname><surname>Leroux</surname><given-name>Lionel</given-name><initials>L.</initials><afid>60102125</afid><afid>60102125</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644539500</author-url><authid>56644539500</authid><authname>Peragallo N.</authname><surname>Peragallo</surname><given-name>Nathalie</given-name><initials>N.</initials><afid>60102125</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36639299200</author-url><authid>36639299200</authid><authname>Dijos M.</authname><surname>Dijos</surname><given-name>Marina</given-name><initials>M.</initials><afid>60102125</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644938700</author-url><authid>56644938700</authid><authname>Murman M.</authname><surname>Murman</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60102125</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6505882778</author-url><authid>6505882778</authid><authname>Casassus F.</authname><surname>Casassus</surname><given-name>Frederic</given-name><initials>F.</initials><afid>60102125</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004309111</author-url><authid>7004309111</authid><authname>Coste P.</authname><surname>Coste</surname><given-name>Pierre</given-name><initials>P.</initials><afid>60102125</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55665050800</author-url><authid>55665050800</authid><authname>Dos Santos P.</authname><surname>Dos Santos</surname><given-name>Pierre</given-name><initials>P.</initials><afid>60102125</afid></author><authkeywords>Lead apron | Mitral stenosis | Percutaneous mitral commissurotomy | Pregnancy | Radiation protection | Valvular heart disease</authkeywords><intid>1785946389</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929332066"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929332066?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929332066&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929332066&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008682"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929332066</prism:url><dc:identifier>SCOPUS_ID:84929332066</dc:identifier><eid>2-s2.0-84929332066</eid><dc:title>A novel troponin T peptide in humans: Assay, biochemistry and preliminary findings in acute coronary syndromes</dc:title><dc:creator>Lee J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>68-74</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.145</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Introduction: High sensitivity assays for cardiac troponin (cTn) have reduced time to diagnosis of myocardial infarction (MI) but at costs to diagnostic specificity. We hypothesised that measurement of an upstream open reading frame peptide (uORF) from the human cTnT gene (TnTuORF) might improve cTn specificity in MI patients. Methods: A novel immunoassay to TnTuORF was developed and used to document circulating concentrations in normal healthy volunteers (n = 150); assess potential trans-organ secretion in patients undergoing cardiac catheterisation (n = 16); characterise temporal TnTuORF concentrations during ST-elevation MI (STEMI, n = 4) and assess the potential of TnTuORF to assist the diagnosis and prognosis of MI in patients presenting with chest pain suspicious of ACS (n = 502). Plasma immunoreactive TnTuORF was characterised on reverse phase and size exclusion HPLC. Results: In normal volunteers and suspected acute coronary syndrome (ACS) patients, TnTuORF had no relationship with TnI or TnT. Trans-organ venous sampling suggested TnTuORF secretion is not exclusively cardiac based. In STEMI patients, TnTuORF concentrations decreased for up to 12 h after onset. In suspected ACS patients, TnTuORF could not diagnose MI (ROC AUC = 0.446, P = 0.117) but could diagnose cardiac disorders other than MI (AUC = 0.79, P &lt; 0.001). Conclusion: This is the first evidence for a circulating uORF peptide. TnTuORF does not appear to aid the diagnosis of MI but further studies to assess its potential in cardiovascular disease are required.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017311</affiliation-url><afid>60017311</afid><affilname>University of Otago</affilname><name-variant>University of Otago</name-variant><affiliation-city>Dunedin</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017311</affiliation-url><afid>60017311</afid><affilname>University of Otago</affilname><name-variant>University of Otago</name-variant><affiliation-city>Dunedin</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031678</affiliation-url><afid>60031678</afid><affilname>Christchurch Hospital New Zealand</affilname><name-variant>Christchurch Hosp.</name-variant><affiliation-city>Christchurch</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644149100</author-url><authid>56644149100</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>J.</given-name><initials>J.</initials><afid>60017311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643573900</author-url><authid>56643573900</authid><authname>Young J.</authname><surname>Young</surname><given-name>J.</given-name><initials>J.</initials><afid>60017311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:18934387500</author-url><authid>18934387500</authid><authname>Frampton C.</authname><surname>Frampton</surname><given-name>C. M.</given-name><initials>C.M.</initials><afid>60017311</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37058583300</author-url><authid>37058583300</authid><authname>Aldous S.</authname><surname>Aldous</surname><given-name>S.</given-name><initials>S.</initials><afid>60031678</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701515502</author-url><authid>6701515502</authid><authname>Troughton R.</authname><surname>Troughton</surname><given-name>R. W.</given-name><initials>R.W.</initials><afid>60017311</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56545334400</author-url><authid>56545334400</authid><authname>Than M.</authname><surname>Than</surname><given-name>M.</given-name><initials>M.</initials><afid>60031678</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56260590000</author-url><authid>56260590000</authid><authname>Richards A.</authname><surname>Richards</surname><given-name>A. M.</given-name><initials>A.M.</initials><afid>60017311</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003383566</author-url><authid>7003383566</authid><authname>Pemberton C.</authname><surname>Pemberton</surname><given-name>C. J.</given-name><initials>C.J.</initials><afid>60017311</afid></author><authkeywords>Biomarkers | Myocardial infarction | Troponin | Upstream open reading frame</authkeywords><intid>1535944118</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929314500"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929314500?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929314500&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929314500&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007676"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929314500</prism:url><dc:identifier>SCOPUS_ID:84929314500</dc:identifier><eid>2-s2.0-84929314500</eid><dc:title>Effect of concurrent elevation of serum creatinine and C-reactive protein values on the long-term outcome in patients with ST-elevation acute myocardial infarction</dc:title><dc:creator>Kamishima K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>102-104</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.048</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025639</affiliation-url><afid>60025639</afid><affilname>Tokyo Women's Medical University</affilname><name-variant>Tokyo Women's Medical University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55618156000</author-url><authid>55618156000</authid><authname>Kamishima K.</authname><surname>Kamishima</surname><given-name>Kazuho</given-name><initials>K.</initials><afid>60025639</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56126346000</author-url><authid>56126346000</authid><authname>Yamaguchi J.</authname><surname>Yamaguchi</surname><given-name>Junichi</given-name><initials>J.</initials><afid>60025639</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35373361700</author-url><authid>35373361700</authid><authname>Honda A.</authname><surname>Honda</surname><given-name>Atsushi</given-name><initials>A.</initials><afid>60025639</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643701100</author-url><authid>56643701100</authid><authname>Ogawa H.</authname><surname>Ogawa</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60025639</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56490077200</author-url><authid>56490077200</authid><authname>Hagiwara N.</authname><surname>Hagiwara</surname><given-name>Nobuhisa</given-name><initials>N.</initials><afid>60025639</afid></author><authkeywords>Acute myocardial infarction | C-reactive protein | Creatinine | Long-term outcome</authkeywords><intid>1035941547</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359352"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359352?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359352&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359352&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007238"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359352</prism:url><dc:identifier>SCOPUS_ID:84929359352</dc:identifier><eid>2-s2.0-84929359352</eid><dc:title>Intracoronary blood sampling with a microcatheter for the diagnosis of giant infective coronary aneurysm: Melioidosis of coronary artery mycotic aneurysm</dc:title><dc:creator>Yew K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>530-531</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.013</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009426</affiliation-url><afid>60009426</afid><affilname>Sarawak General Hospital</affilname><name-variant>Sarawak General Hospital</name-variant><affiliation-city>Kuching</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012727</affiliation-url><afid>60012727</afid><affilname>Hospital Sultanah Aminah</affilname><name-variant>Hospital Sultanah Aminah</name-variant><affiliation-city>Johor Bahru</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42762568900</author-url><authid>42762568900</authid><authname>Yew K.</authname><surname>Yew</surname><given-name>Kuan Leong</given-name><initials>K.L.</initials><afid>60009426</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644133000</author-url><authid>56644133000</authid><authname>Choy C.</authname><surname>Choy</surname><given-name>Chun Ngok</given-name><initials>C.N.</initials><afid>60012727</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644346900</author-url><authid>56644346900</authid><authname>Kam J.</authname><surname>Kam</surname><given-name>Ji Yen</given-name><initials>J.Y.</initials><afid>60012727</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56602295900</author-url><authid>56602295900</authid><authname>Kang Z.</authname><surname>Kang</surname><given-name>Zarrin</given-name><initials>Z.</initials><afid>60009426</afid></author><authkeywords>Burkholderia pseudomallei | Coronary aneurysm | Intracoronary | Melioidosis | Microcatheter | Mycotic aneurysm</authkeywords><intid>35943042</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929464323"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929464323?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929464323&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929464323&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005501"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929464323</prism:url><dc:identifier>SCOPUS_ID:84929464323</dc:identifier><eid>2-s2.0-84929464323</eid><dc:title>Dynamic drug-induced organic mitral regurgitation during exercise echocardiography following chronic exposure to ergotamine</dc:title><dc:creator>Maréchaux S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>106-108</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.310</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104665</affiliation-url><afid>60104665</afid><affilname>Universite Lille Nord de France</affilname><name-variant>Université Lille Nord de</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115249939</affiliation-url><afid>115249939</afid><affilname>Clinique Anne d'Artois</affilname><name-variant>Clinique Anne d'Artois</name-variant><affiliation-city>Bethune</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005851</affiliation-url><afid>60005851</afid><affilname>Centre Hospitalier Universitaire de Grenoble</affilname><name-variant>CHU</name-variant><affiliation-city>Grenoble</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002810</affiliation-url><afid>60002810</afid><affilname>CHU Amiens Picardie</affilname><name-variant>CHU</name-variant><affiliation-city>Amiens</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016097</affiliation-url><afid>60016097</afid><affilname>Universite de Picardie Jules Verne</affilname><name-variant>Université de Picardie Jules Verne</name-variant><affiliation-city>Amiens</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23389906300</author-url><authid>23389906300</authid><authname>Maréchaux S.</authname><surname>Maréchaux</surname><given-name>Sylvestre</given-name><initials>S.</initials><afid>60104665</afid><afid>60016097</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23389906300</author-url><authid>23389906300</authid><authname>Maréchaux S.</authname><surname>Maréchaux</surname><given-name>Sylvestre</given-name><initials>S.</initials><afid>60104665</afid><afid>60016097</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648010100</author-url><authid>56648010100</authid><authname>Brahim Y.</authname><surname>Brahim</surname><given-name>Yassine Ben</given-name><initials>Y.B.</initials><afid>115249939</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603064319</author-url><authid>6603064319</authid><authname>Ennezat P.</authname><surname>Ennezat</surname><given-name>Pierre Vladimir</given-name><initials>P.V.</initials><afid>60005851</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37123871200</author-url><authid>37123871200</authid><authname>Delelis F.</authname><surname>Delelis</surname><given-name>François</given-name><initials>F.</initials><afid>60104665</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55242655700</author-url><authid>55242655700</authid><authname>Tribouilloy C.</authname><surname>Tribouilloy</surname><given-name>Christophe</given-name><initials>C.</initials><afid>60002810</afid></author><authkeywords>Drug-induced valvular heart disease | Echocardiography | Mitral regurgitation</authkeywords><intid>1785964055</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378657"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378657?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378657&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378657&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007962"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378657</prism:url><dc:identifier>SCOPUS_ID:84929378657</dc:identifier><eid>2-s2.0-84929378657</eid><dc:title>The causal link between the blood borne catecholamines and takotsubo syndrome: Too many flaws</dc:title><dc:creator>Y-Hassan S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>194-195</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.075</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24385154200</author-url><authid>24385154200</authid><authname>Y-Hassan S.</authname><surname>Y-Hassan</surname><given-name>Shams</given-name><initials>S.</initials><afid>60019295</afid></author><authkeywords>Apical ballooning | Broken heart syndrome | Catecholamines | Epinephrine | Sympathetic activation | Takotsubo</authkeywords><intid>35943421</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929336225"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929336225?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929336225&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929336225&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006294"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929336225</prism:url><dc:identifier>SCOPUS_ID:84929336225</dc:identifier><eid>2-s2.0-84929336225</eid><dc:title>Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study</dc:title><dc:creator>Brown R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>414-416</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.371</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019702</affiliation-url><afid>60019702</afid><affilname>University of Birmingham</affilname><name-variant>University of Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025471</affiliation-url><afid>60025471</afid><affilname>Sandwell General Hospital</affilname><name-variant>Sandwell Hospital</name-variant><affiliation-city>West Bromwich</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55980533200</author-url><authid>55980533200</authid><authname>Brown R.</authname><surname>Brown</surname><given-name>R. A.</given-name><initials>R.A.</initials><afid>60019702</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56601772800</author-url><authid>56601772800</authid><authname>Lip G.</authname><surname>Lip</surname><given-name>G. Y H</given-name><initials>G.Y.H.</initials><afid>60019702</afid><afid>60025471</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56601772800</author-url><authid>56601772800</authid><authname>Lip G.</authname><surname>Lip</surname><given-name>G. Y H</given-name><initials>G.Y.H.</initials><afid>60019702</afid><afid>60025471</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:13408221300</author-url><authid>13408221300</authid><authname>Varma C.</authname><surname>Varma</surname><given-name>C.</given-name><initials>C.</initials><afid>60025471</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:14025045800</author-url><authid>14025045800</authid><authname>Shantsila E.</authname><surname>Shantsila</surname><given-name>E.</given-name><initials>E.</initials><afid>60019702</afid><afid>60025471</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:14025045800</author-url><authid>14025045800</authid><authname>Shantsila E.</authname><surname>Shantsila</surname><given-name>E.</given-name><initials>E.</initials><afid>60019702</afid><afid>60025471</afid></author><authkeywords>Diurnal variation | Ethnicity | St elevation myocardial infarction | Symptom onset</authkeywords><intid>1035939322</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929298421"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929298421?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929298421&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929298421&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008244"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929298421</prism:url><dc:identifier>SCOPUS_ID:84929298421</dc:identifier><eid>2-s2.0-84929298421</eid><dc:title>Clinical significance of pulse pressure in patients with coronary artery disease</dc:title><dc:creator>Tokitsu T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>299-301</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.101</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021120</affiliation-url><afid>60021120</afid><affilname>Kumamoto University</affilname><name-variant>Kumamoto University</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100503921</affiliation-url><afid>100503921</afid><affilname>Jinnouchi Hospital</affilname><name-variant>Jinnouchi Hospital</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56012276800</author-url><authid>56012276800</authid><authname>Tokitsu T.</authname><surname>Tokitsu</surname><given-name>Takanori</given-name><initials>T.</initials><afid>60021120</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8528284300</author-url><authid>8528284300</authid><authname>Yamamoto E.</authname><surname>Yamamoto</surname><given-name>Eiichiro</given-name><initials>E.</initials><afid>60021120</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56089350200</author-url><authid>56089350200</authid><authname>Hirata Y.</authname><surname>Hirata</surname><given-name>Yoshihiro</given-name><initials>Y.</initials><afid>60021120</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55662420700</author-url><authid>55662420700</authid><authname>Fujisue K.</authname><surname>Fujisue</surname><given-name>Koichiro</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:47962595500</author-url><authid>47962595500</authid><authname>Sueta D.</authname><surname>Sueta</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60021120</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13104105900</author-url><authid>13104105900</authid><authname>Sugamura K.</authname><surname>Sugamura</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56405911900</author-url><authid>56405911900</authid><authname>Sakamoto K.</authname><surname>Sakamoto</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603691533</author-url><authid>6603691533</authid><authname>Kaikita K.</authname><surname>Kaikita</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603712750</author-url><authid>6603712750</authid><authname>Hokimoto S.</authname><surname>Hokimoto</surname><given-name>Seiji</given-name><initials>S.</initials><afid>60021120</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56471244600</author-url><authid>56471244600</authid><authname>Sugiyama S.</authname><surname>Sugiyama</surname><given-name>Seigo</given-name><initials>S.</initials><afid>60021120</afid><afid>100503921</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56471244600</author-url><authid>56471244600</authid><authname>Sugiyama S.</authname><surname>Sugiyama</surname><given-name>Seigo</given-name><initials>S.</initials><afid>60021120</afid><afid>100503921</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56559155300</author-url><authid>56559155300</authid><authname>Ogawa H.</authname><surname>Ogawa</surname><given-name>Hisao</given-name><initials>H.</initials><afid>60021120</afid></author><authkeywords>Coronary artery disease | Follow-up study | Pulse pressure</authkeywords><intid>1535945566</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929326597"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929326597?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929326597&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929326597&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006063"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929326597</prism:url><dc:identifier>SCOPUS_ID:84929326597</dc:identifier><eid>2-s2.0-84929326597</eid><dc:title>Reperfusion therapy for ST elevation acute myocardial infarction in Yemen: Description of the current situation data from Gulf Registry of Acute Coronary Events (the Gulf RACE-I)</dc:title><dc:creator>Munibari A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>128-129</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.348</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115241881</affiliation-url><afid>115241881</afid><affilname>AlThawra Modern Teaching General Hospital</affilname><name-variant>AlThawra Modern Teaching General Hospital</name-variant><affiliation-city/><affiliation-country>Yemen</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644673000</author-url><authid>56644673000</authid><authname>Munibari A.</authname><surname>Munibari</surname><given-name>A. Nasser</given-name><initials>A.N.</initials><afid>115241881</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506895008</author-url><authid>6506895008</authid><authname>Al-Motarreb A.</authname><surname>Al-Motarreb</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>115241881</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644898800</author-url><authid>56644898800</authid><authname>Alansi A.</authname><surname>Alansi</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>115241881</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:49460916900</author-url><authid>49460916900</authid><authname>Cimino S.</authname><surname>Cimino</surname><given-name>Sara</given-name><initials>S.</initials><afid>60032350</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644481700</author-url><authid>56644481700</authid><authname>LaTorre G.</authname><surname>LaTorre</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005121188</author-url><authid>7005121188</authid><authname>Agati L.</authname><surname>Agati</surname><given-name>Luciano</given-name><initials>L.</initials><afid>115241881</afid><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005121188</author-url><authid>7005121188</authid><authname>Agati L.</authname><surname>Agati</surname><given-name>Luciano</given-name><initials>L.</initials><afid>115241881</afid><afid>60032350</afid></author><authkeywords>Acute coronary syndrome | Gulf race | Thrombolytic therapy | Yemen</authkeywords><intid>535946759</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929335581"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929335581?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929335581&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929335581&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005380"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929335581</prism:url><dc:identifier>SCOPUS_ID:84929335581</dc:identifier><eid>2-s2.0-84929335581</eid><dc:title>Centenarians with acute coronary syndrome - Biological and not chronological age counts</dc:title><dc:creator>Erne P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>154</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.298</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60074583</affiliation-url><afid>60074583</afid><affilname>Klinik St. Anna</affilname><name-variant>Klinik St. Anna</name-variant><affiliation-city>Luzern</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010987</affiliation-url><afid>60010987</afid><affilname>UniversitatsSpital Bern</affilname><name-variant>University Hospital</name-variant><affiliation-city>Bern</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012614</affiliation-url><afid>60012614</afid><affilname>Universitat Zurich</affilname><name-variant>University of Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006914312</author-url><authid>7006914312</authid><authname>Erne P.</authname><surname>Erne</surname><given-name>Paul</given-name><initials>P.</initials><afid>60074583</afid><afid>60019619</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006914312</author-url><authid>7006914312</authid><authname>Erne P.</authname><surname>Erne</surname><given-name>Paul</given-name><initials>P.</initials><afid>60074583</afid><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35290764000</author-url><authid>35290764000</authid><authname>Schoenenberger A.</authname><surname>Schoenenberger</surname><given-name>Andreas W.</given-name><initials>A.W.</initials><afid>60010987</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56461552500</author-url><authid>56461552500</authid><authname>Radovanovic D.</authname><surname>Radovanovic</surname><given-name>Dragana</given-name><initials>D.</initials><afid>60012614</afid></author><authkeywords>Acute coronary syndrome | Centenarians | Outcome | Therapy</authkeywords><intid>1535943697</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929456945"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929456945?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929456945&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929456945&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500858X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929456945</prism:url><dc:identifier>SCOPUS_ID:84929456945</dc:identifier><eid>2-s2.0-84929456945</eid><dc:title>The ATLANTIC trial does not support the safety of prehospital ticagrelor treatment for patients with ST-elevation myocardial infarction</dc:title><dc:creator>Redfors B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>157-158</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.135</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54885641000</author-url><authid>54885641000</authid><authname>Redfors B.</authname><surname>Redfors</surname><given-name>Björn</given-name><initials>B.</initials><afid>60031699</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55580696900</author-url><authid>55580696900</authid><authname>Angerås O.</authname><surname>Angerås</surname><given-name>Oskar</given-name><initials>O.</initials><afid>60031699</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14422757800</author-url><authid>14422757800</authid><authname>Petursson P.</authname><surname>Petursson</surname><given-name>Petur</given-name><initials>P.</initials><afid>60031699</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12040029100</author-url><authid>12040029100</authid><authname>Råmunddal T.</authname><surname>Råmunddal</surname><given-name>Truls</given-name><initials>T.</initials><afid>60031699</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603106682</author-url><authid>6603106682</authid><authname>Omerovic E.</authname><surname>Omerovic</surname><given-name>Elmir</given-name><initials>E.</initials><afid>60031699</afid></author><authkeywords>Pre-hospital treatment | Primary percutaneous coronary intervention | ST-elevation myocardial infarction | Ticagrelor</authkeywords><intid>1785964870</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376618"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376618?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376618&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376618&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007913"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376618</prism:url><dc:identifier>SCOPUS_ID:84929376618</dc:identifier><eid>2-s2.0-84929376618</eid><dc:title>Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation</dc:title><dc:creator>Phan K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>199-203</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.072</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004437</affiliation-url><afid>60004437</afid><affilname>Westmead Hospital</affilname><name-variant>Westmead Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007895</affiliation-url><afid>60007895</afid><affilname>University Hospital Maastricht</affilname><name-variant>University Hospital Maastricht</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004437</affiliation-url><afid>60004437</afid><affilname>Westmead Hospital</affilname><name-variant>Westmead Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56527944800</author-url><authid>56527944800</authid><authname>Phan K.</authname><surname>Phan</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60004437</afid><afid>60025709</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56527944800</author-url><authid>56527944800</authid><authname>Phan K.</authname><surname>Phan</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60004437</afid><afid>60025709</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472140400</author-url><authid>56472140400</authid><authname>Wang N.</authname><surname>Wang</surname><given-name>Nelson</given-name><initials>N.</initials><afid>60025709</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26642819800</author-url><authid>26642819800</authid><authname>Pison L.</authname><surname>Pison</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60007895</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55969944400</author-url><authid>55969944400</authid><authname>Kumar N.</authname><surname>Kumar</surname><given-name>Narendra</given-name><initials>N.</initials><afid>60007895</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507964374</author-url><authid>6507964374</authid><authname>Hitos K.</authname><surname>Hitos</surname><given-name>Kerry</given-name><initials>K.</initials><afid>60025709</afid><afid>60004437</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507964374</author-url><authid>6507964374</authid><authname>Hitos K.</authname><surname>Hitos</surname><given-name>Kerry</given-name><initials>K.</initials><afid>60025709</afid><afid>60004437</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7404653959</author-url><authid>7404653959</authid><authname>Thomas S.</authname><surname>Thomas</surname><given-name>Stuart P.</given-name><initials>S.P.</initials><afid>60004437</afid><afid>60025709</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7404653959</author-url><authid>7404653959</authid><authname>Thomas S.</authname><surname>Thomas</surname><given-name>Stuart P.</given-name><initials>S.P.</initials><afid>60004437</afid><afid>60025709</afid></author><authkeywords>Catheter ablation | Dabigatran | Systematic review | Thromboembolism | VKA | Warfarin</authkeywords><intid>1035939098</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929323762"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929323762?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929323762&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929323762&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007494"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929323762</prism:url><dc:identifier>SCOPUS_ID:84929323762</dc:identifier><eid>2-s2.0-84929323762</eid><dc:title>Balloon pulmonary angioplasty using contrast agents improves impaired renal function in patients with chronic thromboembolic pulmonary hypertension</dc:title><dc:creator>Kimura M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>41-42</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.030</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025252</affiliation-url><afid>60025252</afid><affilname>Keio University School of Medicine</affilname><name-variant>Keio University School of Medicine</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56116746500</author-url><authid>56116746500</authid><authname>Kimura M.</authname><surname>Kimura</surname><given-name>Mai</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23479673700</author-url><authid>23479673700</authid><authname>Kataoka M.</authname><surname>Kataoka</surname><given-name>Masaharu</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35752049600</author-url><authid>35752049600</authid><authname>Kawakami T.</authname><surname>Kawakami</surname><given-name>Takashi</given-name><initials>T.</initials><afid>60025252</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55883638800</author-url><authid>55883638800</authid><authname>Inohara T.</authname><surname>Inohara</surname><given-name>Taku</given-name><initials>T.</initials><afid>60025252</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55365612500</author-url><authid>55365612500</authid><authname>Takei M.</authname><surname>Takei</surname><given-name>Makoto</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56364619400</author-url><authid>56364619400</authid><authname>Fukuda K.</authname><surname>Fukuda</surname><given-name>Keiichi</given-name><initials>K.</initials><afid>60025252</afid></author><authkeywords>Balloon pulmonary angioplasty | Chronic thromboembolic pulmonary | Hypertension | Renal function</authkeywords><intid>35945091</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929303067"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929303067?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929303067&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929303067&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006713"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929303067</prism:url><dc:identifier>SCOPUS_ID:84929303067</dc:identifier><eid>2-s2.0-84929303067</eid><dc:title>Empiric slow pathway ablation in suspected but not proven AVNRT: Reply to letter from Dr. Yetkin</dc:title><dc:creator>Shurrab M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>40</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.408</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029150</affiliation-url><afid>60029150</afid><affilname>Sunnybrook Health Sciences Centre</affilname><name-variant>Sunnybrook Health Sciences Centre</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37031998500</author-url><authid>37031998500</authid><authname>Shurrab M.</authname><surname>Shurrab</surname><given-name>Mohammed</given-name><initials>M.</initials><afid>60029150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472310500</author-url><authid>56472310500</authid><authname>Newman D.</authname><surname>Newman</surname><given-name>David</given-name><initials>D.</initials><afid>60029150</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35428230600</author-url><authid>35428230600</authid><authname>Crystal E.</authname><surname>Crystal</surname><given-name>Eugene</given-name><initials>E.</initials><afid>60029150</afid></author><authkeywords>AVNRT | Electrophysiology study | Empiric slow pathway ablation</authkeywords><intid>2035938583</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929497656"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929497656?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929497656&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929497656&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008980"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929497656</prism:url><dc:identifier>SCOPUS_ID:84929497656</dc:identifier><eid>2-s2.0-84929497656</eid><dc:title>Iatrogenic takotsubo cardiomyopathy</dc:title><dc:creator>Guglin M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>183-184</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.174</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507906109</author-url><authid>6507906109</authid><authname>Guglin M.</authname><surname>Guglin</surname><given-name>Maya</given-name><initials>M.</initials><afid>60015941</afid></author><authkeywords>Cardiomyopathy | Heart failure | Heart transplantation | Iatrogenic | Takotsubo</authkeywords><intid>35963508</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379974"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379974?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379974&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379974&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008190"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379974</prism:url><dc:identifier>SCOPUS_ID:84929379974</dc:identifier><eid>2-s2.0-84929379974</eid><dc:title>Discordant changes in peak O&lt;inf&gt;2&lt;/inf&gt; consumption and peak cardiac power during weight loaded treadmill exercise</dc:title><dc:creator>Lewis N.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>185-186</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.096</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024453</affiliation-url><afid>60024453</afid><affilname>Sheffield Teaching Hospitals NHS Foundation Trust</affilname><name-variant>Sheffield Teaching Hospitals NHS Trust</name-variant><affiliation-city>Sheffield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033125</affiliation-url><afid>60033125</afid><affilname>University of Leicester</affilname><name-variant>University of Leicester</name-variant><affiliation-city>Leicester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026712</affiliation-url><afid>60026712</afid><affilname>University of Newcastle upon Tyne, Faculty of Medicine</affilname><name-variant>The University</name-variant><affiliation-city>Newcastle</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006866</affiliation-url><afid>60006866</afid><affilname>Leeds General Infirmary</affilname><name-variant>Leeds General Infirmary</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15760488500</author-url><authid>15760488500</authid><authname>Lewis N.</authname><surname>Lewis</surname><given-name>N. T.</given-name><initials>N.T.</initials><afid>60024453</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22953833800</author-url><authid>22953833800</authid><authname>Hothi S.</authname><surname>Hothi</surname><given-name>S. S.</given-name><initials>S.S.</initials><afid>60033125</afid><afid>60031101</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22953833800</author-url><authid>22953833800</authid><authname>Hothi S.</authname><surname>Hothi</surname><given-name>S. S.</given-name><initials>S.S.</initials><afid>60033125</afid><afid>60031101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36060533800</author-url><authid>36060533800</authid><authname>Tan D.</authname><surname>Tan</surname><given-name>D. K H</given-name><initials>D.K.H.</initials><afid>60026712</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402233480</author-url><authid>7402233480</authid><authname>Tan L.</authname><surname>Tan</surname><given-name>L. B.</given-name><initials>L.B.</initials><afid>60006866</afid></author><authkeywords>Cardiac function | Cardiopulmonary exercise testing | Obesity | Oxygen consumption</authkeywords><intid>1535945411</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325619"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325619?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325619&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325619&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005574"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325619</prism:url><dc:identifier>SCOPUS_ID:84929325619</dc:identifier><eid>2-s2.0-84929325619</eid><dc:title>Noninvasive vagus nerve stimulation: Novel promising modulator for cardiac autonomic nerve system dysfunction</dc:title><dc:creator>Chen M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>338-339</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.317</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55882770400</author-url><authid>55882770400</authid><authname>Chen M.</authname><surname>Chen</surname><given-name>Mingxian</given-name><initials>M.</initials><afid>60082822</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35312999700</author-url><authid>35312999700</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lilei</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55712203000</author-url><authid>55712203000</authid><authname>Liu Q.</authname><surname>Liu</surname><given-name>Qiming</given-name><initials>Q.</initials><afid>60082822</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56400341600</author-url><authid>56400341600</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhuo</given-name><initials>Z.</initials><afid>60080982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56231354500</author-url><authid>56231354500</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Songyun</given-name><initials>S.</initials><afid>60080982</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640120200</author-url><authid>56640120200</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Liping</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56278651700</author-url><authid>56278651700</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56401367700</author-url><authid>56401367700</authid><authname>Zhou S.</authname><surname>Zhou</surname><given-name>Shenghua</given-name><initials>S.</initials><afid>60082822</afid></author><authkeywords>Atrial fibrillation | Autonomic nerve system | Coronary heart disease | Heart failure | Vagus nerve stimulation</authkeywords><intid>35945967</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377623"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377623?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377623&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377623&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008475"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377623</prism:url><dc:identifier>SCOPUS_ID:84929377623</dc:identifier><eid>2-s2.0-84929377623</eid><dc:title>Utility of both carotid intima-media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms</dc:title><dc:creator>Matsuzawa Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>90-98</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.124</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Myocardial perfusion scintigraphy (MPS) is used widely to assess cardiovascular risk in patients with chest pain. The utility of carotid intima-media thickness (CIMT) and endothelial function as assessed by reactive hyperemia-peripheral arterial tonometry index (RHI) in risk stratifying patients with angina-like symptoms needs to be defined. We investigated whether the addition of CIMT and RHI to Framingham Cardiovascular Risk Score (FCVRS) and MPS improves comprehensive cardiovascular risk prediction in patients presenting with angina-like symptoms. Methods: We enrolled 343 consecutive patients with angina-like symptoms suspected of having stable angina. MPS, CIMT, and RHI were performed and patients were followed for cardiovascular events for a median of 5.3 years (range 4.4-6.2). Patients were stratified by FCVRS and MPS. Results: During the follow-up, 57 patients (16.6%) had cardiovascular events. Among patients without perfusion defect, low RHI was significantly associated with cardiovascular events in the intermediate and high FCVRS groups (hazard ratio (HR) [95% confidence interval (CI)] of RHI ≤ 2.11 was 6.99 [1.34-128] in the intermediate FCVRS group and 6.08 [1.08-114] in the high FCVRS group). Furthermore, although MPS did not predict, only RHI predicted hard cardiovascular events (cardiovascular death, myocardial infarction, and stroke) independent from FCVRS, and adding RHI to FCVRS improved net reclassification index (20.9%, 95% CI 0.8-41.1, p = 0.04). Especially, RHI was significantly associated with hard cardiovascular events in the high FCVRS group (HR [95% CI] of RHI ≤ 1.93 was 5.66 [1.54-36.4], p = 0.007). Conclusions: Peripheral endothelial function may improve discrimination in identifying at-risk patients for future cardiovascular events when added to FCVRS-MPS-based risk stratification.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016437</affiliation-url><afid>60016437</afid><affilname>Goteborgs Universitet</affilname><name-variant>Göteborg University</name-variant><affiliation-city>Goteborg</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003214</affiliation-url><afid>60003214</afid><affilname>San Francisco General Hospital and Trauma Center</affilname><name-variant>San Francisco General Hospital</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000666</affiliation-url><afid>60000666</afid><affilname>AstraZeneca Sweden</affilname><name-variant>AstraZeneca Sweden ^</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56440926000</author-url><authid>56440926000</authid><authname>Matsuzawa Y.</authname><surname>Matsuzawa</surname><given-name>Yasushi</given-name><initials>Y.</initials><afid>60005558</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23991771800</author-url><authid>23991771800</authid><authname>Svedlund S.</authname><surname>Svedlund</surname><given-name>Sara</given-name><initials>S.</initials><afid>60016437</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56123800800</author-url><authid>56123800800</authid><authname>Aoki T.</authname><surname>Aoki</surname><given-name>Tatsuo</given-name><initials>T.</initials><afid>60005558</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55547377100</author-url><authid>55547377100</authid><authname>Guddeti R.</authname><surname>Guddeti</surname><given-name>Raviteja R.</given-name><initials>R.R.</initials><afid>60005558</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56425013800</author-url><authid>56425013800</authid><authname>Kwon T.</authname><surname>Kwon</surname><given-name>Taek Geun</given-name><initials>T.G.</initials><afid>60005558</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56123730900</author-url><authid>56123730900</authid><authname>Cilluffo R.</authname><surname>Cilluffo</surname><given-name>Rebecca</given-name><initials>R.</initials><afid>60005558</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55026333900</author-url><authid>55026333900</authid><authname>Widmer R.</authname><surname>Widmer</surname><given-name>R. Jay</given-name><initials>R.J.</initials><afid>60005558</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55451986000</author-url><authid>55451986000</authid><authname>Nelson R.</authname><surname>Nelson</surname><given-name>Rebecca E.</given-name><initials>R.E.</initials><afid>60005558</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56441114500</author-url><authid>56441114500</authid><authname>Lennon R.</authname><surname>Lennon</surname><given-name>Ryan J.</given-name><initials>R.J.</initials><afid>60005558</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56425474100</author-url><authid>56425474100</authid><authname>Lerman L.</authname><surname>Lerman</surname><given-name>Lilach O.</given-name><initials>L.O.</initials><afid>60005558</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56643636200</author-url><authid>56643636200</authid><authname>Gao S.</authname><surname>Gao</surname><given-name>Sinsia</given-name><initials>S.</initials><afid>60016437</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56644155700</author-url><authid>56644155700</authid><authname>Ganz P.</authname><surname>Ganz</surname><given-name>Peter</given-name><initials>P.</initials><afid>60003214</afid><afid>60023691</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56644155700</author-url><authid>56644155700</authid><authname>Ganz P.</authname><surname>Ganz</surname><given-name>Peter</given-name><initials>P.</initials><afid>60003214</afid><afid>60023691</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7202593214</author-url><authid>7202593214</authid><authname>Gan L.</authname><surname>Gan</surname><given-name>Li Ming</given-name><initials>L.M.</initials><afid>60016437</afid><afid>60000666</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7202593214</author-url><authid>7202593214</authid><authname>Gan L.</authname><surname>Gan</surname><given-name>Li Ming</given-name><initials>L.M.</initials><afid>60016437</afid><afid>60000666</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7103374935</author-url><authid>7103374935</authid><authname>Lerman A.</authname><surname>Lerman</surname><given-name>Amir</given-name><initials>A.</initials><afid>60005558</afid></author><authkeywords>Cardiovascular disease | Carotid intima-media thickness | Endothelial function | Framingham cardiovascular risk score | Myocardial perfusion | Noninvasive</authkeywords><intid>35943719</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927673835"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927673835?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927673835&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927673835&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0079656515000175"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927673835</prism:url><dc:identifier>SCOPUS_ID:84927673835</dc:identifier><eid>2-s2.0-84927673835</eid><dc:title>Small animal cardiovascular MR imaging and spectroscopy</dc:title><dc:creator>Bakermans A.</dc:creator><prism:publicationName>Progress in Nuclear Magnetic Resonance Spectroscopy</prism:publicationName><prism:issn>00796565</prism:issn><prism:volume>88-89</prism:volume><prism:pageRange>1-47</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pnmrs.2015.03.001</prism:doi><pii>S0079656515000175</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. The use of MR imaging and spectroscopy for studying cardiovascular disease processes in small animals has increased tremendously over the past decade. This is the result of the remarkable advances in MR technologies and the increased availability of genetically modified mice. MR techniques provide a window on the entire timeline of cardiovascular disease development, ranging from subtle early changes in myocardial metabolism that often mark disease onset to severe myocardial dysfunction associated with end-stage heart failure. MR imaging and spectroscopy techniques play an important role in basic cardiovascular research and in cardiovascular disease diagnosis and therapy follow-up. This is due to the broad range of functional, structural and metabolic parameters that can be quantified by MR under in vivo conditions non-invasively. This review describes the spectrum of MR techniques that are employed in small animal cardiovascular disease research and how the technological challenges resulting from the small dimensions of heart and blood vessels as well as high heart and respiratory rates, particularly in mice, are tackled.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Eindhoven University of Technology</affilname><name-variant>Biomedical NMR</name-variant><name-variant>Department of Biomedical Engineering</name-variant><affiliation-city>Eindhoven</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Amsterdam</affilname><name-variant>Academic Medical Center</name-variant><name-variant>University of Amsterdam</name-variant><affiliation-city/><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54400805800</author-url><authid>54400805800</authid><authname>Bakermans A.</authname><surname>Bakermans</surname><given-name>Adrianus J.</given-name><initials>A.J.</initials><afid/><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54400805800</author-url><authid>54400805800</authid><authname>Bakermans A.</authname><surname>Bakermans</surname><given-name>Adrianus J.</given-name><initials>A.J.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15061009100</author-url><authid>15061009100</authid><authname>Abdurrachim D.</authname><surname>Abdurrachim</surname><given-name>Desiree</given-name><initials>D.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37117398900</author-url><authid>37117398900</authid><authname>Moonen R.</authname><surname>Moonen</surname><given-name>Rik P M</given-name><initials>R.P.M.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26428327000</author-url><authid>26428327000</authid><authname>Motaal A.</authname><surname>Motaal</surname><given-name>Abdallah G.</given-name><initials>A.G.</initials><afid/><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26428327000</author-url><authid>26428327000</authid><authname>Motaal A.</authname><surname>Motaal</surname><given-name>Abdallah G.</given-name><initials>A.G.</initials><afid/><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6601895167</author-url><authid>6601895167</authid><authname>Prompers J.</authname><surname>Prompers</surname><given-name>Jeanine J.</given-name><initials>J.J.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701384173</author-url><authid>6701384173</authid><authname>Strijkers G.</authname><surname>Strijkers</surname><given-name>Gustav J.</given-name><initials>G.J.</initials><afid/><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701384173</author-url><authid>6701384173</authid><authname>Strijkers G.</authname><surname>Strijkers</surname><given-name>Gustav J.</given-name><initials>G.J.</initials><afid/><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36081477500</author-url><authid>36081477500</authid><authname>Vandoorne K.</authname><surname>Vandoorne</surname><given-name>Katrien</given-name><initials>K.</initials><afid/></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7007180335</author-url><authid>7007180335</authid><authname>Nicolay K.</authname><surname>Nicolay</surname><given-name>Klaas</given-name><initials>K.</initials><afid/></author><authkeywords>Cardiovascular diseases | Metabolism | Molecular imaging | MRI | MRS | Rodents</authkeywords><intid>535648932</intid><source-id>24085</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921516235"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921516235?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921516235&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921516235&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012283"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921516235</prism:url><dc:identifier>SCOPUS_ID:84921516235</dc:identifier><eid>2-s2.0-84921516235</eid><dc:title>Impact of overweight on myocardial infarct size in patients undergoing primary percutaneous coronary intervention: A magnetic resonance imaging study</dc:title><dc:creator>Sohn G.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>570-575</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.961</prism:doi><pii>S0021915014012283</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Although obesity is a risk factor for cardiovascular disease and mortality, several studies have reported that patients with obesity who have suffered acute myocardial infarction or have undergone percutaneous coronary intervention (PCI) have better clinical outcomes than their normal weight counterparts. We evaluated the impact of overweight on myocardial infarct size in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI). Methods: We performed contrast-enhanced magnetic resonance imaging on 193 patients undergoing primary PCI for STEMI. Infarct size was measured with delayed-enhancement imaging and the area at risk was quantified on T2-weighted images. Results: Baseline characteristics and angiographic findings were not significantly different between the normal weight group (body mass index [BMI]&lt;25kg/m2, n=110) and the overweight group (BMI≥25kg/m2, n=83). The median percent infarct volume and area at risk were significantly smaller in the overweight group than the normal weight group (17.9% [9.0-24.9%] vs. 20.8% [11.4-33.1%], p=0.04 and 29.4% [20.5-37.6%] vs. 36.0% [25.7-49.6%], p&lt;0.01, respectively). However, the myocardial salvage index was not different between the 2 groups (overweight group vs. normal weight group, 43.2% vs. 39.2%, p=0.69). BMI≥25kg/m2 was an independent predictor of smaller infarct size in multivariate analysis (Odds ratio 0.51, 95% Confidence interval 0.27-0.97, p=0.039). Conclusion: Overweight (BMI≥25kg/m2) is independently associated with smaller infarct size in patients undergoing primary PCI for STEMI.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><pubmed-id>24956530</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35206507900</author-url><authid>35206507900</authid><authname>Sohn G.</authname><surname>Sohn</surname><given-name>Gwan Hyeop</given-name><initials>G.H.</initials><afid>60016329</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56488944000</author-url><authid>56488944000</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eun Kyoung</given-name><initials>E.K.</initials><afid>60016329</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12771661800</author-url><authid>12771661800</authid><authname>Hahn J.</authname><surname>Hahn</surname><given-name>Joo Yong</given-name><initials>J.Y.</initials><afid>60016329</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56201565700</author-url><authid>56201565700</authid><authname>Song Y.</authname><surname>Song</surname><given-name>Young Bin</given-name><initials>Y.B.</initials><afid>60016329</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56124374000</author-url><authid>56124374000</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jeong Hoon</given-name><initials>J.H.</initials><afid>60016329</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56204083200</author-url><authid>56204083200</authid><authname>Chang S.</authname><surname>Chang</surname><given-name>Sung A.</given-name><initials>S.A.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56204083200</author-url><authid>56204083200</authid><authname>Chang S.</authname><surname>Chang</surname><given-name>Sung A.</given-name><initials>S.A.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56027272800</author-url><authid>56027272800</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Chol</given-name><initials>S.C.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56027272800</author-url><authid>56027272800</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Chol</given-name><initials>S.C.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36902660100</author-url><authid>36902660100</authid><authname>Choe Y.</authname><surname>Choe</surname><given-name>Yeon Hyeon</given-name><initials>Y.H.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36902660100</author-url><authid>36902660100</authid><authname>Choe Y.</authname><surname>Choe</surname><given-name>Yeon Hyeon</given-name><initials>Y.H.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56124099700</author-url><authid>56124099700</authid><authname>Choi S.</authname><surname>Choi</surname><given-name>Seung Hyuk</given-name><initials>S.H.</initials><afid>60016329</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56124484000</author-url><authid>56124484000</authid><authname>Choi J.</authname><surname>Choi</surname><given-name>Jin Ho</given-name><initials>J.H.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56124484000</author-url><authid>56124484000</authid><authname>Choi J.</authname><surname>Choi</surname><given-name>Jin Ho</given-name><initials>J.H.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56490432100</author-url><authid>56490432100</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Hoon</given-name><initials>S.H.</initials><afid>60016329</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7402155034</author-url><authid>7402155034</authid><authname>Oh J.</authname><surname>Oh</surname><given-name>Jae K.</given-name><initials>J.K.</initials><afid>60016329</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6603262426</author-url><authid>6603262426</authid><authname>Gwon H.</authname><surname>Gwon</surname><given-name>Hyeon Cheol</given-name><initials>H.C.</initials><afid>60016329</afid></author><authkeywords>Magnetic resonance imaging | Myocardial infarction | Obesity</authkeywords><intid>1034649902</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329112"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329112?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329112&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329112&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008670"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329112</prism:url><dc:identifier>SCOPUS_ID:84929329112</dc:identifier><eid>2-s2.0-84929329112</eid><dc:title>Urinary 8-hydroxy-2′-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis</dc:title><dc:creator>Kobayashi S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>319-328</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.144</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Inflammation and oxidative stress play a crucial role in the pathogenesis of cardiac sarcoidosis (SAR). We investigated whether urinary (U) 8-hydroxy-2′-deoxyguanosine (8-OHdG)-an oxidative DNA damage marker-was related to SAR inflammatory activity. Methods: U-8-OHdG levels were measured in 31 SAR patients, classified as active (n = 17) or non-active (n = 14) based on &lt;sup&gt;18&lt;/sup&gt;F-fluorodeoxyglucose positron emission tomography-computed tomography (&lt;sup&gt;18&lt;/sup&gt;F-FDG-PET/CT), 28 dilated cardiomyopathy (DCM) patients, and 30 controls. In active SAR patients, U-8-OHdG levels were reexamined and compared with &lt;sup&gt;18&lt;/sup&gt;F-FDG-PET/CT results at 6 months after corticosteroid treatment to assess therapeutic response. Results: Immunohistochemical examination of left ventricle (LV) autopsy samples from SAR patients revealed positive 8-OHdG staining in cardiomyocyte nuclei from LV sections showing &lt;sup&gt;18&lt;/sup&gt;F-FDG accumulation on PET/CT, while serum 8-OHdG levels were significantly higher in the coronary sinus than in the aortic root only in active SAR patients. U-8-OHdG levels in SAR patients were higher than those in controls, and significantly higher in active SAR patients than in non-active SAR and DCM patients. U-8-OHdG was a powerful predictor of active SAR in receiver operating characteristic curve analysis (AUC, 0.98; 95% CI, 0.94-1.02; optimal cutoff value, 13.1 ng/mg creatinine), with a sensitivity of 88.2% and a specificity of 92.9%. U-8-OHdG levels in responders significantly decreased at 6 months after corticosteroid treatment initiation, in proportion with the decrease in the focal cardiac uptake of &lt;sup&gt;18&lt;/sup&gt;F-FDG. Conclusions: U-8-OHdG is a potentially clinically useful biomarker for evaluating inflammatory activity and monitoring the effectiveness of corticosteroid therapy in SAR patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090377</affiliation-url><afid>60090377</afid><affilname>Yamaguchi University Graduate School of Medicine</affilname><name-variant>Yamaguchi University Graduate School of Medicine</name-variant><affiliation-city>Ube</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090377</affiliation-url><afid>60090377</afid><affilname>Yamaguchi University Graduate School of Medicine</affilname><name-variant>Yamaguchi University Graduate School of Medicine</name-variant><affiliation-city>Ube</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100766297</affiliation-url><afid>100766297</afid><affilname>St. Hill Hospital</affilname><name-variant>St. Hill Hospital</name-variant><affiliation-city>Ube</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55489588900</author-url><authid>55489588900</authid><authname>Kobayashi S.</authname><surname>Kobayashi</surname><given-name>Shigeki</given-name><initials>S.</initials><afid>60090377</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56020275400</author-url><authid>56020275400</authid><authname>Myoren T.</authname><surname>Myoren</surname><given-name>Takeki</given-name><initials>T.</initials><afid>60090377</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643959700</author-url><authid>56643959700</authid><authname>Oda S.</authname><surname>Oda</surname><given-name>Seiko</given-name><initials>S.</initials><afid>60090377</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644639900</author-url><authid>56644639900</authid><authname>Inari M.</authname><surname>Inari</surname><given-name>Makana</given-name><initials>M.</initials><afid>60090377</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36672922600</author-url><authid>36672922600</authid><authname>Ishiguchi H.</authname><surname>Ishiguchi</surname><given-name>Hironori</given-name><initials>H.</initials><afid>60090377</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:52564065800</author-url><authid>52564065800</authid><authname>Murakami W.</authname><surname>Murakami</surname><given-name>Wakako</given-name><initials>W.</initials><afid>60090377</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55057596100</author-url><authid>55057596100</authid><authname>Fukuda M.</authname><surname>Fukuda</surname><given-name>Masakazu</given-name><initials>M.</initials><afid>60090377</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56643443100</author-url><authid>56643443100</authid><authname>Tanaka T.</authname><surname>Tanaka</surname><given-name>Takeo</given-name><initials>T.</initials><afid>60090377</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55933368300</author-url><authid>55933368300</authid><authname>Okuda S.</authname><surname>Okuda</surname><given-name>Shinichi</given-name><initials>S.</initials><afid>60090377</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56036800100</author-url><authid>56036800100</authid><authname>Nao T.</authname><surname>Nao</surname><given-name>Tomoko</given-name><initials>T.</initials><afid>60090377</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56021437100</author-url><authid>56021437100</authid><authname>Doi M.</authname><surname>Doi</surname><given-name>Masahiro</given-name><initials>M.</initials><afid>60090377</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55651555600</author-url><authid>55651555600</authid><authname>Yamada J.</authname><surname>Yamada</surname><given-name>Jutaro</given-name><initials>J.</initials><afid>60090377</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56036800800</author-url><authid>56036800800</authid><authname>Okamura T.</authname><surname>Okamura</surname><given-name>Takayuki</given-name><initials>T.</initials><afid>60090377</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7003326335</author-url><authid>7003326335</authid><authname>Hoshii Y.</authname><surname>Hoshii</surname><given-name>Yoshinobu</given-name><initials>Y.</initials><afid>60090377</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56644129600</author-url><authid>56644129600</authid><authname>Suga K.</authname><surname>Suga</surname><given-name>Kazuyoshi</given-name><initials>K.</initials><afid>100766297</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56496337000</author-url><authid>56496337000</authid><authname>Matsuzaki M.</authname><surname>Matsuzaki</surname><given-name>Masunori</given-name><initials>M.</initials><afid>60090377</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:55988563800</author-url><authid>55988563800</authid><authname>Yano M.</authname><surname>Yano</surname><given-name>Masafumi</given-name><initials>M.</initials><afid>60090377</afid></author><authkeywords>Biomarker | Cardiac sarcoidosis | Oxidative stress</authkeywords><intid>2035940226</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929455969"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929455969?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929455969&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929455969&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008463"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929455969</prism:url><dc:identifier>SCOPUS_ID:84929455969</dc:identifier><eid>2-s2.0-84929455969</eid><dc:title>Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci</dc:title><dc:creator>Cecchi E.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>151-156</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.123</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Introduction: The epidemiology of infective endocarditis (IE) is changing due to a number of factors, including aging and health related comorbidities and medical procedures. The aim of this study is to describe the main clinical, epidemiologic and etiologic changes of IE from a large database in Italy. Methods: We prospectively collected episodes of IE in 17 Italian centers from July 2007 to December 2010. Results: We enrolled 677 patients with definite IE, of which 24% health-care associated. Patients were male (73%) with a median age of 62 years (IQR: 49-74) and 61% had several comorbidities. One hundred and twenty-eight (19%) patients had prosthetic left side IE, 391 (58%) native left side IE, 94 (14%) device-related IE and 54 (8%) right side IE. A predisposing cardiopathy was present in 50%, while odontoiatric and non odontoiatric procedures were reported in 5% and 21% of patients respectively. Symptoms were usually atypical and precocious. The prevalent etiology was represented by Staphylococcus aureus (27%) followed by coagulase-negative staphylococci (CNS, 21%), Streptococcus viridans (15%) and enterococci (14%). CNS and enterococci were relatively more frequent in patients with intravascular devices and prosthesis and S. viridans in left native valve. Diagnosis was made by transthoracic and transesophageal echocardiography in 62% and 94% of cases, respectively. The in-hospital mortality was 14% and 1-year mortality was 21%. Conclusion: The epidemiology is changing in Italy, where IE more often affects older patients with comorbidities and intravascular devices, with an acute onset and including a high frequency of enterococci. There were few preceding odontoiatric procedures.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60056635</affiliation-url><afid>60056635</afid><affilname>Ospedale Maria Vittoria</affilname><name-variant>Maria Vittoria Hospital</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114000263</affiliation-url><afid>114000263</afid><affilname>Ca' Foncello Hospital</affilname><name-variant>Ca' Foncello Hospital</name-variant><affiliation-city>Treviso</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115250050</affiliation-url><afid>115250050</afid><affilname>SSCVD Epidemiologia Clinica E Valutativa</affilname><name-variant>SSCVD Epidemiologia Clinica E Valutativa</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015300</affiliation-url><afid>60015300</afid><affilname>Universita degli Studi di Brescia</affilname><name-variant>University of Brescia</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085015</affiliation-url><afid>60085015</afid><affilname>Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona</affilname><name-variant>Ospedali Riuniti</name-variant><affiliation-city>Ancona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015708</affiliation-url><afid>60015708</afid><affilname>Ospedale Niguarda, Milan</affilname><name-variant>Niguarda Ca' Granda Hospital</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002200</affiliation-url><afid>60002200</afid><affilname>Ospedale Luigi Sacco</affilname><name-variant>Ospedale L. Sacco</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012259</affiliation-url><afid>60012259</afid><affilname>Universita degli Studi di Torino</affilname><name-variant>University of Torino</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009636</affiliation-url><afid>60009636</afid><affilname>Ospedale Mauriziano Umberto I</affilname><name-variant>Ospedale Mauriziano</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007467</affiliation-url><afid>60007467</afid><affilname>Azienda Ospedaliero - Universitaria di Parma</affilname><name-variant>Ospedale Maggiore</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012259</affiliation-url><afid>60012259</afid><affilname>Universita degli Studi di Torino</affilname><name-variant>University of Torino</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101552630</affiliation-url><afid>101552630</afid><affilname>Ospedale di Chieri</affilname><name-variant>Ospedale di Chieri</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100314780</affiliation-url><afid>100314780</afid><affilname>Reggio Emilia Hospital</affilname><name-variant>Hospital of Reggio Emilia</name-variant><affiliation-city>Reggio Emilia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019304</affiliation-url><afid>60019304</afid><affilname>Ospedale V. Cervello</affilname><name-variant>Ospedale V. Cervello</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085196</affiliation-url><afid>60085196</afid><affilname>Ospedale G. Bosco</affilname><name-variant>Ospedale G. Bosco</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109859469</affiliation-url><afid>109859469</afid><affilname>University Hospital of Firenze</affilname><name-variant>Firenze Hospital</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086666</affiliation-url><afid>60086666</afid><affilname>Ospedale Civile di Ivrea</affilname><name-variant>Ospedale di Ivrea</name-variant><affiliation-city>Ivrea</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101356028</affiliation-url><afid>101356028</afid><affilname>Rimini Hospital</affilname><name-variant>Rimini Hospital</name-variant><affiliation-city>Rimini</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103322</affiliation-url><afid>60103322</afid><affilname>Ospedale Civile di Senigallia</affilname><name-variant>Senigallia Hospital</name-variant><affiliation-city>Senigallia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">23</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003838515</author-url><authid>7003838515</authid><authname>Cecchi E.</authname><surname>Cecchi</surname><given-name>Enrico</given-name><initials>E.</initials><afid>60056635</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701716157</author-url><authid>6701716157</authid><authname>Chirillo F.</authname><surname>Chirillo</surname><given-name>Fabio</given-name><initials>F.</initials><afid>114000263</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23007542100</author-url><authid>23007542100</authid><authname>Castiglione A.</authname><surname>Castiglione</surname><given-name>Anna</given-name><initials>A.</initials><afid>115250050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005603164</author-url><authid>7005603164</authid><authname>Faggiano P.</authname><surname>Faggiano</surname><given-name>Pompilio</given-name><initials>P.</initials><afid>60015300</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003384445</author-url><authid>7003384445</authid><authname>Cecconi M.</authname><surname>Cecconi</surname><given-name>Moreno</given-name><initials>M.</initials><afid>60085015</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36807886900</author-url><authid>36807886900</authid><authname>Moreo A.</authname><surname>Moreo</surname><given-name>Antonella</given-name><initials>A.</initials><afid>60015708</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603491814</author-url><authid>6603491814</authid><authname>Cialfi A.</authname><surname>Cialfi</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60002200</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202149735</author-url><authid>7202149735</authid><authname>Rinaldi M.</authname><surname>Rinaldi</surname><given-name>Mauro</given-name><initials>M.</initials><afid>60012259</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:54584135500</author-url><authid>54584135500</authid><authname>Ponte S.</authname><surname>Ponte</surname><given-name>Stefano Del</given-name><initials>S.D.</initials><afid>60009636</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24071898400</author-url><authid>24071898400</authid><authname>Squeri A.</authname><surname>Squeri</surname><given-name>Angelo</given-name><initials>A.</initials><afid>60007467</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55323311100</author-url><authid>55323311100</authid><authname>Corcione S.</authname><surname>Corcione</surname><given-name>Silvia</given-name><initials>S.</initials><afid>60012259</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:8578490600</author-url><authid>8578490600</authid><authname>Canta F.</authname><surname>Canta</surname><given-name>Francesca</given-name><initials>F.</initials><afid>101552630</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6602807185</author-url><authid>6602807185</authid><authname>Gaddi O.</authname><surname>Gaddi</surname><given-name>Oscar</given-name><initials>O.</initials><afid>100314780</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6701734743</author-url><authid>6701734743</authid><authname>Enia F.</authname><surname>Enia</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60019304</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:8396787400</author-url><authid>8396787400</authid><authname>Forno D.</authname><surname>Forno</surname><given-name>Davide</given-name><initials>D.</initials><afid>60056635</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:16554412700</author-url><authid>16554412700</authid><authname>Costanzo P.</authname><surname>Costanzo</surname><given-name>Piera</given-name><initials>P.</initials><afid>60085196</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7004270642</author-url><authid>7004270642</authid><authname>Zuppiroli A.</authname><surname>Zuppiroli</surname><given-name>Alfredo</given-name><initials>A.</initials><afid>109859469</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602163496</author-url><authid>6602163496</authid><authname>Ronzani G.</authname><surname>Ronzani</surname><given-name>Giuliana</given-name><initials>G.</initials><afid>60086666</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:6602573035</author-url><authid>6602573035</authid><authname>Bologna F.</authname><surname>Bologna</surname><given-name>Flavio</given-name><initials>F.</initials><afid>101356028</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:25646405600</author-url><authid>25646405600</authid><authname>Patrignani A.</authname><surname>Patrignani</surname><given-name>Anna</given-name><initials>A.</initials><afid>60103322</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:7003836380</author-url><authid>7003836380</authid><authname>Belli R.</authname><surname>Belli</surname><given-name>Riccardo</given-name><initials>R.</initials><afid>60056635</afid></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:24828301300</author-url><authid>24828301300</authid><authname>Ciccone G.</authname><surname>Ciccone</surname><given-name>Giovannino</given-name><initials>G.</initials><afid>115250050</afid></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:52564256400</author-url><authid>52564256400</authid><authname>De Rosa F.</authname><surname>De Rosa</surname><given-name>Francesco Giuseppe</given-name><initials>F.G.</initials><afid>60012259</afid></author><authkeywords>Clinical presentation | Enterococcal endocarditis | Epidemiology | Infective endocarditis</authkeywords><intid>1785964897</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930225307"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930225307?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930225307&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930225307&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001583"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930225307</prism:url><dc:identifier>SCOPUS_ID:84930225307</dc:identifier><eid>2-s2.0-84930225307</eid><dc:title>Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis</dc:title><dc:creator>De Giusti C.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>58-70</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.010</prism:doi><pii>S0022282815001583</pii><dc:description>© 2015 Elsevier Ltd. Macrophage influx and galectin 3 production have been suggested as major players driving acute inflammation and chronic fibrosis in many diseases. However, their involvement in the pathogenesis of viral myocarditis and subsequent cardiomyopathy are unknown. Our aim was to characterise the role of macrophages and galectin 3 on survival, clinical course, viral burden, acute pathology, and chronic fibrosis in coxsackievirus B3 (CVB3)-induced myocarditis. Our results showed that C3H/HeJ mice infected with CVB3 and depleted of macrophages by liposome-encapsulated clodronate treatment compared with infected untreated mice presented higher viral titres but reduced acute myocarditis and chronic fibrosis, compared with untreated infected mice. Increased galectin 3 transcriptional and translational expression levels correlated with CVB3 infection in macrophages and in non-depleted mice. Disruption of the galectin 3 gene did not affect viral titres but reduced acute myocarditis and chronic fibrosis compared with C57BL/6J wild-type mice. Similar results were observed after pharmacological inhibition of galectin 3 with N-acetyl-. d-lactosamine in C3H/HeJ mice. Our results showed a critical role of macrophages and their galectin 3 in controlling acute viral-induced cardiac injury and the subsequent fibrosis. Moreover, the fact that pharmacological inhibition of galectin 3 induced similar results to macrophage depletion regarding the degree of acute cardiac inflammation and chronic fibrosis opens up the possibility of new pharmacological strategies for viral myocarditis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032057</affiliation-url><afid>60032057</afid><affilname>Universidad Nacional de La Plata</affilname><name-variant>Universidad Nacional de La Plata</name-variant><affiliation-city>La Plata</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115177124</affiliation-url><afid>115177124</afid><affilname>CONICET-ANM</affilname><name-variant>CONICET-ANM</name-variant><affiliation-city/><affiliation-country>Argentina</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36140139100</author-url><authid>36140139100</authid><authname>De Giusti C.</authname><surname>De Giusti</surname><given-name>Carolina Jaquenod</given-name><initials>C.J.</initials><afid>60032057</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24779125900</author-url><authid>24779125900</authid><authname>Ure A.</authname><surname>Ure</surname><given-name>Agustín E.</given-name><initials>A.E.</initials><afid>60032057</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54786943200</author-url><authid>54786943200</authid><authname>Rivadeneyra L.</authname><surname>Rivadeneyra</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>115177124</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003862385</author-url><authid>7003862385</authid><authname>Schattner M.</authname><surname>Schattner</surname><given-name>Mirta</given-name><initials>M.</initials><afid>115177124</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55909102600</author-url><authid>55909102600</authid><authname>Gomez R.</authname><surname>Gomez</surname><given-name>Ricardo M.</given-name><initials>R.M.</initials><afid>60032057</afid></author><authkeywords>Coxsackievirus B3 | Fibrosis | Galectin 3 | Macrophages | Myocarditis</authkeywords><intid>1536087061</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359356"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359356?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359356&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359356&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006324"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359356</prism:url><dc:identifier>SCOPUS_ID:84929359356</dc:identifier><eid>2-s2.0-84929359356</eid><dc:title>Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program</dc:title><dc:creator>Michal M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>614-619</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.374</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background/objectives: Depression and anxiety are highly prevalent in cardiovascular patients. Therefore, we examined whether the 4-item Patient Health Questionnaire (PHQ-4, measuring symptoms of depression and anxiety) predicts all-cause mortality in outpatients with long-term oral anticoagulation (OAC). Methods: The sample comprised n = 1384 outpatients from a regular medical care setting receiving long-term OAC with vitamin K antagonists. At baseline, symptoms of anxiety and depression were assessed with the PHQ-4 and the past medical history was taken. The outcome was all-cause mortality in the 24 month observation period. The median follow-up time was 13.3 months. Results: N = 191 patients from n = 1384 died (death rate 13.8%). Each point increase in the PHQ-4 score was associated with a 10% increase in mortality (hazard ratio [HR] 1.10, 95% confidence interval [95% CI] 1.05-1.16) after adjustment for age, sex, high school graduation, partnership, smoking, obesity, frailty according to the Barthel Index, Charlson Comorbidity Index and CHA&lt;inf&gt;2&lt;/inf&gt;DS&lt;inf&gt;2&lt;/inf&gt;-VASc score. The depression component (PHQ-2) increased mortality by 22% and anxiety (GAD-2) by 11% respectively. Neither medical history of any mental disorder, nor intake of antidepressants, anxiolytics or hypnotics predicted excess mortality. Conclusions: Elevated symptoms of depression and, to a lesser degree, symptoms of anxiety are independently associated with all-cause mortality in OAC outpatients. The PHQ-4 questionnaire provides valuable prognostic information. These findings emphasize the need for implementing regular screening procedures and the development and evaluation of appropriate psychosocial treatment approaches for OAC patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022135</affiliation-url><afid>60022135</afid><affilname>Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin</affilname><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022135</affiliation-url><afid>60022135</afid><affilname>Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin</affilname><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022135</affiliation-url><afid>60022135</afid><affilname>Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin</affilname><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113254928</affiliation-url><afid>113254928</afid><affilname>German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main</affilname><name-variant>German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main</name-variant><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102740772</author-url><authid>7102740772</authid><authname>Michal M.</authname><surname>Michal</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102740772</author-url><authid>7102740772</authid><authname>Michal M.</authname><surname>Michal</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56442130200</author-url><authid>56442130200</authid><authname>Prochaska J.</authname><surname>Prochaska</surname><given-name>Jürgen H.</given-name><initials>J.H.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56442130200</author-url><authid>56442130200</authid><authname>Prochaska J.</authname><surname>Prochaska</surname><given-name>Jürgen H.</given-name><initials>J.H.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55574241423</author-url><authid>55574241423</authid><authname>Keller K.</authname><surname>Keller</surname><given-name>Karsten</given-name><initials>K.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55574241423</author-url><authid>55574241423</authid><authname>Keller K.</authname><surname>Keller</surname><given-name>Karsten</given-name><initials>K.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24314755100</author-url><authid>24314755100</authid><authname>Göbel S.</authname><surname>Göbel</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24314755100</author-url><authid>24314755100</authid><authname>Göbel S.</authname><surname>Göbel</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9278235600</author-url><authid>9278235600</authid><authname>Coldewey M.</authname><surname>Coldewey</surname><given-name>Meike</given-name><initials>M.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9278235600</author-url><authid>9278235600</authid><authname>Coldewey M.</authname><surname>Coldewey</surname><given-name>Meike</given-name><initials>M.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56442170300</author-url><authid>56442170300</authid><authname>Ullmann A.</authname><surname>Ullmann</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56442170300</author-url><authid>56442170300</authid><authname>Ullmann A.</authname><surname>Ullmann</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56370855700</author-url><authid>56370855700</authid><authname>Schulz A.</authname><surname>Schulz</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60022135</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56539797900</author-url><authid>56539797900</authid><authname>Lamparter H.</authname><surname>Lamparter</surname><given-name>Heidrun</given-name><initials>H.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56539797900</author-url><authid>56539797900</authid><authname>Lamparter H.</authname><surname>Lamparter</surname><given-name>Heidrun</given-name><initials>H.</initials><afid>60022135</afid><afid>60022135</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005738983</author-url><authid>7005738983</authid><authname>Münzel T.</authname><surname>Münzel</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005738983</author-url><authid>7005738983</authid><authname>Münzel T.</authname><surname>Münzel</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60022135</afid><afid>113254928</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602671690</author-url><authid>6602671690</authid><authname>Reiner I.</authname><surname>Reiner</surname><given-name>Iris</given-name><initials>I.</initials><afid>60022135</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005494922</author-url><authid>7005494922</authid><authname>Beutel M.</authname><surname>Beutel</surname><given-name>Manfred E.</given-name><initials>M.E.</initials><afid>60022135</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35075353400</author-url><authid>35075353400</authid><authname>Wild P.</authname><surname>Wild</surname><given-name>Philipp S.</given-name><initials>P.S.</initials><afid>60022135</afid><afid>60022135</afid><afid>113254928</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35075353400</author-url><authid>35075353400</authid><authname>Wild P.</authname><surname>Wild</surname><given-name>Philipp S.</given-name><initials>P.S.</initials><afid>60022135</afid><afid>60022135</afid><afid>113254928</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35075353400</author-url><authid>35075353400</authid><authname>Wild P.</authname><surname>Wild</surname><given-name>Philipp S.</given-name><initials>P.S.</initials><afid>60022135</afid><afid>60022135</afid><afid>113254928</afid></author><authkeywords>Anxiety | Depression | Mortality | Oral anticoagulation | Patient Health Questionnaire (PHQ) | Screening</authkeywords><intid>2035940662</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929466621"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929466621?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929466621&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929466621&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008153"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929466621</prism:url><dc:identifier>SCOPUS_ID:84929466621</dc:identifier><eid>2-s2.0-84929466621</eid><dc:title>Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats</dc:title><dc:creator>Simko F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>128-130</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.092</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005728</affiliation-url><afid>60005728</afid><affilname>Comenius University Medical School</affilname><name-variant>Comenius University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005728</affiliation-url><afid>60005728</afid><affilname>Comenius University Medical School</affilname><name-variant>Comenius University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013083</affiliation-url><afid>60013083</afid><affilname>Institute of Experimental Endocrinology Slovak Academy of Sciences</affilname><name-variant>Slovak Acad. Sci.</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112967128</affiliation-url><afid>112967128</afid><affilname>Center of Excellence NOREG</affilname><name-variant>Center of Excellence NOREG</name-variant><affiliation-city/><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010330</affiliation-url><afid>60010330</afid><affilname>Slovak Academy of Sciences</affilname><name-variant>Slovak Academy of Sciences</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006176257</author-url><authid>7006176257</authid><authname>Simko F.</authname><surname>Simko</surname><given-name>Fedor</given-name><initials>F.</initials><afid>60005728</afid><afid>60005728</afid><afid>60013083</afid><afid>112967128</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006176257</author-url><authid>7006176257</authid><authname>Simko F.</authname><surname>Simko</surname><given-name>Fedor</given-name><initials>F.</initials><afid>60005728</afid><afid>60005728</afid><afid>60013083</afid><afid>112967128</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006176257</author-url><authid>7006176257</authid><authname>Simko F.</authname><surname>Simko</surname><given-name>Fedor</given-name><initials>F.</initials><afid>60005728</afid><afid>60005728</afid><afid>60013083</afid><afid>112967128</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006176257</author-url><authid>7006176257</authid><authname>Simko F.</authname><surname>Simko</surname><given-name>Fedor</given-name><initials>F.</initials><afid>60005728</afid><afid>60005728</afid><afid>60013083</afid><afid>112967128</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003414054</author-url><authid>7003414054</authid><authname>Pechanova O.</authname><surname>Pechanova</surname><given-name>Olga</given-name><initials>O.</initials><afid>112967128</afid><afid>60010330</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003414054</author-url><authid>7003414054</authid><authname>Pechanova O.</authname><surname>Pechanova</surname><given-name>Olga</given-name><initials>O.</initials><afid>112967128</afid><afid>60010330</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23477543000</author-url><authid>23477543000</authid><authname>Krajcirovicova K.</authname><surname>Krajcirovicova</surname><given-name>Kristina</given-name><initials>K.</initials><afid>60005728</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8506172400</author-url><authid>8506172400</authid><authname>Matuskova J.</authname><surname>Matuskova</surname><given-name>Jana</given-name><initials>J.</initials><afid>60005728</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006975962</author-url><authid>7006975962</authid><authname>Pelouch V.</authname><surname>Pelouch</surname><given-name>Vaclav</given-name><initials>V.</initials><afid>60016605</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003586451</author-url><authid>7003586451</authid><authname>Adamcova M.</authname><surname>Adamcova</surname><given-name>Michaela</given-name><initials>M.</initials><afid>60016605</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14032104600</author-url><authid>14032104600</authid><authname>Paulis L.</authname><surname>Paulis</surname><given-name>Ludovit</given-name><initials>L.</initials><afid>60005728</afid><afid>112967128</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14032104600</author-url><authid>14032104600</authid><authname>Paulis L.</authname><surname>Paulis</surname><given-name>Ludovit</given-name><initials>L.</initials><afid>60005728</afid><afid>112967128</afid></author><authkeywords>Captopril | Endothelial function | Fibrosis | Non-diseased heart | Protection | Protein remodeling | Simvastatin | Spironolactone</authkeywords><intid>2035959435</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929457974"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929457974?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929457974&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929457974&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007706"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929457974</prism:url><dc:identifier>SCOPUS_ID:84929457974</dc:identifier><eid>2-s2.0-84929457974</eid><dc:title>Extracardiac autonomic modulations: Potential therapeutic options for myocardial ischemia-induced ventricular arrhythmia</dc:title><dc:creator>Huang B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>45-46</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.051</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55572503600</author-url><authid>55572503600</authid><authname>Huang B.</authname><surname>Huang</surname><given-name>Bing</given-name><initials>B.</initials><afid>60080982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56231023800</author-url><authid>56231023800</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiaoya</given-name><initials>X.</initials><afid>60080982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56400341600</author-url><authid>56400341600</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhuo</given-name><initials>Z.</initials><afid>60080982</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56231354500</author-url><authid>56231354500</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Songyun</given-name><initials>S.</initials><afid>60080982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35312999700</author-url><authid>35312999700</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lilei</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56278651700</author-url><authid>56278651700</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><authkeywords>Autonomic nervous system | Myocardial ischemia | Ventricular arrhythmia</authkeywords><intid>535964749</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302065"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302065?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302065&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302065&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008232"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302065</prism:url><dc:identifier>SCOPUS_ID:84929302065</dc:identifier><eid>2-s2.0-84929302065</eid><dc:title>VO&lt;inf&gt;2max&lt;/inf&gt;/kg is expected to be lower in obese individuals!</dc:title><dc:creator>Krachler B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>234</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.100</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103673</affiliation-url><afid>60103673</afid><affilname>Ita-Suomen yliopisto</affilname><name-variant>University of Eastern Finland</name-variant><affiliation-city>Kuopio</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031040</affiliation-url><afid>60031040</afid><affilname>Umea universitet</affilname><name-variant>Umeå University</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024252</affiliation-url><afid>60024252</afid><affilname>University Central Hospital Kuopio</affilname><name-variant>Kuopio University Hospital</name-variant><affiliation-city>Kuopio</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103673</affiliation-url><afid>60103673</afid><affilname>Ita-Suomen yliopisto</affilname><name-variant>University of Eastern Finland</name-variant><affiliation-city>Kuopio</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9038104900</author-url><authid>9038104900</authid><authname>Krachler B.</authname><surname>Krachler</surname><given-name>Benno</given-name><initials>B.</initials><afid>60103673</afid><afid>60031040</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9038104900</author-url><authid>9038104900</authid><authname>Krachler B.</authname><surname>Krachler</surname><given-name>Benno</given-name><initials>B.</initials><afid>60103673</afid><afid>60031040</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12792938900</author-url><authid>12792938900</authid><authname>Savonen K.</authname><surname>Savonen</surname><given-name>Kai</given-name><initials>K.</initials><afid>60103673</afid><afid>60024252</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12792938900</author-url><authid>12792938900</authid><authname>Savonen K.</authname><surname>Savonen</surname><given-name>Kai</given-name><initials>K.</initials><afid>60103673</afid><afid>60024252</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12759709500</author-url><authid>12759709500</authid><authname>Komulainen P.</authname><surname>Komulainen</surname><given-name>Pirjo</given-name><initials>P.</initials><afid>60103673</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55913227900</author-url><authid>55913227900</authid><authname>Hassinen M.</authname><surname>Hassinen</surname><given-name>Maija</given-name><initials>M.</initials><afid>60103673</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007104204</author-url><authid>7007104204</authid><authname>Lakka T.</authname><surname>Lakka</surname><given-name>Timo A.</given-name><initials>T.A.</initials><afid>60103673</afid><afid>60103673</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007104204</author-url><authid>7007104204</authid><authname>Lakka T.</authname><surname>Lakka</surname><given-name>Timo A.</given-name><initials>T.A.</initials><afid>60103673</afid><afid>60103673</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006315020</author-url><authid>7006315020</authid><authname>Rauramaa R.</authname><surname>Rauramaa</surname><given-name>Rainer</given-name><initials>R.</initials><afid>60103673</afid><afid>60024252</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006315020</author-url><authid>7006315020</authid><authname>Rauramaa R.</authname><surname>Rauramaa</surname><given-name>Rainer</given-name><initials>R.</initials><afid>60103673</afid><afid>60024252</afid></author><authkeywords>Body composition | Cardiopulmonary fitness | Exercise capacity | Heart failure | Maximal oxygen uptake | Obesity</authkeywords><intid>35943140</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928911195"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928911195?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928911195&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928911195&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167488915001354"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928911195</prism:url><dc:identifier>SCOPUS_ID:84928911195</dc:identifier><eid>2-s2.0-84928911195</eid><dc:title>Functional and physiopathological implications of TRP channels</dc:title><dc:creator>Smani T.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Cell Research</prism:publicationName><prism:issn>01674889</prism:issn><prism:eIssn>18792596</prism:eIssn><prism:volume>1853</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1772-1782</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamcr.2015.04.016</prism:doi><pii>S0167488915001354</pii><dc:description>© 2015 Elsevier B.V. Transient Receptor Potential (TRP) channel proteins are a diverse family of proteins that are expressed in many organisms, tissues and cell types. TRP channels respond to a variety of stimuli, including light, mechanical or chemical stimuli, temperature, pH or osmolarity. In addition, several TRP family members have been identified as downstream molecules in the G protein-coupled receptor signaling pathway. TRP proteins are involved in a variety of cell functions both in non-excitable and excitable cells due to their diverse permeability to cations and their ability to modulate intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; signaling. Emerging evidence suggests that TRP channel dysfunction significantly contributes to the physiopathology of a number of diseases, including cardiovascular, neurological, metabolic or neoplastic disorders. This review focuses on the implication of TRP proteins in the pathogenesis of some of the most prevalent disorders in human. We summarize the current findings regarding the role of TRP proteins in the development of cardiovascular disease, diabetes mellitus as well as diabetic complications, and tumorigenesis and present TRP proteins as targets of potential diagnostic and therapeutic strategies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114957639</affiliation-url><afid>114957639</afid><affilname>Institute of Biomedicine of Sevilla</affilname><name-variant>Institute of Biomedicine</name-variant><affiliation-city>Sevilla</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009448</affiliation-url><afid>60009448</afid><affilname>Universite des Sciences et Technologies de Lille</affilname><name-variant>Université des Sciences et Technologies de Lille</name-variant><affiliation-city>Villeneuve d'Ascq Cedex</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017838</affiliation-url><afid>60017838</afid><affilname>Universidad de Extremadura</affilname><name-variant>Universidad de Extremadura</name-variant><affiliation-city>Badajoz</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603352960</author-url><authid>6603352960</authid><authname>Smani T.</authname><surname>Smani</surname><given-name>Tarik</given-name><initials>T.</initials><afid>114957639</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701427450</author-url><authid>6701427450</authid><authname>Shapovalov G.</authname><surname>Shapovalov</surname><given-name>George</given-name><initials>G.</initials><afid>60009448</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003889998</author-url><authid>7003889998</authid><authname>Skryma R.</authname><surname>Skryma</surname><given-name>Roman</given-name><initials>R.</initials><afid>60009448</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003870328</author-url><authid>7003870328</authid><authname>Prevarskaya N.</authname><surname>Prevarskaya</surname><given-name>Natalia</given-name><initials>N.</initials><afid>60009448</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007174034</author-url><authid>7007174034</authid><authname>Rosado J.</authname><surname>Rosado</surname><given-name>Juan A.</given-name><initials>J.A.</initials><afid>60017838</afid></author><authkeywords>Cancer cells | Cardiovascular disorders | Diabetes mellitus | TRP channels | Tumorigenesis</authkeywords><intid>1535861141</intid><source-id>18408</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929298923"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929298923?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929298923&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929298923&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008050"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929298923</prism:url><dc:identifier>SCOPUS_ID:84929298923</dc:identifier><eid>2-s2.0-84929298923</eid><dc:title>Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis</dc:title><dc:creator>Rossi A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>15-17</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.083</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032256</affiliation-url><afid>60032256</afid><affilname>Universita degli Studi di Verona</affilname><name-variant>University of Verona</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018722</affiliation-url><afid>60018722</afid><affilname>IRCCS Fondazione Salvatore Maugeri</affilname><name-variant>IRCCS</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004969</affiliation-url><afid>60004969</afid><affilname>Universita degli Studi di Parma</affilname><name-variant>Università di Parma</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100332328</affiliation-url><afid>100332328</afid><affilname>Villa Bianca Hospital</affilname><name-variant>Villa Bianca Hospital</name-variant><affiliation-city>Trento</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112361108</affiliation-url><afid>112361108</afid><affilname>Cardiology Service</affilname><name-variant>Cardiology Service</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015300</affiliation-url><afid>60015300</afid><affilname>Universita degli Studi di Brescia</affilname><name-variant>University of Brescia</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112788309</affiliation-url><afid>112788309</afid><affilname>Maria Cecilia Hospital</affilname><name-variant>Maria Cecilia Hospital</name-variant><affiliation-city>Cotignola</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7403475016</author-url><authid>7403475016</authid><authname>Rossi A.</authname><surname>Rossi</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60032256</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35588032100</author-url><authid>35588032100</authid><authname>Temporelli P.</authname><surname>Temporelli</surname><given-name>Pier Luigi</given-name><initials>P.L.</initials><afid>60018722</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003362045</author-url><authid>7003362045</authid><authname>Cicoira M.</authname><surname>Cicoira</surname><given-name>Mariantonietta</given-name><initials>M.</initials><afid>60032256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603190525</author-url><authid>6603190525</authid><authname>Gaibazzi N.</authname><surname>Gaibazzi</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60004969</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005213408</author-url><authid>7005213408</authid><authname>Cioffi G.</authname><surname>Cioffi</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>100332328</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701778266</author-url><authid>6701778266</authid><authname>Nistri S.</authname><surname>Nistri</surname><given-name>Stefano</given-name><initials>S.</initials><afid>112361108</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55659847000</author-url><authid>55659847000</authid><authname>Magatelli M.</authname><surname>Magatelli</surname><given-name>Marco</given-name><initials>M.</initials><afid>60015300</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102746954</author-url><authid>7102746954</authid><authname>Tavazzi L.</authname><surname>Tavazzi</surname><given-name>Luigi</given-name><initials>L.</initials><afid>112788309</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005603164</author-url><authid>7005603164</authid><authname>Faggiano P.</authname><surname>Faggiano</surname><given-name>Pompilio</given-name><initials>P.</initials><afid>60015300</afid></author><authkeywords>Aortic stenosis | Beta blockers | Prognosis</authkeywords><intid>535947415</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927133231"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927133231?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927133231&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927133231&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0269749115001803"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927133231</prism:url><dc:identifier>SCOPUS_ID:84927133231</dc:identifier><eid>2-s2.0-84927133231</eid><dc:title>Ambient air pollution, temperature and out-of-hospital coronary deaths in Shanghai, China</dc:title><dc:creator>Dai J.</dc:creator><prism:publicationName>Environmental Pollution</prism:publicationName><prism:issn>02697491</prism:issn><prism:eIssn>18736424</prism:eIssn><prism:volume>203</prism:volume><prism:pageRange>116-121</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envpol.2015.03.050</prism:doi><pii>S0269749115001803</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Few studies have evaluated the effects of ambient air pollution and temperature in triggering out-of-hospital coronary deaths (OHCDs) in China. We evaluated the associations of air pollution and temperature with daily OHCDs in Shanghai, China from 2006 to 2011. We applied an over-dispersed generalized additive model and a distributed lag nonlinear model to analyze the effects of air pollution and temperature, respectively. A 10 μg/m&lt;sup&gt;3&lt;/sup&gt; increase in the present-day PM&lt;inf&gt;10&lt;/inf&gt;, PM&lt;inf&gt;2.5&lt;/inf&gt;, SO&lt;inf&gt;2&lt;/inf&gt;, NO&lt;inf&gt;2&lt;/inf&gt; and CO were associated with increases in OHCD mortality of 0.49%, 0.68%, 0.88%, 1.60% and 0.08%, respectively. A 1 °C decrease below the minimum-mortality temperature corresponded to a 3.81% increase in OHCD mortality on lags days 0-21, and a 1 °C increase above minimum-mortality temperature corresponded to a 4.61% increase over lag days 0-3. No effects were found for in-hospital coronary deaths. This analysis suggests that air pollution, low temperature and high temperature may increase the risk of OHCDs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Shandong Provincial Environmental Monitoring Center Station</affilname><affiliation-city>Ji'nan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Fudan University</affilname><name-variant>School of Public Health</name-variant><name-variant>Key Lab of Public Health Safety of the Ministry of Education</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Fudan University</affilname><name-variant>Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3)</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Fudan University</affilname><name-variant>Key Lab of Health Technology Assessment of the Ministry of Health</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587248000</author-url><authid>56587248000</authid><authname>Dai J.</authname><surname>Dai</surname><given-name>Jinping</given-name><initials>J.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55718473600</author-url><authid>55718473600</authid><authname>Chen R.</authname><surname>Chen</surname><given-name>Renjie</given-name><initials>R.</initials><afid/><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55718473600</author-url><authid>55718473600</authid><authname>Chen R.</authname><surname>Chen</surname><given-name>Renjie</given-name><initials>R.</initials><afid/><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55718473600</author-url><authid>55718473600</authid><authname>Chen R.</authname><surname>Chen</surname><given-name>Renjie</given-name><initials>R.</initials><afid/><afid/><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55513685100</author-url><authid>55513685100</authid><authname>Meng X.</authname><surname>Meng</surname><given-name>Xia</given-name><initials>X.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56395614400</author-url><authid>56395614400</authid><authname>Yang C.</authname><surname>Yang</surname><given-name>Changyuan</given-name><initials>C.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56306712700</author-url><authid>56306712700</authid><authname>Zhao Z.</authname><surname>Zhao</surname><given-name>Zhuohui</given-name><initials>Z.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101602991</author-url><authid>7101602991</authid><authname>Kan H.</authname><surname>Kan</surname><given-name>Haidong</given-name><initials>H.</initials><afid/><afid/><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101602991</author-url><authid>7101602991</authid><authname>Kan H.</authname><surname>Kan</surname><given-name>Haidong</given-name><initials>H.</initials><afid/><afid/><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101602991</author-url><authid>7101602991</authid><authname>Kan H.</authname><surname>Kan</surname><given-name>Haidong</given-name><initials>H.</initials><afid/><afid/><afid/></author><authkeywords>Air pollution | Coronary heart disease | Out-of-hospital | Risk factors | Temperature</authkeywords><intid>1785571354</intid><source-id>23916</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929324579"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929324579?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929324579&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929324579&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008104"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929324579</prism:url><dc:identifier>SCOPUS_ID:84929324579</dc:identifier><eid>2-s2.0-84929324579</eid><dc:title>Unilateral low-level transcutaneous electrical vagus nerve stimulation: A novel noninvasive treatment for myocardial infarction</dc:title><dc:creator>Wang Z.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>9-10</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.087</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029310</affiliation-url><afid>60029310</afid><affilname>Zhejiang University School of Medicine</affilname><name-variant>Zhejiang Medical University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56400341600</author-url><authid>56400341600</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhuo</given-name><initials>Z.</initials><afid>60080982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56231023800</author-url><authid>56231023800</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiaoya</given-name><initials>X.</initials><afid>60080982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640621300</author-url><authid>56640621300</authid><authname>Sheng X.</authname><surname>Sheng</surname><given-name>Xia</given-name><initials>X.</initials><afid>60029310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35312999700</author-url><authid>35312999700</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lilei</given-name><initials>L.</initials><afid>60080982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56278651700</author-url><authid>56278651700</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><authkeywords>Myocardial infarction | Remodeling | Unilateral transcutaneous vagus nerve stimulation</authkeywords><intid>2035941146</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929466098"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929466098?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929466098&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929466098&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008025"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929466098</prism:url><dc:identifier>SCOPUS_ID:84929466098</dc:identifier><eid>2-s2.0-84929466098</eid><dc:title>Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia</dc:title><dc:creator>Tsai W.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>172-181</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.080</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Sex hormones and calcium (Ca&lt;sup&gt;2+&lt;/sup&gt;) regulation play roles in the pathophysiology of ventricular tachycardia from right ventricular outflow tract (RVOT). The purpose of this study was to evaluate whether androgen receptor knockout (ARKO) can increase RVOT arrhythmogenesis through modulating RVOT electrophysiology and Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis. Methods: Conventional microelectrodes were used to study the action potential (AP) in RVOT tissues prepared from wild type (WT) and ARKO mice (aged 6-10 months) before and after caffeine (1 mM), isoproterenol (1 μM), adenosine (10 μM) and flecainide (5 μM) administration. The Fluo-3 fluorescence Ca&lt;sup&gt;2+&lt;/sup&gt; imaging with confocal microscopy and western blots were used to investigate intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; (Ca&lt;sup&gt;2+&lt;/sup&gt;&lt;inf&gt;i&lt;/inf&gt;) transients, Ca&lt;sup&gt;2+&lt;/sup&gt; sparks, and the expressions of ionic channel proteins in ARKO and WT RVOT myocytes. Results: We found that ARKO RVOTs (n = 13) had longer AP duration, faster burst firing (5.4 ± 0.7 vs. 3.4 ± 0.7 Hz, P &lt; 0.05), and higher incidence of early afterdepolarizations (82% vs. 8%, P &lt; 0.001) than WT RVOTs (n = 11). Adenosine and flecainide can suppress caffeine- or isoproterenol-induced spontaneous rates and burst firing in WT RVOTs, but not in ARKO RVOTs. ARKO RVOT myocytes had a higher frequency (7.7 ± 2.8 vs. 1.3 ± 0.4 spark/mm/s, P &lt; 0.05) and incidence (89% vs. 47%, P &lt; 0.05) of Ca&lt;sup&gt;2+&lt;/sup&gt; sparks, and greater expressions of Cav1.2, NCX, phosphorylated RyR (s2814), phosphorylated phospholamban (Thr17), CAMKII and GRK2 than WT RVOT myocytes. However, ARKO and WT RVOT myocytes exhibit similar Ca&lt;sup&gt;2+&lt;/sup&gt;&lt;inf&gt;i&lt;/inf&gt; transients and SR Ca&lt;sup&gt;2+&lt;/sup&gt; content, and less expression of calsequestrin. Conclusions: ARKO changes RVOT electrophysiology and Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis with increased ventricular arrhythmogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021326</affiliation-url><afid>60021326</afid><affilname>Buddhist Tzu-Chi General Hospital Taiwan</affilname><name-variant>Buddhist Dalin Tzu Chi General Hospital</name-variant><affiliation-city>Hualien</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027173</affiliation-url><afid>60027173</afid><affilname>Cathay General Hospital Taiwan</affilname><name-variant>Cathay General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004965</affiliation-url><afid>60004965</afid><affilname>National Defense Medical Center Taiwan</affilname><name-variant>National Defense Medical Center</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012370</affiliation-url><afid>60012370</afid><affilname>National Chiao Tung University Taiwan</affilname><name-variant>National Chiao-Tung University</name-variant><affiliation-city>Hsin-chu</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013314</affiliation-url><afid>60013314</afid><affilname>Veterans General Hospital-Taipei</affilname><name-variant>Taipei Veterans General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56647408600</author-url><authid>56647408600</authid><authname>Tsai W.</authname><surname>Tsai</surname><given-name>Wen Chin</given-name><initials>W.C.</initials><afid>60021326</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36463932500</author-url><authid>36463932500</authid><authname>Lu Y.</authname><surname>Lu</surname><given-name>Yen Yu</given-name><initials>Y.Y.</initials><afid>60027173</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7601425035</author-url><authid>7601425035</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yao Chang</given-name><initials>Y.C.</initials><afid>60004965</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56647026100</author-url><authid>56647026100</authid><authname>Chang C.</authname><surname>Chang</surname><given-name>Chien Jung</given-name><initials>C.J.</initials><afid>60012370</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34768538800</author-url><authid>34768538800</authid><authname>Kao Y.</authname><surname>Kao</surname><given-name>Yu Hsun</given-name><initials>Y.H.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34768538800</author-url><authid>34768538800</authid><authname>Kao Y.</authname><surname>Kao</surname><given-name>Yu Hsun</given-name><initials>Y.H.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7407354659</author-url><authid>7407354659</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yung Kuo</given-name><initials>Y.K.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7407354659</author-url><authid>7407354659</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yung Kuo</given-name><initials>Y.K.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56255855800</author-url><authid>56255855800</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yu Hsin</given-name><initials>Y.H.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56255855800</author-url><authid>56255855800</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yu Hsin</given-name><initials>Y.H.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7410249147</author-url><authid>7410249147</authid><authname>Chen S.</authname><surname>Chen</surname><given-name>Shih Ann</given-name><initials>S.A.</initials><afid>60013314</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8893236100</author-url><authid>8893236100</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Liang Yo</given-name><initials>L.Y.</initials><afid>60022095</afid><afid>60022095</afid><afid>60022095</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8893236100</author-url><authid>8893236100</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Liang Yo</given-name><initials>L.Y.</initials><afid>60022095</afid><afid>60022095</afid><afid>60022095</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8893236100</author-url><authid>8893236100</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Liang Yo</given-name><initials>L.Y.</initials><afid>60022095</afid><afid>60022095</afid><afid>60022095</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36041187900</author-url><authid>36041187900</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yi Jen</given-name><initials>Y.J.</initials><afid>60022095</afid><afid>60022095</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36041187900</author-url><authid>36041187900</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yi Jen</given-name><initials>Y.J.</initials><afid>60022095</afid><afid>60022095</afid></author><authkeywords>Arrhythmogenicity | Calcium handling | Right ventricular outflow tract | Ventricular arrhythmias</authkeywords><intid>35963598</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346663"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346663?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346663&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346663&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007548"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346663</prism:url><dc:identifier>SCOPUS_ID:84929346663</dc:identifier><eid>2-s2.0-84929346663</eid><dc:title>Digoxin use may increase the relative risk of acute pancreatitis</dc:title><dc:creator>Aksu U.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>33</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.035</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000021</affiliation-url><afid>60000021</afid><affilname>Ataturk Universitesi</affilname><name-variant>Atatürk University</name-variant><affiliation-city>Erzurum</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113149498</affiliation-url><afid>113149498</afid><affilname>Malkara State Hospital</affilname><name-variant>Malkara State Hospital</name-variant><affiliation-city>Tekirdag</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644623400</author-url><authid>56644623400</authid><authname>Aksu U.</authname><surname>Aksu</surname><given-name>Ugur</given-name><initials>U.</initials><afid>60000021</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55355185600</author-url><authid>55355185600</authid><authname>Kalkan K.</authname><surname>Kalkan</surname><given-name>Kamuran</given-name><initials>K.</initials><afid>113149498</afid></author><authkeywords>Digoxin | Pancreatitis</authkeywords><intid>35944412</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929320920"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929320920?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929320920&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929320920&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006580"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929320920</prism:url><dc:identifier>SCOPUS_ID:84929320920</dc:identifier><eid>2-s2.0-84929320920</eid><dc:title>Contribution of ultrasound contrast in predicting conduction disturbances during percutaneous alcohol septal ablation</dc:title><dc:creator>Ternacle J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>436-437</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.395</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55531510000</author-url><authid>55531510000</authid><authname>Ternacle J.</authname><surname>Ternacle</surname><given-name>Julien</given-name><initials>J.</initials><afid>60000905</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644394400</author-url><authid>56644394400</authid><authname>Boiron P.</authname><surname>Boiron</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55544650600</author-url><authid>55544650600</authid><authname>Gallet R.</authname><surname>Gallet</surname><given-name>Romain</given-name><initials>R.</initials><afid>60000905</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701834893</author-url><authid>6701834893</authid><authname>Champagne S.</authname><surname>Champagne</surname><given-name>Stéphane</given-name><initials>S.</initials><afid>60000905</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:51565841400</author-url><authid>51565841400</authid><authname>Krapf L.</authname><surname>Krapf</surname><given-name>Laura</given-name><initials>L.</initials><afid>60000905</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644362900</author-url><authid>56644362900</authid><authname>Doan H.</authname><surname>Doan</surname><given-name>Huy Long</given-name><initials>H.L.</initials><afid>60000905</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35974536600</author-url><authid>35974536600</authid><authname>Dubois Randé J.</authname><surname>Dubois Randé</surname><given-name>Jean Luc</given-name><initials>J.L.</initials><afid>60000905</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004006258</author-url><authid>7004006258</authid><authname>Teiger E.</authname><surname>Teiger</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60000905</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56472347600</author-url><authid>56472347600</authid><authname>Lim P.</authname><surname>Lim</surname><given-name>Pascal</given-name><initials>P.</initials><afid>60000905</afid></author><authkeywords>Alcohol septal ablation | Conduction disturbance | Hypertrophic cardiomyopathy | Ultrasound contrast</authkeywords><intid>1035941071</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929310023"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929310023?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929310023&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929310023&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007524"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929310023</prism:url><dc:identifier>SCOPUS_ID:84929310023</dc:identifier><eid>2-s2.0-84929310023</eid><dc:title>Relationship between left atrial appendage morphology and thrombus formation in patients with atrial fibrillation</dc:title><dc:creator>Zhao Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>86-88</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.033</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643409700</author-url><authid>56643409700</authid><authname>Zhao Y.</authname><surname>Zhao</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60025084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55491585400</author-url><authid>55491585400</authid><authname>Zhang P.</authname><surname>Zhang</surname><given-name>Peng Pai</given-name><initials>P.P.</initials><afid>60025084</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26028726400</author-url><authid>26028726400</authid><authname>Xu Q.</authname><surname>Xu</surname><given-name>Quan Fu</given-name><initials>Q.F.</initials><afid>60025084</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55488259500</author-url><authid>55488259500</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Ling Wei</given-name><initials>L.W.</initials><afid>60025084</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56403553600</author-url><authid>56403553600</authid><authname>Yu Y.</authname><surname>Yu</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55718906500</author-url><authid>55718906500</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yi Gang</given-name><initials>Y.G.</initials><afid>60025084</afid></author><authkeywords>Atrial fibrillation | Chads&lt;inf&gt;2&lt;/inf&gt; score | Left atrial appendage | Thrombus</authkeywords><intid>535945393</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930201370"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930201370?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930201370&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930201370&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001571"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930201370</prism:url><dc:identifier>SCOPUS_ID:84930201370</dc:identifier><eid>2-s2.0-84930201370</eid><dc:title>Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4</dc:title><dc:creator>Lees-Miller J.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>71-78</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.009</prism:doi><pii>S0022282815001571</pii><dc:description>© 2015 Elsevier Ltd. In Europe, ivabradine has recently been approved to treat patients with angina who have intolerance to beta blockers and/or heart failure. Ivabradine is considered to act specifically on the sinoatrial node by inhibiting the I&lt;inf&gt;f&lt;/inf&gt; current (the funny current) to slow automaticity. However, in vitro studies show that ivabradine prolongs phase 3 repolarization in ventricular tissue. No episodes of Torsades de Pointes have been reported in randomized clinical studies. The objective of this study is to assess whether ivabradine blocked the hERG1 current. In the present study we discovered that ivabradine prolongs action potential and blocks the hERG current over a range of concentrations overlapping with those required to block HCN4. Ivabradine produced tonic, rather than use-dependent block. The mutation Y652A significantly suppressed pharmacologic block of hERG by ivabradine. Disruption of C-type inactivation also suppressed block of hERG1 by ivabradine. Molecular docking and molecular dynamics simulations indicate that ivabradine may access the inner cavity of the hERG1 via a lipophilic route and has a well-defined binding site in the closed state of the channel. Structural organization of the binding pockets for ivabradine is discussed. Ivabradine blocks hERG and prolongs action potential duration. Our study is potentially important because it indicates the need for active post marketing surveillance of ivabradine. Importantly, proarrhythmia of a number of other drugs has only been discovered during post marketing surveillance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002306</affiliation-url><afid>60002306</afid><affilname>University of Calgary</affilname><name-variant>University of Calgary</name-variant><affiliation-city>Calgary</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002306</affiliation-url><afid>60002306</afid><affilname>University of Calgary</affilname><name-variant>University of Calgary</name-variant><affiliation-city>Calgary</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603742062</author-url><authid>6603742062</authid><authname>Lees-Miller J.</authname><surname>Lees-Miller</surname><given-name>James P.</given-name><initials>J.P.</initials><afid>60002306</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7404488994</author-url><authid>7404488994</authid><authname>Guo J.</authname><surname>Guo</surname><given-name>Jiqing</given-name><initials>J.</initials><afid>60002306</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56006740600</author-url><authid>56006740600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yibo</given-name><initials>Y.</initials><afid>60002306</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8355781600</author-url><authid>8355781600</authid><authname>Perissinotti L.</authname><surname>Perissinotti</surname><given-name>Laura L.</given-name><initials>L.L.</initials><afid>60002306</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004042121</author-url><authid>7004042121</authid><authname>Noskov S.</authname><surname>Noskov</surname><given-name>Sergei Y.</given-name><initials>S.Y.</initials><afid>60002306</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330191</author-url><authid>7006330191</authid><authname>Duff H.</authname><surname>Duff</surname><given-name>Henry J.</given-name><initials>H.J.</initials><afid>60002306</afid></author><authkeywords>HERG KCNH2 | Ivabradine | Potassium channels | Tonic block</authkeywords><intid>1786088576</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929347025"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929347025?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929347025&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929347025&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005653"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929347025</prism:url><dc:identifier>SCOPUS_ID:84929347025</dc:identifier><eid>2-s2.0-84929347025</eid><dc:title>Fractional flow-guided management in patients with acute coronary syndromes: A systematic review and meta-analysis</dc:title><dc:creator>Briasoulis A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>334-337</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.325</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009408</affiliation-url><afid>60009408</afid><affilname>Wayne State University</affilname><name-variant>Wayne State University</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23501496400</author-url><authid>23501496400</authid><authname>Briasoulis A.</authname><surname>Briasoulis</surname><given-name>Alexandros</given-name><initials>A.</initials><afid>60009408</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55547303800</author-url><authid>55547303800</authid><authname>Palla M.</authname><surname>Palla</surname><given-name>Mohan</given-name><initials>M.</initials><afid>60009408</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54391627900</author-url><authid>54391627900</authid><authname>Mostafa A.</authname><surname>Mostafa</surname><given-name>Ashraf</given-name><initials>A.</initials><afid>60009408</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12787915500</author-url><authid>12787915500</authid><authname>Afonso L.</authname><surname>Afonso</surname><given-name>Luis</given-name><initials>L.</initials><afid>60009408</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101768210</author-url><authid>7101768210</authid><authname>Grines C.</authname><surname>Grines</surname><given-name>Cindy</given-name><initials>C.</initials><afid>60009408</afid></author><authkeywords>Fractional flow reserve | Meta-analysis | Non-ST-elevation myocardial infarction</authkeywords><intid>1785946663</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929335081"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929335081?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929335081&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929335081&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006130"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929335081</prism:url><dc:identifier>SCOPUS_ID:84929335081</dc:identifier><eid>2-s2.0-84929335081</eid><dc:title>Is hypothyroidism (on levothyroxine replacement) a precipitant of Takotsubo syndrome?</dc:title><dc:creator>Madias J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>29-30</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.355</prism:doi><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016846</affiliation-url><afid>60016846</afid><affilname>Elmhurst Hospital Center</affilname><name-variant>City Hospital Center at Elmhurst</name-variant><affiliation-city>Elmhurst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><authkeywords>Autonomic nervous system | Hyperthyroidism | Hypothyroidism | Postmenopause | Prevalence of hypothyroidism | Takotsubo syndrome</authkeywords><intid>1785945499</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928138155"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928138155?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928138155&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928138155&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000570"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928138155</prism:url><dc:identifier>SCOPUS_ID:84928138155</dc:identifier><eid>2-s2.0-84928138155</eid><dc:title>Impact of methylmercury exposure on mitochondrial energetics in AC16 and H9C2 cardiomyocytes</dc:title><dc:creator>Truong J.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>953-961</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.03.016</prism:doi><pii>S0887233315000570</pii><dc:description>© 2015 Elsevier Ltd. It has been reported that chronic low dose exposures of methylmercury (MeHg) is associated with cardiovascular diseases in many populations worldwide. The toxic mechanisms through which these adverse effects occur are currently unknown. The objective of this study was to determine the bioenergetic and cytotoxic effects of MeHg on AC16 and H9C2 cardiomyocyte cell lines. Both cell lines exhibit significantly decreased mitochondrial function, cell viability and increased reactive oxygen species (ROS) production. Decreases in maximal respiration and reserve capacity was observed in both cell lines at 1μM. Bioenergetic profile experiments were also performed in tandem with cells exposed to diamide or menadione, compounds which accumulate in mitochondria and disrupt oxidative phosphorylation. AC16 cells show MeHg dose dependant sensitivities with State&lt;inf&gt;apparent&lt;/inf&gt; and ATP production values, but H9C2 cells do not show these trends. H9C2 cells may be more resistant to MeHg toxicity than AC16 cells as reflected in the increases of proton leak and State&lt;inf&gt;apparent&lt;/inf&gt;. No changes in expression of respiratory complexes were observed. Results suggest that MeHg has the potential to induce cytotoxicity. Furthermore, MeHg may have differential effects on AC16 and H9C2 cells, derived from human and rat cardiac tissue respectively, suggesting that differences in MeHg toxicity may be species-dependent.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56362922400</author-url><authid>56362922400</authid><authname>Truong J.</authname><surname>Truong</surname><given-name>Jocelyn</given-name><initials>J.</initials><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8664226100</author-url><authid>8664226100</authid><authname>Mailloux R.</authname><surname>Mailloux</surname><given-name>Ryan J.</given-name><initials>R.J.</initials><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54790510400</author-url><authid>54790510400</authid><authname>Chan H.</authname><surname>Chan</surname><given-name>Hing Man</given-name><initials>H.M.</initials><afid>60028897</afid></author><authkeywords>AC16 | Bioenergetics | Cardiomyocytes | H9C2 | Methylmercury | Mitochondria</authkeywords><intid>2035728532</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325604"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325604?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325604&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325604&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008839"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325604</prism:url><dc:identifier>SCOPUS_ID:84929325604</dc:identifier><eid>2-s2.0-84929325604</eid><dc:title>Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial</dc:title><dc:creator>Adamo M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>242-245</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.159</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015300</affiliation-url><afid>60015300</afid><affilname>Universita degli Studi di Brescia</affilname><name-variant>University of Brescia</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012753</affiliation-url><afid>60012753</afid><affilname>Universita degli Studi di Messina, Facolta di Medicina e Chirurgia</affilname><name-variant>Policlinico Universitario</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101186958</affiliation-url><afid>101186958</afid><affilname>Hartcentrum Hasselt</affilname><name-variant>Hartcentrum</name-variant><affiliation-city>Hasselt</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026556</affiliation-url><afid>60026556</afid><affilname>Fondazione IRCCS Policlinico San Matteo</affilname><name-variant>IRCCS Policlinico S. Matteo</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025310</affiliation-url><afid>60025310</afid><affilname>Heinrich Heine Universitat</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114899900</affiliation-url><afid>114899900</afid><affilname>Syst. Investigation and Research on Interventions and Outcomes (SIRIO) MEDICINE Research Network</affilname><name-variant>Syst. Investigation and Research on Interventions and Outcomes (SIRIO) MEDICINE Research Network</name-variant><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070156</affiliation-url><afid>60070156</afid><affilname>Cardialysis BV</affilname><name-variant>Cardialysis BV</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55553203700</author-url><authid>55553203700</authid><authname>Adamo M.</authname><surname>Adamo</surname><given-name>Marianna</given-name><initials>M.</initials><afid>60032114</afid><afid>60015300</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55553203700</author-url><authid>55553203700</authid><authname>Adamo M.</authname><surname>Adamo</surname><given-name>Marianna</given-name><initials>M.</initials><afid>60032114</afid><afid>60015300</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472295400</author-url><authid>56472295400</authid><authname>Costa F.</authname><surname>Costa</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60032114</afid><afid>60012753</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472295400</author-url><authid>56472295400</authid><authname>Costa F.</authname><surname>Costa</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60032114</afid><afid>60012753</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603261242</author-url><authid>6603261242</authid><authname>Vranckx P.</authname><surname>Vranckx</surname><given-name>Pascal</given-name><initials>P.</initials><afid>101186958</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36059439800</author-url><authid>36059439800</authid><authname>Leonardi S.</authname><surname>Leonardi</surname><given-name>Sergio</given-name><initials>S.</initials><afid>60026556</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14123804500</author-url><authid>14123804500</authid><authname>Navarese E.</authname><surname>Navarese</surname><given-name>Eliano P.</given-name><initials>E.P.</initials><afid>60025310</afid><afid>114899900</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14123804500</author-url><authid>14123804500</authid><authname>Navarese E.</authname><surname>Navarese</surname><given-name>Eliano P.</given-name><initials>E.P.</initials><afid>60025310</afid><afid>114899900</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9633803100</author-url><authid>9633803100</authid><authname>Garcia-Garcia H.</authname><surname>Garcia-Garcia</surname><given-name>Hector M.</given-name><initials>H.M.</initials><afid>60032114</afid><afid>60070156</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9633803100</author-url><authid>9633803100</authid><authname>Garcia-Garcia H.</authname><surname>Garcia-Garcia</surname><given-name>Hector M.</given-name><initials>H.M.</initials><afid>60032114</afid><afid>60070156</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003820244</author-url><authid>7003820244</authid><authname>Valgimigli M.</authname><surname>Valgimigli</surname><given-name>Marco</given-name><initials>M.</initials><afid>60032114</afid></author><authkeywords>Clopidogrel | Outcome | Smoking</authkeywords><intid>1535945523</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377629"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377629?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377629&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377629&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008487"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377629</prism:url><dc:identifier>SCOPUS_ID:84929377629</dc:identifier><eid>2-s2.0-84929377629</eid><dc:title>Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality"</dc:title><dc:creator>Pastori D.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>247-248</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.125</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35741492700</author-url><authid>35741492700</authid><authname>Pastori D.</authname><surname>Pastori</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60032350</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56637122500</author-url><authid>56637122500</authid><authname>Farcomeni A.</authname><surname>Farcomeni</surname><given-name>Alessio</given-name><initials>A.</initials><afid>60032350</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14071056200</author-url><authid>14071056200</authid><authname>Bucci T.</authname><surname>Bucci</surname><given-name>Tommaso</given-name><initials>T.</initials><afid>60032350</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602899071</author-url><authid>6602899071</authid><authname>Cangemi R.</authname><surname>Cangemi</surname><given-name>Roberto</given-name><initials>R.</initials><afid>60032350</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56470722300</author-url><authid>56470722300</authid><authname>Ciacci P.</authname><surname>Ciacci</surname><given-name>Paolo</given-name><initials>P.</initials><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55224447300</author-url><authid>55224447300</authid><authname>Vicario T.</authname><surname>Vicario</surname><given-name>Tommasa</given-name><initials>T.</initials><afid>60032350</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35467774400</author-url><authid>35467774400</authid><authname>Violi F.</authname><surname>Violi</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60032350</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003808847</author-url><authid>7003808847</authid><authname>Pignatelli P.</authname><surname>Pignatelli</surname><given-name>Pasquale</given-name><initials>P.</initials><afid>60032350</afid></author><authkeywords>Anticoagulation | Atrial fibrillation | Digoxin | Heart failure | Mortality | Time in therapeutic range</authkeywords><intid>1035940879</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340002"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340002?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340002&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340002&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007664"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340002</prism:url><dc:identifier>SCOPUS_ID:84929340002</dc:identifier><eid>2-s2.0-84929340002</eid><dc:title>Tako-tsubo cardiomyopathy is age-dependent in men, but not in women</dc:title><dc:creator>Otten A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>65-66</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.047</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002573</affiliation-url><afid>60002573</afid><affilname>Radboud University Nijmegen Medical Centre</affilname><name-variant>University Hospital Nijmegen</name-variant><affiliation-city>Nijmegen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242398</affiliation-url><afid>115242398</afid><affilname>Dpt. Cardiology</affilname><name-variant>Dpt. Cardiology</name-variant><affiliation-city>Zwolle</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26024858400</author-url><authid>26024858400</authid><authname>Otten A.</authname><surname>Otten</surname><given-name>Amber M.</given-name><initials>A.M.</initials><afid>60002573</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006268840</author-url><authid>7006268840</authid><authname>Ottervanger J.</authname><surname>Ottervanger</surname><given-name>Jan Paul</given-name><initials>J.P.</initials><afid>60002573</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506150344</author-url><authid>6506150344</authid><authname>Symersky T.</authname><surname>Symersky</surname><given-name>Tomas</given-name><initials>T.</initials><afid>60002573</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007005550</author-url><authid>7007005550</authid><authname>Suryapranata H.</authname><surname>Suryapranata</surname><given-name>Harry</given-name><initials>H.</initials><afid>60002573</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101856269</author-url><authid>7101856269</authid><authname>De Boer M.</authname><surname>De Boer</surname><given-name>Menko Jan</given-name><initials>M.J.</initials><afid>115242398</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35511852200</author-url><authid>35511852200</authid><authname>Maas A.</authname><surname>Maas</surname><given-name>Angela H E M</given-name><initials>A.H.E.M.</initials><afid>115242398</afid></author><authkeywords>Age | Gender | STEMI | Tako tsubo cardiomyopathy</authkeywords><intid>35945580</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929310786"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929310786?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929310786&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929310786&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006373"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929310786</prism:url><dc:identifier>SCOPUS_ID:84929310786</dc:identifier><eid>2-s2.0-84929310786</eid><dc:title>New-onset atrial fibrillation may be a more important predictor of cardiac mortality in acute myocardial infarction patients than preexisting atrial fibrillation</dc:title><dc:creator>Morishima I.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>475-477</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.379</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002119</affiliation-url><afid>60002119</afid><affilname>Ogaki Municipal Hospital</affilname><name-variant>Ogaki Municipal Hospital</name-variant><affiliation-city>Ogaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113015050</affiliation-url><afid>113015050</afid><affilname>Tohno Kosei Hospital</affilname><name-variant>Tohno Kosei Hospital</name-variant><affiliation-city>Mizunami</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020492</affiliation-url><afid>60020492</afid><affilname>Nagoya University School of Medicine</affilname><name-variant>Nagoya University School of Medicine</name-variant><affiliation-city>Nagoya</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113015050</affiliation-url><afid>113015050</afid><affilname>Tohno Kosei Hospital</affilname><name-variant>Tohno Kosei Hospital</name-variant><affiliation-city>Mizunami</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7101819139</author-url><authid>7101819139</authid><authname>Morishima I.</authname><surname>Morishima</surname><given-name>Itsuro</given-name><initials>I.</initials><afid>60002119</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644452700</author-url><authid>56644452700</authid><authname>Tomomatsu T.</authname><surname>Tomomatsu</surname><given-name>Toshiro</given-name><initials>T.</initials><afid>60002119</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402772466</author-url><authid>7402772466</authid><authname>Okumura K.</authname><surname>Okumura</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60002119</afid><afid>113015050</afid><afid>113015050</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402772466</author-url><authid>7402772466</authid><authname>Okumura K.</authname><surname>Okumura</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60002119</afid><afid>113015050</afid><afid>113015050</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402772466</author-url><authid>7402772466</authid><authname>Okumura K.</authname><surname>Okumura</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60002119</afid><afid>113015050</afid><afid>113015050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56549566300</author-url><authid>56549566300</authid><authname>Sone T.</authname><surname>Sone</surname><given-name>Takahito</given-name><initials>T.</initials><afid>60002119</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56549591400</author-url><authid>56549591400</authid><authname>Tsuboi H.</authname><surname>Tsuboi</surname><given-name>Hideyuki</given-name><initials>H.</initials><afid>60002119</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643850700</author-url><authid>56643850700</authid><authname>Morita Y.</authname><surname>Morita</surname><given-name>Yasuhiro</given-name><initials>Y.</initials><afid>60002119</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55303165000</author-url><authid>55303165000</authid><authname>Inoue Y.</authname><surname>Inoue</surname><given-name>Yosuke</given-name><initials>Y.</initials><afid>60002119</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644013100</author-url><authid>56644013100</authid><authname>Yoshida R.</authname><surname>Yoshida</surname><given-name>Ruka</given-name><initials>R.</initials><afid>60002119</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55919245800</author-url><authid>55919245800</authid><authname>Yura Y.</authname><surname>Yura</surname><given-name>Yoshimitsu</given-name><initials>Y.</initials><afid>60020492</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005982703</author-url><authid>7005982703</authid><authname>Murohara T.</authname><surname>Murohara</surname><given-name>Toyoaki</given-name><initials>T.</initials><afid>60020492</afid></author><authkeywords>Acute myocardial infarction | Atrial fibrillation | Cardiac mortality | Pump failure</authkeywords><intid>1785945647</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378011"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378011?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378011&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378011&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006531"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378011</prism:url><dc:identifier>SCOPUS_ID:84929378011</dc:identifier><eid>2-s2.0-84929378011</eid><dc:title>Acute coronary syndrome and scombroid syndrome</dc:title><dc:creator>Cucunato M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>317-318</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.390</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115241677</affiliation-url><afid>115241677</afid><affilname>Endoscopy and Gastroenterology</affilname><name-variant>Endoscopy and Gastroenterology</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112774345</affiliation-url><afid>112774345</afid><affilname>Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte</affilname><name-variant>Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644998900</author-url><authid>56644998900</authid><authname>Cucunato M.</authname><surname>Cucunato</surname><given-name>M.</given-name><initials>M.</initials><afid>115241677</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641835700</author-url><authid>56641835700</authid><authname>Cannavà G.</authname><surname>Cannavà</surname><given-name>G.</given-name><initials>G.</initials><afid>112774345</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23982063600</author-url><authid>23982063600</authid><authname>Currò A.</authname><surname>Currò</surname><given-name>Alessio</given-name><initials>A.</initials><afid>112774345</afid></author><authkeywords>Acute coronary syndrome | Coronary artery disease in food-borne disease | Kounis syndrome | Scombroid syndrome</authkeywords><intid>1535944058</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329231"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329231?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329231&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329231&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500844X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329231</prism:url><dc:identifier>SCOPUS_ID:84929329231</dc:identifier><eid>2-s2.0-84929329231</eid><dc:title>Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study</dc:title><dc:creator>Chang S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>20-25</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.121</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Recent trials have shown a reduction in the risk of major adverse cardiac events (MACE) with simvastatin-ezetimibe therapy in patients with acute coronary syndrome. The potential benefits of simvastatin-ezetimibe for patients at a lower risk of MACE are unclear. This study aimed to investigate the differences of MACE risk between patients with type 2 diabetes mellitus (DM) using simvastatin-ezetimibe or high potency statins. Methods: This population-based dynamic cohort study used data from the Taiwan National Health Insurance Database. The study subjects were patients with type 2 DM, aged between 40 and 75 years. The simvastatin-ezetimibe group took simvastatin-ezetimibe only, and the statin group took atorvastatin or rosuvastatin but not simvastatin or ezetimibe. The two groups were matched for age, gender, medication date, DM diagnosis date, hypertension, and cardiovascular complications. The outcome variable was new-onset MACE. Univariate and multivariate survival analyses were performed. Results: A total of 20,485 patients (53% male; 4099 in the simvastatin-ezetimibe group and 16,396 in the statin group) were included, with a mean age of 59.1 years. In a total of 37,388 person-years, 1100 patients developed new-onset MACE. The annual incidence rate of new-onset MACE was lower in the simvastatin-ezetimibe group (2.61%) than that in the statin group (3.02%) (p = 0.0476). After Cox regression analysis, simvastatin-ezetimibe use was independently associated with a lower risk of MACE (HR, 0.77; 95% confidence interval 0.66-0.90). Conclusions: Compared to high potency statins alone, simvastatin-ezetimibe therapy was associated with a lower incidence of MACE in patients with type 2 DM.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020351</affiliation-url><afid>60020351</afid><affilname>Chang Gung University</affilname><name-variant>Chang Gung University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020351</affiliation-url><afid>60020351</afid><affilname>Chang Gung University</affilname><name-variant>Chang Gung University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020351</affiliation-url><afid>60020351</afid><affilname>Chang Gung University</affilname><name-variant>Chang Gung University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643433200</author-url><authid>56643433200</authid><authname>Chang S.</authname><surname>Chang</surname><given-name>Shang Hung</given-name><initials>S.H.</initials><afid>60020351</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56387826800</author-url><authid>56387826800</authid><authname>Wu L.</authname><surname>Wu</surname><given-name>Lung Sheng</given-name><initials>L.S.</initials><afid>60020351</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56468231900</author-url><authid>56468231900</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Cheng Hung</given-name><initials>C.H.</initials><afid>60020351</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56555628900</author-url><authid>56555628900</authid><authname>Kuo C.</authname><surname>Kuo</surname><given-name>Chi Tai</given-name><initials>C.T.</initials><afid>60020351</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56388796700</author-url><authid>56388796700</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jia Rou</given-name><initials>J.R.</initials><afid>60020351</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56388270800</author-url><authid>56388270800</authid><authname>Wen M.</authname><surname>Wen</surname><given-name>Ming Shien</given-name><initials>M.S.</initials><afid>60020351</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55784966000</author-url><authid>55784966000</authid><authname>Chen W.</authname><surname>Chen</surname><given-name>Wei Jan</given-name><initials>W.J.</initials><afid>60020351</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006538250</author-url><authid>7006538250</authid><authname>See L.</authname><surname>See</surname><given-name>Lai Chu</given-name><initials>L.C.</initials><afid>60020351</afid><afid>60020351</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006538250</author-url><authid>7006538250</authid><authname>See L.</authname><surname>See</surname><given-name>Lai Chu</given-name><initials>L.C.</initials><afid>60020351</afid><afid>60020351</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56388234400</author-url><authid>56388234400</authid><authname>Yeh Y.</authname><surname>Yeh</surname><given-name>Yung Hsin</given-name><initials>Y.H.</initials><afid>60020351</afid></author><authkeywords>Major adverse cardiac events | Simvastatin-ezetimibe | Statins | Type 2 diabetes</authkeywords><intid>35943105</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929335430"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929335430?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929335430&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929335430&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008578"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929335430</prism:url><dc:identifier>SCOPUS_ID:84929335430</dc:identifier><eid>2-s2.0-84929335430</eid><dc:title>Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction</dc:title><dc:creator>Zellweger C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>190-197</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.134</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Diabetes is a major risk factor for acute myocardial infarction (AMI). Assessment of diabetic patients is challenging due to an often atypical presentation of symptoms. We aimed to evaluate the two novel biomarkers copeptin and high-sensitive cardiac troponin (hs-TnT) for the improvement of early diagnosis and risk-stratification in patients with diabetes and suspected AMI. Methods: In this prospective international multicenter study we evaluated 379 patients with diabetes in a cohort of 1991 patients presenting with symptoms suggestive of AMI. The measurement of biomarkers was performed at presentation. Results: Among the 379 diabetic patients, 32.7% had AMI, and in the 1621 patients without diabetes, 18.8% had AMI. The additional use of copeptin improved the diagnostic accuracy provided by conventional troponin alone (AUC 0.86 vs. 0.79, p = 0.004). During a median follow-up of 814 days, 49 (13.1%) diabetic patients died. Cumulative 2-year survival rate for patients with copeptin levels below 9 pmol/l was 96.6% compared to 82.8% in patients above that level (p &lt; 0.001). The same was observed for hs-TnT with a cutoff level of 14 ng/l (97.7% vs. 82.0%, p &lt; 0.001) respective of cTnT with a cutoff level of 10 ng/l (93.5% vs. 75.6%, p &lt; 0.001). In multivariate Cox analysis, copeptin, hs-TnT and cTnT were strong and independent predictors of 24-month-mortality. Using the dual marker strategy (copeptin and troponin) identified two groups of high-risk patients where 22.5% of the group with hs-cTnT and copeptin above the cutoff and 28.6% with cTnT and copeptin above the cutoff died. Conclusion: In diabetic patients, copeptin only slightly improves the early diagnosis of AMI provided by hs-cTnT. However, both markers (copeptin and troponin) predict long-term mortality accurately and independently of each other.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011568</affiliation-url><afid>60011568</afid><affilname>University of Tanta</affilname><name-variant>Tanta University</name-variant><affiliation-city>Tanta</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004531</affiliation-url><afid>60004531</afid><affilname>Azienda Ospedaliera Universitaria San Martino</affilname><name-variant>Ospedale S. Martino</name-variant><affiliation-city>Genoa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023506</affiliation-url><afid>60023506</afid><affilname>Hospital del Mar</affilname><name-variant>Hospital del Mar</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242295</affiliation-url><afid>115242295</afid><affilname>Brahms Thermo Fisher</affilname><name-variant>Brahms Thermo Fisher</name-variant><affiliation-city>Hennigsdorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54682513800</author-url><authid>54682513800</authid><authname>Zellweger C.</authname><surname>Zellweger</surname><given-name>C.</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37102901200</author-url><authid>37102901200</authid><authname>Wildi K.</authname><surname>Wildi</surname><given-name>K.</given-name><initials>K.</initials><afid>60028287</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34067894400</author-url><authid>34067894400</authid><authname>Twerenbold R.</authname><surname>Twerenbold</surname><given-name>R.</given-name><initials>R.</initials><afid>60028287</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24451019600</author-url><authid>24451019600</authid><authname>Reichlin T.</authname><surname>Reichlin</surname><given-name>T.</given-name><initials>T.</initials><afid>60028287</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644879300</author-url><authid>56644879300</authid><authname>Naduvilekoot A.</authname><surname>Naduvilekoot</surname><given-name>A.</given-name><initials>A.</initials><afid>60028287</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644246600</author-url><authid>56644246600</authid><authname>Neuhaus J.</authname><surname>Neuhaus</surname><given-name>J. D.</given-name><initials>J.D.</initials><afid>60028287</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:47460994100</author-url><authid>47460994100</authid><authname>Balmelli C.</authname><surname>Balmelli</surname><given-name>C.</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644822200</author-url><authid>56644822200</authid><authname>Gabutti M.</authname><surname>Gabutti</surname><given-name>M.</given-name><initials>M.</initials><afid>60028287</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55646333100</author-url><authid>55646333100</authid><authname>Afify A.</authname><surname>Afify</surname><given-name>A. Al</given-name><initials>A.A.</initials><afid>60011568</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602637262</author-url><authid>6602637262</authid><authname>Ballarino P.</authname><surname>Ballarino</surname><given-name>P.</given-name><initials>P.</initials><afid>60004531</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644267700</author-url><authid>56644267700</authid><authname>Jäger C.</authname><surname>Jäger</surname><given-name>C.</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56576278300</author-url><authid>56576278300</authid><authname>Druey S.</authname><surname>Druey</surname><given-name>S.</given-name><initials>S.</initials><afid>60028287</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:37053943100</author-url><authid>37053943100</authid><authname>Haaf P.</authname><surname>Haaf</surname><given-name>P.</given-name><initials>P.</initials><afid>60028287</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:38662075400</author-url><authid>38662075400</authid><authname>Vilaplana C.</authname><surname>Vilaplana</surname><given-name>C.</given-name><initials>C.</initials><afid>60023506</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56644610700</author-url><authid>56644610700</authid><authname>Darbouret B.</authname><surname>Darbouret</surname><given-name>B.</given-name><initials>B.</initials><afid>115242295</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:55661345600</author-url><authid>55661345600</authid><authname>Ebmeyer S.</authname><surname>Ebmeyer</surname><given-name>S.</given-name><initials>S.</initials><afid>115242295</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>Gimenez M.</authname><surname>Gimenez</surname><given-name>M. Rubini</given-name><initials>M.R.</initials><afid>60028287</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:54407138700</author-url><authid>54407138700</authid><authname>Moehring B.</authname><surname>Moehring</surname><given-name>B.</given-name><initials>B.</initials><afid>60028287</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55825305800</author-url><authid>55825305800</authid><authname>Osswald S.</authname><surname>Osswald</surname><given-name>S.</given-name><initials>S.</initials><afid>60028287</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:55694346400</author-url><authid>55694346400</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>C.</given-name><initials>C.</initials><afid>60028287</afid></author><authkeywords>Acute myocardial infarction | Conventional cardiac troponin | Copeptin | Diabetes | High sensitive cardiac troponin</authkeywords><intid>1785945101</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330777"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330777?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330777&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330777&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007196"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330777</prism:url><dc:identifier>SCOPUS_ID:84929330777</dc:identifier><eid>2-s2.0-84929330777</eid><dc:title>Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study</dc:title><dc:creator>Menon J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>519-524</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.009</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Introduction: India carries the greatest burden of global non-communicable diseases (NCDs). Poverty is strongly associated with NCDs but there are few prevalence studies which have measured poverty in India, particularly in rural settings. Methods: In Kerala, India, a population of 113,462 individuals was identified. The "Epidemiology of Noncommunicable Diseases in Rural Areas" (ENDIRA) study was conducted via ASHAs (Accredited Social Health Activists). Standardised questionnaires were used in household interviews of individuals ≥18 years during 2012 to gather sociodemographic, lifestyle and medical data for this population. The Government of Kerala definition of "the poverty line" was used. The association between below poverty line (BPL) status, NCDs and risk factors was analysed in multivariable regression models. Results: 84,456 adults were included in the analyses (25.4% below the poverty line). The prevalence of NCDs was relatively common: myocardial infarction (MI) 1.4%, stroke 0.3%, respiratory diseases 5.0%, and cancer 1.1%. BPL status was not associated with age (p = 0.96) or gender (p = 0.26). Compared with those above the poverty line (APL), the BPL group was less likely to have diabetes, hypertension or dyslipidaemia (p &lt; 0.0001), and more likely to smoke (p &lt; 0.0001). Compared with APL, BPL was associated with stroke (OR 1.33, 1.04-1.69; p = 0.02) and respiratory disease (OR 1.23, 1.15-1.32; p &lt; 0.0001) in multivariable analyses, but not MI or cancer. Conclusions: In rural Kerala, BPL status was associated with stroke and respiratory diseases, but not with MI and cancer although it was associated with smoking status, compared with above poverty line status.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007898</affiliation-url><afid>60007898</afid><affilname>Amrita Institute of Medical Sciences India</affilname><name-variant>Amrita Institute of Medical Sciences and Research Centre</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242176</affiliation-url><afid>115242176</afid><affilname>Aluva Taluk Hospital</affilname><name-variant>Aluva Taluk Hospital</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60094569</affiliation-url><afid>60094569</afid><affilname>Little Flower Hospital &amp; Research Center</affilname><name-variant>Little Flower Hospital and Research Center</name-variant><affiliation-city>Ernakulam</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113332299</affiliation-url><afid>113332299</afid><affilname>MAGJ Hospital</affilname><name-variant>MAGJ Hospital</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242203</affiliation-url><afid>115242203</afid><affilname>Aiswarya Clinic</affilname><name-variant>Aiswarya Clinic</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110205172</affiliation-url><afid>110205172</afid><affilname>Lakshmi Hospital</affilname><name-variant>Lakshmi Hospital</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101617547</affiliation-url><afid>101617547</afid><affilname>Deva Matha Hospital</affilname><name-variant>Devamatha Hospital</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019702</affiliation-url><afid>60019702</afid><affilname>University of Birmingham</affilname><name-variant>University of Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55554023800</author-url><authid>55554023800</authid><authname>Menon J.</authname><surname>Menon</surname><given-name>Jaideep</given-name><initials>J.</initials><afid>60007898</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602969596</author-url><authid>6602969596</authid><authname>Vijayakumar N.</authname><surname>Vijayakumar</surname><given-name>N.</given-name><initials>N.</initials><afid>115242176</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643870500</author-url><authid>56643870500</authid><authname>Joseph J.</authname><surname>Joseph</surname><given-name>Joseph K.</given-name><initials>J.K.</initials><afid>60094569</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643974400</author-url><authid>56643974400</authid><authname>David P.</authname><surname>David</surname><given-name>P. C.</given-name><initials>P.C.</initials><afid>113332299</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644049400</author-url><authid>56644049400</authid><authname>Menon M.</authname><surname>Menon</surname><given-name>M. N.</given-name><initials>M.N.</initials><afid>115242203</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644424200</author-url><authid>56644424200</authid><authname>Mukundan S.</authname><surname>Mukundan</surname><given-name>Shyam</given-name><initials>S.</initials><afid>110205172</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644728200</author-url><authid>56644728200</authid><authname>Dorphy P.</authname><surname>Dorphy</surname><given-name>P. D.</given-name><initials>P.D.</initials><afid>101617547</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35323896700</author-url><authid>35323896700</authid><authname>Banerjee A.</authname><surname>Banerjee</surname><given-name>Amitava</given-name><initials>A.</initials><afid>60019702</afid></author><authkeywords>Cardiovascular disease | Non-communicable disease | Poverty | Smoking</authkeywords><intid>1035940706</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929453856"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929453856?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929453856&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929453856&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007421"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929453856</prism:url><dc:identifier>SCOPUS_ID:84929453856</dc:identifier><eid>2-s2.0-84929453856</eid><dc:title>Black carbon exposure, oxidative stress markers and major adverse cardiovascular events in patients with acute coronary syndromes</dc:title><dc:creator>Dominguez-Rodriguez A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>47-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.023</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013249</affiliation-url><afid>60013249</afid><affilname>Hospital Universitario de Canarias</affilname><name-variant>Hospital Universitario de Canarias</name-variant><affiliation-city>Santa Cruz de Tenerife</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113152757</affiliation-url><afid>113152757</afid><affilname>Universidad Europea de Canarias</affilname><name-variant>Universidad Europea de Canarias</name-variant><affiliation-city>Santa Cruz de Tenerife</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112999284</affiliation-url><afid>112999284</afid><affilname>Unidad Asociada Al CSIC</affilname><name-variant>Unidad Asociada al CSIC</name-variant><affiliation-city>Santa Cruz de Tenerife</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003044</affiliation-url><afid>60003044</afid><affilname>Universidad de la Laguna</affilname><name-variant>Universidad de la Laguna</name-variant><affiliation-city>San Cristobal de La Laguna</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016862</affiliation-url><afid>60016862</afid><affilname>Hospital Universitario Central de Asturias</affilname><name-variant>Hospital Central de Asturias</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006072782</author-url><authid>7006072782</authid><authname>Dominguez-Rodriguez A.</authname><surname>Dominguez-Rodriguez</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60013249</afid><afid>113152757</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006072782</author-url><authid>7006072782</authid><authname>Dominguez-Rodriguez A.</authname><surname>Dominguez-Rodriguez</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60013249</afid><afid>113152757</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202804467</author-url><authid>7202804467</authid><authname>Rodríguez S.</authname><surname>Rodríguez</surname><given-name>Sergio</given-name><initials>S.</initials><afid>112999284</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603084168</author-url><authid>6603084168</authid><authname>Abreu-Gonzalez P.</authname><surname>Abreu-Gonzalez</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60003044</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603073164</author-url><authid>6603073164</authid><authname>Avanzas P.</authname><surname>Avanzas</surname><given-name>Pablo</given-name><initials>P.</initials><afid>60016862</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36990259800</author-url><authid>36990259800</authid><authname>Juarez-Prera R.</authname><surname>Juarez-Prera</surname><given-name>Ruben A.</given-name><initials>R.A.</initials><afid>60013249</afid></author><authkeywords>Acute coronary syndrome | Air pollution | Black carbon | Major adverse cardiovascular events | Oxidative stress</authkeywords><intid>2035959209</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379607"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379607?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379607&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379607&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008062"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379607</prism:url><dc:identifier>SCOPUS_ID:84929379607</dc:identifier><eid>2-s2.0-84929379607</eid><dc:title>Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention - From the PROTECT II randomized trial</dc:title><dc:creator>Henriques J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>272-278</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.084</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Procedural risk scores facilitate clinical decision making by using individual patient characteristics to estimate the risk of adverse events. The performance of PCI-based risk scores is not well-described among patients undergoing hemodynamically supported high risk PCI. Methods and results: A total of 427 patients with unprotected left main disease, last remaining vessel or threevessel disease with severely reduced left ventricular function underwent supported high-risk PCI with an intra-aortic balloon pump (IABP, N = 211) or a left ventricular assist device (Impella 2.5, N = 216) as part of the PROTECT II trial. We examined the performance of the additive Euroscore, logistic Euroscore, STS mortality score, STS morbidity and mortality score, Mayo Clinic risk score and New York state PCI risk score on the endpoint of 90-day mortality in this unique high-risk population. Mean age was 67.2 ± 10.9 years; 65.8% of patients were in NYHA class III/IV, and mean LVEF was 24%. All-cause 90-day mortality was 10.4%. The scores were generally correlated (p &lt; 0.0001 for all comparisons), with R&lt;sup&gt;2&lt;/sup&gt; values ranging from 0.28 (STS morbidity/mortality and Mayo Clinic) to 0.68 (logistic Euroscore and STS mortality). However, receiver-operator curves for 90-day all-cause mortality for all risk scores demonstrated poor discriminatory performance with c-statistics of 0.542-0.616. Calibration of the risk scores was not poor, but varied according to the specific score examined. Conclusion: The discriminatory capacity of currently available risk models is suboptimal when applied to a cohort of mechanically supported complex high-risk PCI. A risk score designed specifically for this population could help to further refine risk assessment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001157</affiliation-url><afid>60001157</afid><affilname>Academic Medical Centre, University of Amsterdam</affilname><name-variant>University of Amsterdam</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000764</affiliation-url><afid>60000764</afid><affilname>The Mount Sinai Medical Center</affilname><name-variant>Mount Sinai Medical Center</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030058</affiliation-url><afid>60030058</afid><affilname>Beth Israel Deaconess Medical Center</affilname><name-variant>Beth Israel Deaconess Medical Center</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019674</affiliation-url><afid>60019674</afid><affilname>Boston University</affilname><name-variant>Boston University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109625909</affiliation-url><afid>109625909</afid><affilname>Morristown Medical Center</affilname><name-variant>Morristown Medical Center</name-variant><affiliation-city>Morristown</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008578</affiliation-url><afid>60008578</afid><affilname>Henry Ford Hospital</affilname><name-variant>Henry Ford Hospital</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005542445</author-url><authid>7005542445</authid><authname>Henriques J.</authname><surname>Henriques</surname><given-name>José P S</given-name><initials>J.P.S.</initials><afid>60001157</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24449440600</author-url><authid>24449440600</authid><authname>Claessen B.</authname><surname>Claessen</surname><given-name>Bimmer E.</given-name><initials>B.E.</initials><afid>60001157</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006593805</author-url><authid>7006593805</authid><authname>Dangas G.</authname><surname>Dangas</surname><given-name>George D.</given-name><initials>G.D.</initials><afid>60000764</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603083771</author-url><authid>6603083771</authid><authname>Kirtane A.</authname><surname>Kirtane</surname><given-name>Ajay J.</given-name><initials>A.J.</initials><afid>60027565</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56519398800</author-url><authid>56519398800</authid><authname>Popma J.</authname><surname>Popma</surname><given-name>Jeffrey J.</given-name><initials>J.J.</initials><afid>60030058</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003893512</author-url><authid>7003893512</authid><authname>Massaro J.</authname><surname>Massaro</surname><given-name>Joseph M.</given-name><initials>J.M.</initials><afid>60019674</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643786900</author-url><authid>56643786900</authid><authname>Cohen B.</authname><surname>Cohen</surname><given-name>Barry M.</given-name><initials>B.M.</initials><afid>109625909</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56328594400</author-url><authid>56328594400</authid><authname>Ohman E.</authname><surname>Ohman</surname><given-name>E. Magnus</given-name><initials>E.M.</initials><afid>60005200</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7202080898</author-url><authid>7202080898</authid><authname>Moses J.</authname><surname>Moses</surname><given-name>Jeffrey W.</given-name><initials>J.W.</initials><afid>60027565</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55046566600</author-url><authid>55046566600</authid><authname>O'Neill W.</authname><surname>O'Neill</surname><given-name>William W.</given-name><initials>W.W.</initials><afid>60008578</afid></author><authkeywords>Hemodynamix support | High-risk | IABP | Impella | Percutaneous coronar intervention | Risk scores</authkeywords><intid>1035940949</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329162"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329162?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329162&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329162&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007883"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329162</prism:url><dc:identifier>SCOPUS_ID:84929329162</dc:identifier><eid>2-s2.0-84929329162</eid><dc:title>A link between ATP and SUR2A: A novel mechanism explaining cardioprotection at high altitude</dc:title><dc:creator>Mohammed Abdul K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>73-76</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.069</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023622</affiliation-url><afid>60023622</afid><affilname>University of Dundee College of Medicine, Dentistry and Nursing</affilname><name-variant>University of Dundee</name-variant><affiliation-city>Dundee</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56303981400</author-url><authid>56303981400</authid><authname>Mohammed Abdul K.</authname><surname>Mohammed Abdul</surname><given-name>Khaja Shameem</given-name><initials>K.S.</initials><afid>60023622</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102384820</author-url><authid>7102384820</authid><authname>Jovanović S.</authname><surname>Jovanović</surname><given-name>Sofija</given-name><initials>S.</initials><afid>60023622</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56506314100</author-url><authid>56506314100</authid><authname>Du Q.</authname><surname>Du</surname><given-name>Qingyou</given-name><initials>Q.</initials><afid>60023622</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:14040970000</author-url><authid>14040970000</authid><authname>Sukhodub A.</authname><surname>Sukhodub</surname><given-name>Andriy</given-name><initials>A.</initials><afid>60023622</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006571994</author-url><authid>7006571994</authid><authname>Jovanović A.</authname><surname>Jovanović</surname><given-name>Aleksandar</given-name><initials>A.</initials><afid>60023622</afid></author><authkeywords>Cardioprotection | High altitude | Hypoxia | SUR2A</authkeywords><intid>1785945378</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929321840"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929321840?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929321840&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929321840&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007056"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929321840</prism:url><dc:identifier>SCOPUS_ID:84929321840</dc:identifier><eid>2-s2.0-84929321840</eid><dc:title>The effects and safety of vildagliptin on cardiac function after acute myocardial infarction</dc:title><dc:creator>Nishikido T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>13-15</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.433</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019983</affiliation-url><afid>60019983</afid><affilname>Saga University</affilname><name-variant>Saga University</name-variant><affiliation-city>Saga</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114912531</affiliation-url><afid>114912531</afid><affilname>Edogawa Hospital</affilname><name-variant>Edogawa Hospital</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56022203800</author-url><authid>56022203800</authid><authname>Nishikido T.</authname><surname>Nishikido</surname><given-name>Toshiyuki</given-name><initials>T.</initials><afid>60019983</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35514993600</author-url><authid>35514993600</authid><authname>Oyama J.</authname><surname>Oyama</surname><given-name>Jun Ichi</given-name><initials>J.I.</initials><afid>60019983</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644235300</author-url><authid>56644235300</authid><authname>Ohira H.</authname><surname>Ohira</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>114912531</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006002324</author-url><authid>7006002324</authid><authname>Node K.</authname><surname>Node</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60019983</afid></author><authkeywords>Acute coronary syndrome | Cardiac function | Vildagliptin</authkeywords><intid>1535943157</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329960"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329960?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329960&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329960&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006543"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329960</prism:url><dc:identifier>SCOPUS_ID:84929329960</dc:identifier><eid>2-s2.0-84929329960</eid><dc:title>Systematic review of percutaneous coronary intervention and transcatheter aortic valve implantation for concomitant aortic stenosis and coronary artery disease</dc:title><dc:creator>Virk S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>453-455</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.391</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019544</affiliation-url><afid>60019544</afid><affilname>Macquarie University</affilname><name-variant>Macquarie University</name-variant><affiliation-city>North Ryde</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001801</affiliation-url><afid>60001801</afid><affilname>Prince of Wales Hospital</affilname><name-variant>Prince of Wales Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000260</affiliation-url><afid>60000260</afid><affilname>St George Hospital</affilname><name-variant>St George Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001801</affiliation-url><afid>60001801</afid><affilname>Prince of Wales Hospital</affilname><name-variant>Prince of Wales Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028333</affiliation-url><afid>60028333</afid><affilname>University of New South Wales (UNSW) Australia</affilname><name-variant>University of New South Wales</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644431600</author-url><authid>56644431600</authid><authname>Virk S.</authname><surname>Virk</surname><given-name>Sohaib A.</given-name><initials>S.A.</initials><afid>60019544</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643978600</author-url><authid>56643978600</authid><authname>Tian D.</authname><surname>Tian</surname><given-name>David H.</given-name><initials>D.H.</initials><afid>60019544</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56385193300</author-url><authid>56385193300</authid><authname>Liou K.</authname><surname>Liou</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60001801</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56587806400</author-url><authid>56587806400</authid><authname>Pathan F.</authname><surname>Pathan</surname><given-name>Faraz</given-name><initials>F.</initials><afid>60001801</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644245500</author-url><authid>56644245500</authid><authname>Villanueva C.</authname><surname>Villanueva</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60000260</afid><afid>60028333</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644245500</author-url><authid>56644245500</authid><authname>Villanueva C.</authname><surname>Villanueva</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60000260</afid><afid>60028333</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6505451851</author-url><authid>6505451851</authid><authname>Akhunji Z.</authname><surname>Akhunji</surname><given-name>Zakir</given-name><initials>Z.</initials><afid>60001801</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26535393800</author-url><authid>26535393800</authid><authname>Cao C.</authname><surname>Cao</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60019544</afid><afid>60001801</afid><afid>60028333</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26535393800</author-url><authid>26535393800</authid><authname>Cao C.</authname><surname>Cao</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60019544</afid><afid>60001801</afid><afid>60028333</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26535393800</author-url><authid>26535393800</authid><authname>Cao C.</authname><surname>Cao</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60019544</afid><afid>60001801</afid><afid>60028333</afid></author><authkeywords>Aortic stenosis | Coronary artery disease | Percutaneous coronary intervention | Systematic review | TAVI | Transcatheter aortic valve implantation</authkeywords><intid>535947059</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929358999"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929358999?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929358999&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929358999&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008359"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929358999</prism:url><dc:identifier>SCOPUS_ID:84929358999</dc:identifier><eid>2-s2.0-84929358999</eid><dc:title>Heme oxygenase contributes to estradiol and raloxifene-induced vasorelaxation in estrogen deficiency</dc:title><dc:creator>Pósa A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>252-254</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.112</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027332</affiliation-url><afid>60027332</afid><affilname>Szegedi Tudomanyegyetem</affilname><name-variant>University of Szeged</name-variant><affiliation-city>Szeged</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650219700</author-url><authid>56650219700</authid><authname>Pósa A.</authname><surname>Pósa</surname><given-name>Anikó</given-name><initials>A.</initials><afid>60027332</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55884503700</author-url><authid>55884503700</authid><authname>Pávó I.</authname><surname>Pávó</surname><given-name>Imre</given-name><initials>I.</initials><afid>60027332</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15844650400</author-url><authid>15844650400</authid><authname>Varga C.</authname><surname>Varga</surname><given-name>Csaba</given-name><initials>C.</initials><afid>60027332</afid></author><authkeywords>Estrogen | Heme oxygenase | Raloxifene | Selective estrogen receptor modulator</authkeywords><intid>535946143</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928335001"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928335001?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928335001&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928335001&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115001150"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928335001</prism:url><dc:identifier>SCOPUS_ID:84928335001</dc:identifier><eid>2-s2.0-84928335001</eid><dc:title>A new design concept for knitted external vein-graft support mesh</dc:title><dc:creator>Singh C.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>125-133</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.04.001</prism:doi><pii>S1751616115001150</pii><dc:description>© 2015 Elsevier Ltd. Autologous vein-graft failure significantly limits the long-term efficacy of coronary artery bypass procedures. The major cause behind this complication is biomechanical mismatch between the vein and coronary artery. The implanted vein experiences a sudden increase (10-12 fold) in luminal pressures. The resulting vein over-distension or 'ballooning' initiates wall thickening phenomenon and ultimate occlusion. Therefore, a primary goal in improving the longevity of a coronary bypass procedure is to inhibit vein over-distension using mechanical constriction. The idea of using an external vein-graft support mesh has demonstrated sustained benefits and wide acceptance in experimental studies. Nitinol based knitted structures have offered more promising mechanical features than other mesh designs owing to their unique loosely looped construction. However, the conventional plain knit construction still exhibits limitations (radial compliance, deployment ease, flexibility, and bending stresses) which limit this design from proving its real clinical advantage. The new knitted mesh design presented in this study is based on the concept of composite knitting utilising high modulus (nitinol and polyester) and low modulus (polyurethane) material components. The experimental comparison of the new design with a plain knit design demonstrated significant improvement in biomechanical (compliance, flexibility, extensibility, viscoelasticity) and procedural (deployment limit) parameters. The results are indicative of the promising role of new mesh in restoring the lost compliance and pulsatility of vein-graft at high arterial pressures. This way it can assist in controlled vein-graft remodelling and stepwise restoration of vein mechanical homoeostasis. Also, improvement in deployment limit parameter offers more flexibility for a surgeon to use a wide range of vein diameters, which may otherwise be rendered unusable for a plain knit mesh.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018805</affiliation-url><afid>60018805</afid><affilname>Deakin University</affilname><name-variant>Deakin University</name-variant><affiliation-city>Geelong</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104662</affiliation-url><afid>60104662</afid><affilname>Wuhan Textile University</affilname><name-variant>Wuhan Textile University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55265112500</author-url><authid>55265112500</authid><authname>Singh C.</authname><surname>Singh</surname><given-name>Charanpreet</given-name><initials>C.</initials><afid>60018805</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:51664041700</author-url><authid>51664041700</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xungai</given-name><initials>X.</initials><afid>60018805</afid><afid>60104662</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:51664041700</author-url><authid>51664041700</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xungai</given-name><initials>X.</initials><afid>60018805</afid><afid>60104662</afid></author><authkeywords>Compliance | Coronary artery bypass graft | Knitted mesh | Segmented knitting | Vein-graft</authkeywords><intid>35767288</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353446"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353446?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353446&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353446&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005227"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353446</prism:url><dc:identifier>SCOPUS_ID:84929353446</dc:identifier><eid>2-s2.0-84929353446</eid><dc:title>Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I</dc:title><dc:creator>Krintus M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>256-263</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.282</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: To establish and critically evaluate the 99th percentile upper reference limit (URL) for high-sensitivity cardiac troponin I (hs-cTnI) in a large healthy European cohort using different selection criteria. Methods: 1368 presumably healthy individuals from 9 countries were evaluated with surrogate biomarkers for diabetes (glycated hemoglobin [HbA1c] &lt;48 mmol/mol), myocardial (B-type natriuretic peptide [BNP] &lt;35 pg/mL) and renal dysfunction (estimated glomerular filtration rate [eGFR] &gt;60 mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;), and dyslipidemia to refine the healthy cohort. The 99th percentile URLs were independently determined by the non-parametric and robust methods. Results: The use of biomarker selection criteria resulted in a decrease of the 99th percentile URL for hs-cTnI from 23.7 to 14.1 ng/L and from 11.2 to 7.1 ng/L, when using the non-parametric percentile and robust methods, respectively; a further reduction after exclusion of individuals with dyslipidemia was noted. Male gender, BNP, HbA1c and smoking status were independently associated with hs-cTnI concentration in the presumably healthy population, while the impact of age, present in the univariate analysis, decreased after adjustments for gender and surrogate biomarkers. The BNP-based inclusion criterion had the most pronounced effect on the 99th percentile URL, excluding 21% of the study participants and decreasing its value to 11.0 (7.1) ng/L according to the non-parametric (robust) method. Gender, but not age-specific, differences at 99th percentile URL have been identified. Conclusion: The selection of a reference population has a critical impact on the 99th percentile value for hs-cTnI. A uniform protocol for the selection of the healthy reference population is needed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024615</affiliation-url><afid>60024615</afid><affilname>Ludwik Rydygier Collegium Medicum in Bydgoszcz</affilname><name-variant>Nicolaus Copernicus University</name-variant><affiliation-city>Bydgoszcz</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024615</affiliation-url><afid>60024615</afid><affilname>Ludwik Rydygier Collegium Medicum in Bydgoszcz</affilname><name-variant>Nicolaus Copernicus University</name-variant><affiliation-city>Bydgoszcz</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>CHR Mons-Hainaut</affilname><name-variant>Department of Clinical Biology</name-variant><affiliation-city>Mons</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022135</affiliation-url><afid>60022135</afid><affilname>Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin</affilname><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014254</affiliation-url><afid>60014254</afid><affilname>Hopital Tenon</affilname><name-variant>Hôpital Tenon</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072496</affiliation-url><afid>60072496</afid><affilname>Abbott GmbH</affilname><name-variant>Abbott GmbH Diagnostika</name-variant><affiliation-city>Ludwigshafen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001681</affiliation-url><afid>60001681</afid><affilname>Abbott Laboratories</affilname><name-variant>Abbott Laboratories</name-variant><affiliation-city>Abbott Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069103</affiliation-url><afid>60069103</afid><affilname>Stavanger University Hospital</affilname><name-variant>Stavanger University Hospital</name-variant><affiliation-city>Stavanger</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:18037703400</author-url><authid>18037703400</authid><authname>Krintus M.</authname><surname>Krintus</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60024615</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15832254600</author-url><authid>15832254600</authid><authname>Kozinski M.</authname><surname>Kozinski</surname><given-name>Marek</given-name><initials>M.</initials><afid>60024615</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56389423100</author-url><authid>56389423100</authid><authname>Boudry P.</authname><surname>Boudry</surname><given-name>Pascal</given-name><initials>P.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56389293000</author-url><authid>56389293000</authid><authname>Lackner K.</authname><surname>Lackner</surname><given-name>Karl</given-name><initials>K.</initials><afid>60022135</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55208785900</author-url><authid>55208785900</authid><authname>Lefèvre G.</authname><surname>Lefèvre</surname><given-name>Guillaume</given-name><initials>G.</initials><afid>60014254</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507601985</author-url><authid>6507601985</authid><authname>Lennartz L.</authname><surname>Lennartz</surname><given-name>Lieselotte</given-name><initials>L.</initials><afid>60072496</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56389310500</author-url><authid>56389310500</authid><authname>Lotz J.</authname><surname>Lotz</surname><given-name>Johannes</given-name><initials>J.</initials><afid>60022135</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7801635440</author-url><authid>7801635440</authid><authname>Manysiak S.</authname><surname>Manysiak</surname><given-name>Slawomir</given-name><initials>S.</initials><afid>60024615</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7201813197</author-url><authid>7201813197</authid><authname>Shih J.</authname><surname>Shih</surname><given-name>Jessie</given-name><initials>J.</initials><afid>60001681</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6507071996</author-url><authid>6507071996</authid><authname>Skadberg Ø.</authname><surname>Skadberg</surname><given-name>Øyvind</given-name><initials>Ø.</initials><afid>60069103</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56389607500</author-url><authid>56389607500</authid><authname>Chargui A.</authname><surname>Chargui</surname><given-name>Ahmed Taoufik</given-name><initials>A.T.</initials><afid>60014254</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:23977032400</author-url><authid>23977032400</authid><authname>Sypniewska G.</authname><surname>Sypniewska</surname><given-name>Grazyna</given-name><initials>G.</initials><afid>60024615</afid></author><authkeywords>99th percentile url | High-sensitivity troponin | Normality</authkeywords><intid>2035939230</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929304310"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929304310?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929304310&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929304310&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005483"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929304310</prism:url><dc:identifier>SCOPUS_ID:84929304310</dc:identifier><eid>2-s2.0-84929304310</eid><dc:title>Association of aging with glomerular filtration changes in cardiac rehabilitation participants with chronic kidney disease</dc:title><dc:creator>Iso Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>283-285</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.308</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024973</affiliation-url><afid>60024973</afid><affilname>Showa University</affilname><name-variant>Showa University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024973</affiliation-url><afid>60024973</afid><affilname>Showa University</affilname><name-variant>Showa University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023049</affiliation-url><afid>60023049</afid><affilname>Showa University Fujigaoka Hospital</affilname><name-variant>Showa University Fujigaoka Hospital</name-variant><affiliation-city>Yokohama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024973</affiliation-url><afid>60024973</afid><affilname>Showa University</affilname><name-variant>Showa University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028013</affiliation-url><afid>60028013</afid><affilname>Tokyo University of Technology</affilname><name-variant>Tokyo University of Technology</name-variant><affiliation-city>Hachioji</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644351700</author-url><authid>56644351700</authid><authname>Iso Y.</authname><surname>Iso</surname><given-name>Yoshitaka</given-name><initials>Y.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid><afid>60024973</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644351700</author-url><authid>56644351700</authid><authname>Iso Y.</authname><surname>Iso</surname><given-name>Yoshitaka</given-name><initials>Y.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid><afid>60024973</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644351700</author-url><authid>56644351700</authid><authname>Iso Y.</authname><surname>Iso</surname><given-name>Yoshitaka</given-name><initials>Y.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid><afid>60024973</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644351700</author-url><authid>56644351700</authid><authname>Iso Y.</authname><surname>Iso</surname><given-name>Yoshitaka</given-name><initials>Y.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid><afid>60024973</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644550600</author-url><authid>56644550600</authid><authname>Kitai H.</authname><surname>Kitai</surname><given-name>Hitomi</given-name><initials>H.</initials><afid>60024973</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644904300</author-url><authid>56644904300</authid><authname>Kowaita H.</authname><surname>Kowaita</surname><given-name>Hitoshi</given-name><initials>H.</initials><afid>60024973</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644563800</author-url><authid>56644563800</authid><authname>Kyuno E.</authname><surname>Kyuno</surname><given-name>Etsushi</given-name><initials>E.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644563800</author-url><authid>56644563800</authid><authname>Kyuno E.</authname><surname>Kyuno</surname><given-name>Etsushi</given-name><initials>E.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644563800</author-url><authid>56644563800</authid><authname>Kyuno E.</authname><surname>Kyuno</surname><given-name>Etsushi</given-name><initials>E.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36495012200</author-url><authid>36495012200</authid><authname>Maezawa H.</authname><surname>Maezawa</surname><given-name>Hideyuki</given-name><initials>H.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36495012200</author-url><authid>36495012200</authid><authname>Maezawa H.</authname><surname>Maezawa</surname><given-name>Hideyuki</given-name><initials>H.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36495012200</author-url><authid>36495012200</authid><authname>Maezawa H.</authname><surname>Maezawa</surname><given-name>Hideyuki</given-name><initials>H.</initials><afid>60024973</afid><afid>60024973</afid><afid>60023049</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643616800</author-url><authid>56643616800</authid><authname>Hashimoto T.</authname><surname>Hashimoto</surname><given-name>Tohru</given-name><initials>T.</initials><afid>60024973</afid><afid>60024973</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643616800</author-url><authid>56643616800</authid><authname>Hashimoto T.</authname><surname>Hashimoto</surname><given-name>Tohru</given-name><initials>T.</initials><afid>60024973</afid><afid>60024973</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:37122791100</author-url><authid>37122791100</authid><authname>Takahashi T.</authname><surname>Takahashi</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>60024973</afid><afid>60028013</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:37122791100</author-url><authid>37122791100</authid><authname>Takahashi T.</authname><surname>Takahashi</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>60024973</afid><afid>60028013</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602616532</author-url><authid>6602616532</authid><authname>Sanbe T.</authname><surname>Sanbe</surname><given-name>Takeyuki</given-name><initials>T.</initials><afid>60024973</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56411282400</author-url><authid>56411282400</authid><authname>Suzuki H.</authname><surname>Suzuki</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60023049</afid></author><authkeywords>Aging | Cardiac rehabilitation | Chronic kidney disease | Glomerular filtration rate</authkeywords><intid>2035938731</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379604"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379604?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379604&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379604&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008189"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379604</prism:url><dc:identifier>SCOPUS_ID:84929379604</dc:identifier><eid>2-s2.0-84929379604</eid><dc:title>On diet, exercise... and arterial grafting</dc:title><dc:creator>Gaudino M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>232-233</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.095</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007997</affiliation-url><afid>60007997</afid><affilname>Weill Cornell Medical College</affilname><name-variant>Cornell University Medical College</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031984</affiliation-url><afid>60031984</afid><affilname>Universita Cattolica del Sacro Cuore, Rome</affilname><name-variant>Catholic University</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005592319</author-url><authid>7005592319</authid><authname>Gaudino M.</authname><surname>Gaudino</surname><given-name>Mario</given-name><initials>M.</initials><afid>60007997</afid><afid>60031984</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005592319</author-url><authid>7005592319</authid><authname>Gaudino M.</authname><surname>Gaudino</surname><given-name>Mario</given-name><initials>M.</initials><afid>60007997</afid><afid>60031984</afid></author><authkeywords>Arterial grafting | CABG</authkeywords><intid>1535943884</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929484719"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929484719?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929484719&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929484719&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007457"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929484719</prism:url><dc:identifier>SCOPUS_ID:84929484719</dc:identifier><eid>2-s2.0-84929484719</eid><dc:title>QTc interval prolongation and hepatic encephalopathy in patients candidates for liver transplantation: A valid inference?</dc:title><dc:creator>Marafioti V.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>43-44</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.026</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60060733</affiliation-url><afid>60060733</afid><affilname>Ospedale Policlinico</affilname><name-variant>University Hospital</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60060733</affiliation-url><afid>60060733</afid><affilname>Ospedale Policlinico</affilname><name-variant>University Hospital</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012753</affiliation-url><afid>60012753</afid><affilname>Universita degli Studi di Messina, Facolta di Medicina e Chirurgia</affilname><name-variant>Policlinico Universitario</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60060733</affiliation-url><afid>60060733</afid><affilname>Ospedale Policlinico</affilname><name-variant>University Hospital</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603287759</author-url><authid>6603287759</authid><authname>Marafioti V.</authname><surname>Marafioti</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>60060733</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56231199700</author-url><authid>56231199700</authid><authname>Benetti V.</authname><surname>Benetti</surname><given-name>Valentina</given-name><initials>V.</initials><afid>60060733</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507979107</author-url><authid>6507979107</authid><authname>Montin U.</authname><surname>Montin</surname><given-name>Umberto</given-name><initials>U.</initials><afid>60060733</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:18833928200</author-url><authid>18833928200</authid><authname>Carbone V.</authname><surname>Carbone</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>60012753</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56647832800</author-url><authid>56647832800</authid><authname>Petrosino A.</authname><surname>Petrosino</surname><given-name>Alfredo</given-name><initials>A.</initials><afid>60060733</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701560837</author-url><authid>6701560837</authid><authname>Tedeschi U.</authname><surname>Tedeschi</surname><given-name>Umberto</given-name><initials>U.</initials><afid>60060733</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56214868300</author-url><authid>56214868300</authid><authname>Rossi A.</authname><surname>Rossi</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60060733</afid></author><authkeywords>Hepatic encephalopathy | Liver disease | QTc interval</authkeywords><intid>1035959224</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340433"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340433?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340433&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340433&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005987"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340433</prism:url><dc:identifier>SCOPUS_ID:84929340433</dc:identifier><eid>2-s2.0-84929340433</eid><dc:title>Severe recurrent vasovagal syncope and multidisciplinary rehabilitation: A prospective randomized pilot study</dc:title><dc:creator>Siméon E.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>658-659</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.340</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032530</affiliation-url><afid>60032530</afid><affilname>Universite Francois-Rabelais Tours</affilname><name-variant>Université de Tours</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032530</affiliation-url><afid>60032530</afid><affilname>Universite Francois-Rabelais Tours</affilname><name-variant>Université de Tours</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016638</affiliation-url><afid>60016638</afid><affilname>Centre Hospitalier Regional et Universitaire de Tours</affilname><name-variant>CHU</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115241846</affiliation-url><afid>115241846</afid><affilname>Cardiovascular Prevention and Rehabilitation Center Bois Gibert</affilname><name-variant>Cardiovascular Prevention and Rehabilitation Center Bois Gibert</name-variant><affiliation-city/><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016638</affiliation-url><afid>60016638</afid><affilname>Centre Hospitalier Regional et Universitaire de Tours</affilname><name-variant>CHU</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55662075800</author-url><authid>55662075800</authid><authname>Siméon E.</authname><surname>Siméon</surname><given-name>Edouard</given-name><initials>E.</initials><afid>60032530</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36885997600</author-url><authid>36885997600</authid><authname>Bernard A.</authname><surname>Bernard</surname><given-name>Anne</given-name><initials>A.</initials><afid>60032530</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:10243474800</author-url><authid>10243474800</authid><authname>Clémenty N.</authname><surname>Clémenty</surname><given-name>Nicolas</given-name><initials>N.</initials><afid>60032530</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644837000</author-url><authid>56644837000</authid><authname>Herault G.</authname><surname>Herault</surname><given-name>Géraldine</given-name><initials>G.</initials><afid>115241846</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603138203</author-url><authid>6603138203</authid><authname>El-Hage W.</authname><surname>El-Hage</surname><given-name>Wissam</given-name><initials>W.</initials><afid>60032530</afid><afid>60016638</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603138203</author-url><authid>6603138203</authid><authname>El-Hage W.</authname><surname>El-Hage</surname><given-name>Wissam</given-name><initials>W.</initials><afid>60032530</afid><afid>60016638</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701400441</author-url><authid>6701400441</authid><authname>Monpère C.</authname><surname>Monpère</surname><given-name>Catherine</given-name><initials>C.</initials><afid>115241846</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35724121800</author-url><authid>35724121800</authid><authname>Ivanés F.</authname><surname>Ivanés</surname><given-name>Fabrice</given-name><initials>F.</initials><afid>60032530</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55249720400</author-url><authid>55249720400</authid><authname>Angoulvant T.</authname><surname>Angoulvant</surname><given-name>Théodora</given-name><initials>T.</initials><afid>60016638</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005378102</author-url><authid>7005378102</authid><authname>Babuty D.</authname><surname>Babuty</surname><given-name>Dominique</given-name><initials>D.</initials><afid>60032530</afid></author><authkeywords>Post-traumatic stress disorder | Rehabilitation | Tilt test | Vasovagal syncope</authkeywords><intid>1785947102</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84907380058"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84907380058?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84907380058&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84907380058&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012295"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84907380058</prism:url><dc:identifier>SCOPUS_ID:84907380058</dc:identifier><eid>2-s2.0-84907380058</eid><dc:title>Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The coronary artery risk development in young adults study</dc:title><dc:creator>VanWagner L.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>599-605</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.962</prism:doi><pii>S0021915014012295</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Non-alcoholic fatty liver disease (NAFLD) is an obesity-related condition associated with cardiovascular mortality. Yet, whether or not NAFLD is independently related to atherosclerosis is unclear. In a population-based cross-sectional sample of middle-aged adults free from liver or heart disease, we tested the hypothesis that NAFLD is associated with subclinical atherosclerosis (coronary artery (CAC) and abdominal aortic calcification (AAC)) independent of obesity. Methods: Participants from the Coronary Artery Risk Development in Young Adults study with CT quantification of liver fat, CAC and AAC were included (n=2424). NAFLD was defined as liver attenuation ≤40 Hounsfield Units after exclusion of other causes of liver fat. CAC and AAC presence was defined as Agatston score &gt;0. Results: Mean participant age was 50.1±3.6 years, (42.7% men, 50.0% black) and BMI was 30.6±7.2kg/m2. The prevalence of NAFLD, CAC, and AAC was 9.6%, 27.1%, and 51.4%. NAFLD participants had increased prevalence of CAC (37.9% vs. 26.0%, p&lt;0.001) and AAC (65.1% vs. 49.9%, p&lt;0.001). NAFLD remained associated with CAC (OR, 1.33; 95% CI, 1.001-1.82) and AAC (OR, 1.74; 95% CI, 1.29-2.35) after adjustment for demographics and health behaviors. However, these associations were attenuated after additional adjustment for visceral adipose tissue (CAC OR, 1.05; 95% CI, 0.74-1.48, AAC OR=1.20; 95% CI, 0.86-1.67). There was no interaction by race or sex. Conclusion: In contrast to prior research, these findings suggest that obesity attenuates the relationship between NAFLD and subclinical atherosclerosis. Further studies evaluating the role of NAFLD duration on atherosclerotic progression and cardiovascular events are needed.</dc:description><citedby-count>5</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027086</affiliation-url><afid>60027086</afid><affilname>University of Alabama at Birmingham</affilname><name-variant>University of Alabama at Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029833</affiliation-url><afid>60029833</afid><affilname>University of Oklahoma Health Sciences Center</affilname><name-variant>Univ. of Oklahoma Hlth. Sci. Center</name-variant><affiliation-city>Oklahoma City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033114</affiliation-url><afid>60033114</afid><affilname>Wake Forest University</affilname><name-variant>Wake Forest University</name-variant><affiliation-city>Winston Salem</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013223</affiliation-url><afid>60013223</afid><affilname>University of Minnesota School of Public Health</affilname><name-variant>University of Minnesota</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55443034400</author-url><authid>55443034400</authid><authname>VanWagner L.</authname><surname>VanWagner</surname><given-name>Lisa B.</given-name><initials>L.B.</initials><afid>60013227</afid><afid>60013227</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55443034400</author-url><authid>55443034400</authid><authname>VanWagner L.</authname><surname>VanWagner</surname><given-name>Lisa B.</given-name><initials>L.B.</initials><afid>60013227</afid><afid>60013227</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35189429400</author-url><authid>35189429400</authid><authname>Ning H.</authname><surname>Ning</surname><given-name>Hongyan</given-name><initials>H.</initials><afid>60013227</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35372126200</author-url><authid>35372126200</authid><authname>Lewis C.</authname><surname>Lewis</surname><given-name>Cora E.</given-name><initials>C.E.</initials><afid>60027086</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56490663600</author-url><authid>56490663600</authid><authname>Shay C.</authname><surname>Shay</surname><given-name>Christina M.</given-name><initials>C.M.</initials><afid>60029833</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:40361561600</author-url><authid>40361561600</authid><authname>Wilkins J.</authname><surname>Wilkins</surname><given-name>John</given-name><initials>J.</initials><afid>60013227</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35420088500</author-url><authid>35420088500</authid><authname>Carr J.</authname><surname>Carr</surname><given-name>J. Jeffrey</given-name><initials>J.J.</initials><afid>60003915</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103365576</author-url><authid>7103365576</authid><authname>Terry J.</authname><surname>Terry</surname><given-name>James G.</given-name><initials>J.G.</initials><afid>60033114</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004176690</author-url><authid>7004176690</authid><authname>Lloyd-Jones D.</authname><surname>Lloyd-Jones</surname><given-name>Donald M.</given-name><initials>D.M.</initials><afid>60013227</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:24495657500</author-url><authid>24495657500</authid><authname>Jacobs D.</authname><surname>Jacobs</surname><given-name>David R.</given-name><initials>D.R.</initials><afid>60013223</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6604048450</author-url><authid>6604048450</authid><authname>Carnethon M.</authname><surname>Carnethon</surname><given-name>Mercedes R.</given-name><initials>M.R.</initials><afid>60013227</afid></author><authkeywords>Calcium | Cardiovascular diseases | Epidemiology | Imaging | Liver | Obesity | Risk factors</authkeywords><intid>32294688</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929312383"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929312383?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929312383&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929312383&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005422"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929312383</prism:url><dc:identifier>SCOPUS_ID:84929312383</dc:identifier><eid>2-s2.0-84929312383</eid><dc:title>Can treatment with beta blockers trigger episodes of atrial fibrillation in healthy patients?</dc:title><dc:creator>Ramirez-Moreno A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>192</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.302</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101266851</affiliation-url><afid>101266851</afid><affilname>Cardiology Department</affilname><name-variant>Cardiology Department</name-variant><affiliation-city>Tenerife</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602112146</author-url><authid>6602112146</authid><authname>Ramirez-Moreno A.</authname><surname>Ramirez-Moreno</surname><given-name>A.</given-name><initials>A.</initials><afid>101266851</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602602348</author-url><authid>6602602348</authid><authname>Siles-Rubio J.</authname><surname>Siles-Rubio</surname><given-name>J. R.</given-name><initials>J.R.</initials><afid>101266851</afid></author><authkeywords>Atrial fibrillation | Beta blockers | Vagal</authkeywords><intid>535945856</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929304460"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929304460?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929304460&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929304460&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005070"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929304460</prism:url><dc:identifier>SCOPUS_ID:84929304460</dc:identifier><eid>2-s2.0-84929304460</eid><dc:title>Digoxin and risk of acute pancreatitis</dc:title><dc:creator>Shen H.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>120</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.268</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090111</affiliation-url><afid>60090111</afid><affilname>Chi Mei Medical Center</affilname><name-variant>Chi-Mei Medical Center</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36729910800</author-url><authid>36729910800</authid><authname>Shen H.</authname><surname>Shen</surname><given-name>Hsiu Nien</given-name><initials>H.N.</initials><afid>60090111</afid><afid>60014982</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36729910800</author-url><authid>36729910800</authid><authname>Shen H.</authname><surname>Shen</surname><given-name>Hsiu Nien</given-name><initials>H.N.</initials><afid>60090111</afid><afid>60014982</afid></author><authkeywords>Acute pancreatitis | Digoxin</authkeywords><intid>1785945780</intid><source-id>23774</source-id></entry></search-results>
